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Abstract. 
As part of a larger study to identify genes and gene products expressed in vivo by 
Mycobacterium avium subsp. paratuberculosis, two immunogenic clones designated S4 
(1.6 kb) and S8 (3 kb) were extracted from a ?gt1 1 genomic expression library of M.a. 
paratubeculosis by screening with serum from a sheep with clinical Paratuberculosis 
(Johne's disease). The clones were shown by antibody elution and DNA sequencing to 
contain fragments of the same 1.1 kb open reading frame (ORF), which encoded a native 
protein of approximately 34 kDa in M.a. paratuberculosis. The ORF also encoded a 
possible signal peptide from amino acids 1-39, suggesting the native protein is secretory. 
Database searches using the deduced amino acid sequence of the ORF identified a motif 
'GDSGG' which displayed 100 % homology to the residues surrounding the active serine 
in a trypsin-like serine protease. An overall homology of approximately 30 % was 
detected with the HtrA proteins of Escherichia coli, Salmonella typhimurium, Brucella 
abortus, Rochalimea henselae, and Campylobacter jejuni, which are also thought to be 
serine proteases. 
The S8 DNA insert contained the entire 1.1 kb ORF, but due to the presence of the signal 
peptide, the recombinant could not be expressed as a fusion protein. However the insert 
was successfully expressed as a free protein by translational coupling, and was found to 
be secreted into the E. coli periplasm, confirming the presence of a signal sequence. 
When several species of mycobacteria were screened with the 1.1 kb ORF only members 
of the M. aviwn complex (M. avium, M.a. paratuberculosis, M.a. silvaticum, M. 
intracellulare) and M. scrofulaceum were found to contain the gene, although M. 
malmoense and M. marinum reacted weakly and may therefore contain homologous 
genes. The native 34 kDa protein encoded by these clones therefore appears to be a 
novel secretory serine protease specific to the M. aviwn complex of mycobacteria. 
EEL 
However, no proteolytic activity has been demonstrated by either native or recombinant 
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1.1 The Mycobacteriaceae. 
The genus Mycobacterium is a member of the actinomycete group of eubacteria, 
although mycobacteria are often referred to as Nocardioform bacteria due to their 
close relatedness to the other actinomycetes Nocardia, Rhodococcus, and 
Corynebacterium. These organisms share a distinctive and complex cell wall 
configuration which resists staining by the conventional Gram staining method, and 
renders this group of organisms distinct from other bacteria. The high lipid content of 
the mycobacterial cell wall prevents penetration of dyes, and the organism must be 
heated to allow the dye to penetrate. Subsequent destaining is also difficult, and the 
organisms retain the dye even after treatment with acid or alcohol (which would 
decolourise most other bacteria), hence the organisms are classed as acid-fast bacilli, 
and are routinely stained by the Ziehl-Neelsen (ZN) method (Booth & Lowes, 1989). 
1.1.1 The Cell Wall of Mycobacteria. 
Although mycobacteria are classed as acid fast organism:;, they possess a cell wall 
structure rather than a periplasmic space and an inner and outer membrane, and they 
are therefore considered to be Gram-positive organisms. The structure of the 
mycobacterial cell wall is now considered to resemble a lipid bilayer (Minnikin, 1982; 
Nikaido et al., 1993; Brennan & Nikaido, 1995) from electron microscopy studies, 
and the presence of a freeze-fracture plane within the cell wall. Figure 1.1 details the 
appearance of the cell envelope (cell wall and plasma membrane) by electron 
microscopy. The envelope is comprised of the plasma membrane, an electron dense 
inner layer which may contain the peptidoglycan, an electron translucent area (9-10 
nm) approximately twice as wide as that observed within the plasma membrane, and 
an electron dense outer layer of variable thickness. More detailed biochemical 
analysis of the cell wall revealed it to be composed of several unusual lipids and 
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polysaccharides, such as mycolic acids, glycolipids, phenolic glycolipids, 
glycopeptidolipids, and the unique polysaccharide arabinogalactan. The current 
model for the physical organisation of the cell wall is shown in Figure 1.2 (adapted 
from Brennan & Nikaido, 1995). As in Gram-positive organisms, the base of the cell 
wall is peptidoglycan, which in mycobacteria is linked covalently to the galactan core 
of the arabinogalactan polysaccharide. Arabinogalactan is a branched molecule, and 
the terminal arabinan units are linked to mycolic acids, which form the major part of 
the inner leaflet of the cell wall. The structure of mycolic acids favours regular 
parallel packing of the hydrocarbon chains in a direction perpendicular to the plane of 
the cell surface, which is further evidence for the proposed lipid bilayer model for the 
cell wall (Minnikin, 1982; Nikaido et al., 1993). The outer layer of the leaflet is 
thought to be composed of a range of extractable lipids (lipoligosaccharides, 
glycerophospholipids, phenolic glycolipids, and glyceropeptidolipids) which varies 
between species of mycobacteria. The hydrocarbon chains of these lipids assemble 
with those of the mycolic acids to form an asymmetric lipid bilayer of approximately 
twice the thickness of the plasma membrane (Figure 1.2). Unlike the mycolic acids, 
these lipids are not covalently linked to the arabinogalactan and peptidoglycan layer, 
and can be extracted from the cell wall of the organism with solvents. 
The cell wall of mycobacteria has a very low permeability, demonstrated by its 
resistance to Gram staining, and this low permeability is also thought to be responsible 
for the resistance of mycobacteria to a wide range of antibiotics and chemical 
disinfectants. The lipid bilayer model of the cell wall could be responsible for this low 
permeability, as the mycolic acids in the innermost part of the cell wall favour tight 
packing into a near crystalline arrangement (Nikaido et al., 1993), producing a lipid 
environment of very low fluidity, which is a very effective barrier for permeation. 
This arrangement would appear to be detrimental to the bacterium, as the organism 
would also display low permeability to nutrients required for growth. However, porin 
proteins have recently been described in M. chelonae (Trias et al., 1992) and M. 
sniegmatis (Trias & Benz, 1994) which could be responsible for the transport of small 
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minor component of the mycobacterial cell wall, unlike enterobacterial porins, and this 
may also contribute to the observed low hydrophilic permeability of mycobacteria. 
Lipophilic solutes do not utilise the water filled porin channels in order to enter 
bacteria, but instead pass directly through the lipid bilayer due to their hydrophobic 
nature. It has been shown that the most effective antimycobacterial agents 
(rifampicins, tetracyclins, macrolides and fluoroquinolone:;) are lipophilic, and their 
activity increases as more lipophiic derivatives are used (Brennan & Nikaido, 1995). 
This data implies these antibacterial agents utilise the lipid bilayer pathway rather than 
the porin channels, and are therefore more effective. 
Knowledge of the structure and function of the mycobacterial cell envelope is still 
limited, in particular the lipids which are thought to form the outer leaflet of the cell 
wall bilayer. However, recent advances have shed some light on the complex 
structure of the mycobacterial cell wall, and will aid further investigations. 
1.1.2 Mycobacterial Pathogens and Diseases. 
The genus Mycobacterium includes obligate pathogens and opportunistic pathogens, 
as well as non-pathogens commonly found in the environment. The genus is generally 
divided into the classes of slow-growing mycobacteria, which includes most of the 
pathogenic organisms, and fast-growing mycobacteria, which are mainly found in the 
environment. 
The obligate human pathogens are those of the tuberculosis complex (M. 
tuberculosis, M. bovis, M. niicroti and M. africanum) and M. leprae, which are the 
aetiological agents of tuberculosis and leprosy respectively. Obligate animal 
pathogens are M. bovis and M. paratuberculosis (a member of the M. avium 
complex), which cause tuberculosis and paratuberculosis (Johne's disease) in 
ruminants, although M. paratuberculosis has recently been implicated in the human 
enteritis known as Crohn's disease (See section 1.5). Regardless of the host species, 
•1 
these organisms are only recovered from infected tissue, sputum and faeces and milk 
(in the case of paratuberculosis), and not found free in the environment. The diseases 
are transmitted by direct contact with an infected host (or contaminated faeces in the 
case of paratuberculosis), and are usually highly contagious. However, other 
mycobacteria which are responsible for human and animal diseases have demonstrated 
little contagiousness, and are found as viable cells in the environment. These 
organisms are therefore considered to be opportunistic pathogens, and are often 
referred to as 'potentially pathogenic environmental mycobacteria' (PPEM; Wayne & 
Sramek, 1992). This group of PPEM includes members of the M. avium complex 
(MAC), M. kansasii, M. niarinuni, M. scrofulaceum, M. sirniae, M. szulgai, M. 
ulcerans, M. xenopi, M. fortuituni, M. chelonae, M. asiaticuni, and M. malmoense 
(Wayne & Sramek, 1992). Most of these organisms cause a tuberculous pulmonary 
disease, with the exceptions of M. niarinuni, which infects fish and causes skin lesions 
('swimming pool granuloma') in humans, and M. ulcerans, which produces necrotic 
skin lesions in humans. M. chelonae and M. fortuitum are now known also to cause 
skin lesions and post-operative wound infections. However, as all mycobacterial 
diseases are tackled primarily by the cell mediated immune response, these diseases 
have the potential to become disseminated in individuals who are 
immunocompromised. Due to the recent developments in anti-rejection therapy for 
transplant patients, and the increasing incidence of HIV infection and AIDS, the 
number of immunocompromised individuals is escalating, and this has resulted in an 
increase in the incidence of disseminated mycobacterial infections. 
Although most PPEM have been implicated at some time in disseminated infections in 
AIDS patients (Wayne & Sramek, 1992), approximately 90% of infections were 
caused by either M. tuberculosis or M. aviuni. AIDS associated tuberculosis may be 
due to reactivation rather than a primary infection, however, M. aviuni infections do 
appear to be opportunistic, and are more severe in AIDS patients than in other 
immunocomproniised individuals (Peters et al., 1989). The members of the MAC are 
a major cause of disseminated infections in AIDS patients, and appear to be acquired 
by environmental exposure. The prevalence of these diseases emphasises the need for 
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further study of the organisms which form the MAC, namely M. avium, M. 
intracellulare, M. paratuberculosis, M. lepraernurium and the wood pigeon bacillus. 
The importance of these organisms and their close relatedness to each other is 
discussed in the following section. 
1.2 The M. avium Complex (MAC). 
1.2.1 Members of the MAC. 
The M. aviuni complex (MAC) is a group of closely related mycobacteria, comprised 
of M. aviuni, M. intracellulare, M. paratuberculosis, M. lepraemurium, and the 
wood pigeon bacillus. M. aviuni and M. intracellulare were the two species of slow 
growing mycobacteria originally classified as MAC, as the biochemical and 
morphological characteristics of these organisms were identical, making 
differentiation between the species very difficult (Wayne & Sramek, 1992). The 
MAC includes also M. paratuberculosis, M. lepraemurium and the wood pigeon 
bacillus due to the high levels of genetic relatedness observed with M. avium 
(discussed more fully later in this chapter). The classification of these organisms has 
been further confused by the inclusion of M. scrofulaceuin (Tsukamura, 1976), and 
the group is also often referred to in the literature as the MAIS complex (M. 
aviuni/intracellulareiscrofu/aceuni). Bergey 'S Manual of Systematic Bacteriology 
(Vol 2, 1986) refers to the MATS complex classification as a misinterpretation of the 
original proposal, in which some strains of mycobacteria showing biochemical 
properties inconsistent with M. aviuni, M. intracellulare and M. scrofulaceuni, but 
which appeared to belong to one of the three species due to other properties, were 
classified as M. aviuni/intracellulare/scrofulaceu,n (MATS) intermediates until their 
true taxonomic placing could be defined (Hawkins, 1977). Reference to the MATS 
complex of mycobacteria is therefore incorrect, as M. scrofulaceum is a species 
distinct from M. aviunz and M. intracellulare both biochemically and genetically 
(described later in this chapter). 
rel 
M. aviuni and M. intracellulare can be classified by agglutination serotypes using 
antisera directed against the serotype- specific peptidoglycolipids in the cell wall. 
Several independent studies have suggested various groupings of these two organisms 
by serotype (discussed in McFadden et al., 1987a; Inderlied et al., 1993). However, 
current opinion classes serovars 1, 2, 3, 4, 5, 6, 8, 9, 10 and 11 as M. avium, and 
serovars 7, 12, 13, 14, 15, 16, 17, 19, 20 and 25 as M. intracellulare. Other serovars 
are present in the MAC (18, 21, 22, 23, 24) which do not completely tie in with either 
species (Wayne & Sramek, 1992). 
The inclusion of M. paratuberculosis and the wood pigeon bacillus in the MAC has 
caused further confusion with the taxonomy of the group. M. paratuberculosis was 
first classified as belonging to the MAC, and was easily differentiated from M. avium 
by growth characteristics and pathogenicity. M. paratuberculosis was always 
mycobactin dependent in culture, and required 8 - 12 weeks to grow on primary 
isolation, whereas M. aviuni did not require mycobactiri in culture, and grew in 
approximately 4 weeks. M. paratuberculosis was an obligate pathogen and only 
recovered from ruminants with Johne's disease, however M. avium could be 
recovered from many sources in the environment, caused opportunistic infections in 
birds and other animals, but was not capable of producing Johne's disease. These 
criteria were initially successful in differentiating the two species; however the 
discovery of the wood pigeon bacillus (Matthews & McI)airmid, 1979) which was 
mycobactin dependent on primary isolation, and caused both a paratuberculosis-like 
disease in ruminants and tuberculosis in birds, caused problems with this classification. 
Due to these similarities and DNA relatedness (see later) these organisms were 
difficult to correctly identify by culture and pathogenicity, and it was unclear whether 
they were distinct species, or members of a subspecies within M. avium. 
1.2.2 Molecular Characterisation of the MAC. 
During the mid 1980s several new techniques in the field of molecular biology were 
applied to the taxonomy of the tuberculosis complex of niycobacteria (Collins & de 
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Lisle, 1984; Imaeda, 1985; van Embden et a!, 1993). These techniques were used 
also in an attempt to establish the taxonomy of the MAC. 
DNA-DNA Hybridisation. 
DNA-DNA hybridisation studies were performed on members of the MAC, and 
showed M. aviuni, M. paratuberculosis, the wood pigeon bacillus and some strains of 
M. intracellulare to be 70 - 100 % homologous at the genomic level (Hurley et al., 
1988). A higher degree of homology (approximately 90 - 100 %) was detected 
between M. paratuberculosis, the wood pigeon bacillus and some strains of M. avium 
(McFadden et a!, 1987c; Hurley et al., 1988; Yoshimura & Graham, 1988; Saxegaard 
& Baess, 1988), but very little homology was detected between M. scrofulaceum and 
members of the MAC, despite some similar biochemical properties. Hybridisation 
studies detected only 10 - 30 % homology with members of the MAC (Baess, 1983; 
Hurley et al., 1988), and due to this lack of genetic relatedness, most researchers 
consider M. scrofulaceum to be a discrete species (Baess, 1983; Hurley et al., 1988) 
which should not be grouped within the MAC. 
Although the results of DNA-DNA hybridisation studies confirmed the close genetic 
relationship between the members of the MAC, it did not dictate that they were 
members of the same species. DNA homology of >70 % can represent members of 
the same species, but organisms which contain this level of homology yet display 
important phenotypic differences should not be classified by DNA homology alone 
(Chiodini, 1990). The members of the tuberculosis complex (M. tuberculosis, M. 
bovis, M. nzicroti and M. africanum) display over 70 % DNA homology, but are 
designated separate species (Imaeda, 1985). The enteric organisms E. coli and 
Shigella dysentriae are over 90 % related at the DNA level, but warrant and maintain 
their species specificity due to their phenotype and pathogenesis (Hard & Dykhuizen, 
1984). In the eukaryotic kingdom, base substitutions of 1 - 2 % are found also in 
closely related species, as humans and chimpanzees show over 98 % DNA homology 
(King & Wilson, 1975). All of this evidence indicates that DNA homology and base 
substitution are not good indicators on which to base species designation alone in 
either eukaryotes or prokaryotes. The phenotypic expression of an organism must 
always be considered in conjunction with any DNA homology. Phenotypic 
differences may be due only to different regulatory mechanisms, however these may 
be sufficient to completely alter the pathogenic strategy or specificity of an organism. 
With respect to the MAC, the observed differences in growth characteristics and 
pathogenesis suggested that these organisms should not be classed as members of the 
same species. 
Restriction Endonuclease Analysis and RFLP (Restriction Fragment Length 
Polymorphism) Analysis of the MAC. 
Restriction endonuclease analysis of DNA extracted from members of the MAC was 
more successful in determining species and strain differentiation than DNA-DNA 
hybridisation. High molecular weight DNA was extracted from each of the MAC and 
digested with various restriction endonucleases. The fragments resulting from the 
digest were separated on an agarose gel to reveal the banding pattern. 
Polymorphisms in restriction sites resulted in the production of different banding 
patterns, and this technique successfully differentiated between strains of M. avium 
and M. intracellulare in agreement with the current serotype data (Whipple et al., 
1987). All of the M. paratuberculosis isolates examined (with the exception of strain 
18) produced identical banding patterns (Collins & de Lisle, 1986; Whipple et al., 
1987) which were distinct from those obtained from M. aviun2 and M. intracellulare 
isolates. The restriction pattern produced by M. parazuberculosis strain 18 was 
found to be similar to that of M. aviuni serotype 2 and the wood pigeon bacillus, 
suggesting that strain 18 was not a typical isolate of M. paratuberculosis (discussed 
later, section 1.2.2). 
Due to the large number of fragments produced in restriction digests, and the close 
proximity of the bands on agarose gels, banding patterns are often difficult to interpret 
and important differences between isolates can be missed. Hybridisation patterns can 
be more easily distinguished than restriction patterns, hence the use of DNA probes to 
identify restriction fragment length polymorphisms (RFLPs) on Southern blots of 
digested high molecular weight DNA was adopted. 
McFadden (1987a&b) produced RFLPs with randomly selected M.a. 
pararuberculosis DNA probes in an attempt to differentiate more clearly between M. 
avium and M. paratuberculosis. The majority of the probes produced identical 
hybridisation patterns with DNA from both organisms, however one probe (jMB22) 
produced a definite RFLP between the two organisms. As with the restriction 
endonuclease analysis, all isolates of M. paratuberculosis (except strain 18) produced 
identical patterns, although the different serotypes of M. avium were more 
heterogeneous. However, the RFLP produced by M. paratuberculosis strain 18 with 
probe pMB22 was again found to be identical to that of M. aviuni serotype 2. 
Differentiation by RFLP depends heavily on the restriction endonuclease used to 
digest the high molecular weight DNA, and the probe used for hybridisation. 
McFadden initially used a series of random probes prepared from M.a. 
paratuberculosis DNA, one of which (pMB22) was later demonstrated to contain 
1S900 (McFadden et al., 1987a&b). Subsequent studies have used defined probes, 
such as the 5S ribosomal RNA (rRNA) gene (Chiodini, 1990). As slow growing 
mycobacteria contain only one copy of the 5S rRNA gene, this probe produces an 
RFLP with only one fragment, unless the polymorphism is present within the gene, 
which occurred only rarely with M. aviuni (Chiodini, 1)90). Due to the limited 
banding pattern, choice of restriction endonuclease was important in determining the 
level of specificity obtained by this method. No difference in the hybridisation pattern 
was observed on digestion of the DNA with BglJI, EcoRl, EcoRil, HincII and PstI, 
although EcoRTI, HincII and PstI digests produced a MAC specific RFLP. Only 
digestion with AvaI, BaniHI and HindIII produced an RFLP which would 
differentiate between M. avium and M. paratuberculosis on hybridising the 5S rRNA 
probe. 
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RFLP analysis therefore was shown to be capable of identifying each member of the 
MAC, and was able to differentiate between serotypes of M. avium and M. 
intracellulare. However, with the probes so far discussed, this technique could not 
show any strain variation between isolates of M. paratuberculosis. 
The discovery of the M. pararuberculosis specific insertion element IS 900 (Green et 
al., 1989; see section 1.3) provided a far more specific probe for analysis of strain 
variation between M. paratuberculosis isolates. When the species-specific segment at 
the 5' end of 1S900 was used as a probe, it did not hybridise to the DNA of any other 
mycobacteria including M. intracellulare, M. avium and the wood pigeon bacillus, 
and its presence confirmed the identification of M. paratuberculosis. IS 900 was used 
successfully as a probe by many researchers (Collins et al., 1990; Whipple et al., 
1990; de Lisle et al., 1993; Thoresen & Olasker, 1994) to examine strain variation 
between isolates of M. paratuberculosis. 1S900 was found to be present as 15 - 20 
copies in the genome of M. paratuberculosis and therefore produced a detailed 
banding pattern on RFLP analysis. Hybridisation with this specific probe identified 
three major groups of hybridisation patterns within the species. One contained bovine 
isolates, caprine isolates and some cervine isolates, the second group contained ovine 
isolates from New Zealand and the Faroe Islands, and the third group contained ovine 
isolates from South Africa, Iceland and Canada (Collins et al., 1990; de Lisle et al., 
1992, 1993). This observation initially indicated that the organism may exist as host-
specific Strains (Collins et al., 1990; Thoresen & Olasker, 1994); however some ovine 
Strains were show to be capable of causing disease in calves, indicating that this 
association between hybridisation pattern and host species was not absolute. 
Ribosomal RNA (rRNA) Sequences. 
Recent advances in mycobacterial taxonomy have focused on the sequence of the 
ribosomal RNA operon (rrn) which contains the genes for 16S, 23S and 5S rRNA 
separated by spacer-1 and spacer-2 regions respectively (Bercovier et al., 1986). 
Although high levels of rRNA gene homology were found within the genus (>94.3 
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%), specific variable regions were present within the operon which could be used to 
identify various species of mycobacteria. 
The majority of research has concentrated on identifying the variable regions present 
in the 16S rRNA gene (Rogall et al., 1990a&b; Kirschner et al., 1993). Although all 
members of the tuberculosis complex (M. tuberculosis, M. bovis, M microti and M. 
africanurn) were found to possess identical 16S rRNA sequences, differences were 
detected in the variable regions for most other species of mycobacteria. The members 
of the MAC were found to form a discrete cluster, however variations were present in 
the sequence which allowed M. aviuni and M. intrace!!u!are to be distinguished. This 
observation formed the basis of a commercially available diagnostic test, which could 
be used to identify the tuberculosis complex, MAC, M. kansasii and M. gordonae 
(Reisner et al., 1994). The Gen-Probe system (Gen-Probe Inc., San Diego, Calif., 
USA) allowed the rapid identification of these mycobacteria using radiolabelled 
probes directed against their specific 16S rRNA sequences. The test for MAC 
included probes specific for M. aviuni and M. intracellu!are sequences, and this 
system has been used successfully to type strains of M. aviuni and M. intracellulare in 
agreement with the current serotyping data (Saito et al., 1990; Thoresen & 
Saxegaard, 1993). 
Unfortunately, the Gen-Probe MAC test could not differentiate between M. avium 
and M. paratuberculosis (Thoresen & Saxegaard, 1991), as the 16S rRNA genes of 
these two organisms were 99.9 % similar (Rogall et al., 1.990a&b; Kirschner ci' al., 
1993). A single base pair substitution was present in the variable region, but this was 
not identified by the MAC Gen-Probe, and therefore only could be verified by direct 
sequencing of the gene (Rogall et al., 1990a). Amplification of the 16S rRNA gene 
by PCR, and hybridisation with a 'specific' probe has been used to detect M. 
paratuberculosis from cattle with suspected Johne's disease (van der Giessen et al., 
1992). However the probe used to hybridise with the PCR product recognised also 
M. aviuni DNA, and M. gordonae DNA, reducing the specificity of this assay. PCR 
directed at the species-specific 5' segment of IS 900 has been used more successfully in 
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the detection of cattle excreting M. paratuberculosis (Vary et al., 1990; see section 
1.4). 
The 23S rRNA genes and spacer-1 regions also have been sequenced recently in some 
species of mycobacteria, and appeared to be more variable than the 16S rRNA gene, 
even between closely related species (Frothingham & Wilson, 1993; van der Giessen 
et al., 1994). Typing of M. avium and M. intracellulare strains by this method was 
comparable with the results obtained by 16S rRNA comparison and Gen-Probe 
hybridisation (Frothingham & Wilson, 1993); however between M. avium and M. 
pararuberculosis only 9 bp mismatches were detected in the entire 23S gene (3.1 kb). 
The high variability observed between other mycobacteria in the spacer-1 region was 
also absent between M. aviuni and M. paratuberculosis. 
Hence M. aviu.m and M. paratuberculosis were found to contain almost identical 16S, 
23S and spacer sequences; rRNA analysis therefore cannot be used to differentiate 
between the two organisms. None of the recent studies of rRNA sequences within 
the MAC included the wood pigeon bacillus in the panel of mycobacteria (Rogall et 
al., 1990a&b; Thoresen & Saxegaard, 1991 & 1993; van der Giessen et al., 1992 & 
1994; Frothingham & Wilson, 1993; Kirschner ci' al., 1993: Reisner et al., 1994), and 
this omission leaves a gap in the rRNA sequence analysis of the MAC. However, 
from DNA - DNA hybridisation data (McFadden et al., 1987c; Hurley et al., 1988; 
Yoshimura & Graham, 1988; Saxegaard & Baess, 1988) and restriction endonuclease 
analysis (Collins & de Lisle, 1986; Whipple ci' al., 1987) it is highly probable that the 
wood pigeon bacillus would also possess rRNA genes identical to those of M. avium 
and M. paratuberculosis. 
Pulsed-Field Gel Electrophoresis (PFGE). 
The banding patterns obtained by restriction endonuclease analysis of high molecular 
weight DNA are often difficult to interpret due to the presence of a large number of 
closely spaced bands. Patterns can be simplified by hybridising labelled DNA probes 
to the restriction profiles, however, restriction patterns can also be analysed by PFGE, 
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which allows the separation of large DNA fragments to produce patterns composed of 
a few bands, after digestion of high molecular weight DNA with restriction 
endonucleases which cut rarely in G-C rich mycobacterial DNA. When isolates of M. 
avium-M. intracellulare, M. paratuberculosis and the wood pigeon bacillus were 
analysed by field inversion gel electrophoresis (a prototype PFGE system) the results 
obtained were in agreement with restriction endonuclease data, as all M. 
paratuberculosis isolates produced identical restriction patterns Levy-Frebault et al., 
1989). Isolates of the wood pigeon bacillus also produced identical banding patterns, 
which were distinct from both M. paratuberculosis and the M. aviurn-intracellulare 
group. Further analysis of the MAC by PFGE (Coffin et al., 1992) divided the strains 
analysed into four groups on the basis of the restriction profiles. Group 1 contained 
three isolates of M. paratuberculosis plus an M. paratuberculosis type strain; group 2 
contained the M. aviurn serotype 2 type strain, one M. paratuberculosis isolate and 
M. paratuberculosis strain 18; group 3 contained the M. intracellulare type strain 
(serotype 16); and group 4 contained M. aviuni serotype 8 (incorrectly referred to as 
M. intracellulare serotype 8) and one M. paratuberculosis isolate. The authors 
suggested that this method of typing by PFGE could be used to show strain variation 
within M intracellulare, M. aviuni and M. paratuberculosis which could be applied to 
the taxonomy of the group. However, during this study, no isolates of the wood 
pigeon bacillus were analysed for inclusion in the groupings (indeed, reference was 
incorrectly made to the wood pigeon bacillus as W. paratuberculosis isolates from 
wood pigeons"), and none of the seven M. paratuberculosis isolates analysed were 
verified as being M. paratuberculosis by hybridisation with 1S900. Classification was 
based purely on the requirement for mycobactin in culture, which due to the 
identification of mycobactin-dependent strains of M. aviuni (Matthews & McDairmid, 
1979), is not absolute. As several of the cultures examined were primary isolates, it 
was possible that these were isolates of mycobactin-dependent M. aviuni or the wood 
pigeon bacillus, and the groupings listed above therefore may have been grossly 
inaccurate. 
14 
This study was by no means unique in its initial failure to confirm the identity of the 
mycobacterial strains used for genetic analysis. A large volume of data has been 
produced on the genetic relatedness of the members of the MAC, especially on the 
identification and differentiation of M. avium, M. paratuberculosis, and the wood 
pigeon bacillus. However, with the exception of the studies performed on the RFLP 
of 1S900 (Thoresen & Olasker, 1994; de Lisle et al., 1995, Roiz et al., 1995) no 
attempt has been made by most researchers to verify the identity of the strains used in 
their analysis. It is now generally accepted that IS 900 is only present in the genome 
of M. paratuberculosis (Green et al., 1989; Moss et al., 1991), and screening of 
strains, especially when obtained from other laboratories as type strains, should be 
routinely performed to verify the identity of the organism in use. Neither mycobactin 
dependence nor the presence of IS 900 should be used as the sole criteria for 
identifying M. paratuberculosis, as isolates of M. avium exist which are mycobactin 
dependent on primary culture (Matthews & McDairniid, 1979). Mycobactin-
dependent cultures can become mis-identified, and further confuse the taxonomy of 
the MAC if they are included in genetic studies. Therefore a combination of cultural 
characteristics (including mycobactin-dependence and incubation period) and the 
presence of insertion sequences should be used in classifying these bacteria. This type 
of mis-identification has already occurred with M. paratuberculosis strain 18, which 
has been used routinely in laboratories world-wide for the production of antigens, 
mycobactin and vaccines. Analysis of this strain by restriction endonuclease analysis 
(Whipple et al., 1987), RFLP (McFadden et al., 1987a), hybridisation with 1S900 
(Coffins & de Lisle, 1986; Whipple et al., 1990) and PFGE (Levy-Frebault et al., 
1989; Coffin et al., 1992) have shown it to be identical to M. aviurn serotype type 2. 
The strain was also reported to have lost its mycobactin dependence, and grew in 
culture in less than 5 weeks, which also is more characteristic of the mycobactin 
dependent M. aviuni strains than M. paratuberculosis. Strain 18 has been shown to 
possess the insertion element IS901 (Kunze et al., 1991 & 1992; see section 1.3), 
which although related to 1S900, is not found in M. paratuberculosis isolates and 
appears to be restricted to some strains of M. aviuni (Ahrens et al., 1995). The 
current evidence therefore implies that strain 18 is M. aviuni serotype 2, and may have 
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been a laboratory contaminant which overgrew the original M. paratuberculosis strain 
18 and was mistakenly selected and passaged as M. paratuberculosis over the last 50 
years. It could have been also a mycobactin-dependent strain of M. avium, which was 
incorrectly identified as M. paratuberculosis, and subsequently designated a 
laboratory adapted strain, due to its reduced incubation period in culture. However 
regardless of its origins, this strain should no longer be used in studies of M. 
paratuberculosis (Chiodini, 1993), and data based on strain 18 should be carefully 
reviewed in order to determine the true characteristics of M. paratuberculosis. 
The routine use of PCR to screen all strains of M. paratul'erculosis for the insertion 
sequences 1S900 and 1S901 (section 1.3) before any subsequent genetic analysis is 
performed could prevent any further mis-identification of isolates, and ensure that 
work is being performed with pure cultures of the correct organism 
1.2.3 Taxonomy of the MAC. 
It is apparent from the literature discussed in this chapter that the true taxonomy of 
the MAC has been difficult to establish, due to the similarities of the members both 
culturally and biochemically with M. aviun2 and M. intracellulare, and genetically 
with M. aviuni, M. paratuberculosis, and the wood pigeon bacillus. Data from DNA 
- DNA hybridisation, RFLP and rRNA sequences have established that M. avium and 
M. intracellulare are separate species which can be distinguished using the Gen-Probe 
MAC system. M. aviuni, M. paratuberculosis and the wood pigeon bacillus are 
indistinguishable by Gen-Probe, and all appear to belong to the same species by DNA 
- DNA hybridisation and rRNA sequence comparison. However, differences were 
observed between these organisms by RFLP, especially when 1S900 was used as a 
probe, and phenotypic differences in culture and pathogenesis are well documented. 
There are currently two main opinions on the taxonomy of the MAC, one employing 
numerical taxonomy ('Fhorel et al., 1990), the other involving RFLP type and the 
insertion sequences 1S900 and 1S901 (Kunze et al., 1992). Thorel's numerical 
taxonomy examined only the cultural and biochemical tests which varied between 
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isolates of the MAC (listed in detail in Thorel et al., 1990). After being subjected to 
these tests, the strains examined fell into four distinct clusters. Cluster 1 
corresponded to M. paratuberculosis; cluster 2 contained M. avium strains plus the 
M. intracellulare type strain; cluster 3 contained the wood pigeon mycobacteria; and 
cluster 4 contained one isolate of M. paratuberculosis (316F) which had been 
passaged in the laboratory for 40 years and used as a vaccine strain. This separation, 
although based on cultural and biochemical tests, correlated well with the patterns 
obtained with RFLP, PFGE, and the differences in pathogenesis for birds and cattle. 
M. intraceilulare was seen to cluster with M. avium, however this was not surprising, 
as these species cannot be differentiated biochemically and require hybridisation with 
specific probes to determine species specificity. The results of the numerical 
taxonomy, combined with genotypic and phenotypic studies led Thorel to propose the 
following change in nomenclature and taxonomy. M. aviuni, M. paratuberculosis, 
and the wood pigeon bacillus appeared to belong to a single genomic species, but 
were phenotypically distinct as to warrant subspecies status. The organisms were 
therefore re-classified as M. aviuni subsp. aviun? (M.a. aviuni), M. aviurn subsp. 
paratu.bercuiosis (M.a. paratuberculosis) and M. aviuni subsp. silvaticum (M.a. 
silvaticurn; wood pigeon bacillus). 
The second taxonomic classification of the MAC was based on RFLP type and the 
presence of the insertion sequences 1S900 (Green et al., 1989; section 1.3) and 1S901 
(Kunze et al., 1991; section 1.3). 1S900 was known to be specific for M. 
paratuberculosis, and its presence in genomic DNA confirmed the identification of an 
organism as M. paratuberculosis. M. aviuni isolates were divided into two distinct 
groups based on the possession of 1S901. M. avium RFLP type A contained no 
insertion sequence, and was rarely found to be associated with animal disease, and 
was thought to be an environmental mycobacterium. However, this organism was 
frequently the cause of human disease, especially disseminated infections associated 
with AIDS. M. avium RFLP type A/I was 1S901 positive, and was the major cause of 
disease in both animals and birds, and was capable of causing both tuberculosis and 
Johne's disease (Table 1.1). This classification differs from that of Thorel as M. 
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paratuberculosis 316F (Thorel's cluster 4) was found to be a typical M. 
paratuberculosis in the possession of IS 900. All M.a. silvaticuni strains were found 
to be 1S901 positive, however, M.a. silvaticurn did not correspond to M. avium RFLP 
type A/I as several strains in Thorel's cluster 2 (M.a. aviurn) including the strain 
previously known as M. paratuberculosis strain 18, were also found to be M. avium 
RFLP type A/I. 
Hence, although the two classifications agree on some points (summarised in Table 
1. 1), there is still a great deal of confusion associated with the taxonomy of the MAC. 
For the purpose of this thesis, the taxonomy of Thorel has been adopted, and the 
organisms will henceforth be referred to as M.a. aviurn, M.a. silvaticum and M.a. 
paratuberculosis 
M.a. aviuin 	M.a. 	M.a. silvaticuin 	M. aviunz type 
Marker 	/M.aviu,n type A paratuberculosis 	 A/I 
1S900 	 - 	 + 	 - 	 - 
1S901 	 - 	 - 	 + 	 + 
Mycobactin- 	- 	 + 
dependance 
Table 1.1 Summary of the distribution of the markers 1S900 and 1S901, and 
mycobactin dependance in Thorel's M.a. aviuni, M.a. paratuberculosis, and M.a. 
silvaticuni, and in McFadden's M. paratuberculosis, M. aviunz type A and M. avium 
type A/I. 
W. 
1.3 Known Genes and proteins of M.a. avium, M.a. silvaticum, and 
M.a. paratuberculosjs. 
Early work on the identification of mycobacterial genes and gene products 
concentrated on the prominent human pathogens M. tuberculosis and M. leprae, and 
specific genes and gene products were not identified in the MAC until the late 1980s. 
The genes and proteins which have so far been characterised in M.a. avium, M.a. 
silvaticum and M.a. paratuberculosis are listed in Tables 1.1. and 1.2. Many of these 
genes and proteins have been described in other mycobacteria, especially the stress 
proteins of the HSP70 and HSP65 families, which are common to all mycobacteria 
and highly conserved in all living organisms. The most significant discoveries within 
the MAC were of the insertion sequences IS 900 in M.a. paratuberculosis (Green et 
al., 1989) and 1S9011902 t Kunze et al.,1991; Moss et al., 1992a) in M.a. silvaticum 
(or M. avium type A/I; see section 1.2.3). The insertion sequences 1S900 and 1S901 
were 60% similar and belonged to the same family of insertion sequences, which 
included also the Strepton2yces insertion element IS 116 (Leskiw et al., 1990). 
Insertion into the mycobacterial DNA was found to be at the specific sites CATGN(4-
6)*CNCCTI' for 1S900 in M.a. paratuberculosis and CATN(7)*T7CCN .JTC for 
1S901 in M.a. silvaticurn/M. aviurn type A/I (the asterisk denotes the site of 
insertion), and the insertion sequences were found to be integrated into the genome of 
each specific organism. 
Although the DNA sequences of 1S900 and 1S901 are 60% similar, primers were 
designed which allowed the amplification of specific fragments of each insertion 
sequence by PCR (Vary et al., 1990; Kunze et al., 1991). By performing PCR with 
both sets of primers an unknown mycobactin-dependent organism could be identified 
as M.a. paratuberculosis (1S900 positive) or M.a. silvaticurn/M. aviuni type A/I 
(IS901 positive). Kunze (1991) also detected what was classified as M. avium type A 
by PCR using primers flanking the insertion site for 1S901. The amplification of a 
300 bp fragment from an IS 900 negative organism indicated an empty IS 901 insertion 
* 1S901 and 1S902 are the same insertion element, discovered indepeniently by two separate groups. 
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site, corresponding to M. aviun7 type A. These PCR reactions therefore could be 
used routinely in the laboratory to screen harvested organisms to ensure that pure 
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segregates with 1S901 
Membrane protein 
similar to M. leprae 
U15651 
Induces a weak DHT 
response in sensitised 
guinea pigs 
Secretory alpha antigen 
Avi-3 antigen, specific 
for M. aviwn 




catalase HP II 
Similar to IS 1245 - 
Transposase 
Insertion element specific Kunze et al., 1991 
to M. avium type A/I Moss et al., 1992a 
aspartokinase Cirillo et al., 1994 
aspartate semialdehyde Cirillo et al., 1994 
dehydrogenase 
alkyl hydroperoxidase 
Plum & Clark-Curtiss, 
1994 
Ohara et al., 1993 
Yamaguchi et al., 1992 
Rouse etal., 1991 
Kapur et al., 1993 
Burrells et al., 1994 
Ahrens et al., 1995 
Winter et al., 1995 
Hickey, 1994 
unpublished 
Takewaki et al., 1994 
Cambau et al., 1994 
Milano, 1995 
unpublished 
Guerrero et al., 1994 
Honore & Cole, 1994 
Escuyer, 1994 
unpublished 
Belisle et al., 1991 
Mills et al., 1994 
Little et al., 1994 
Rao et al., 1994 
Prinzis et al., 1994 
Table 1.2 	Genes and Proteins of M.a. avium and M.a. silvaticum. 
Gene 	Protein Accession Comments/Function 	Reference 
Size 	number 
(kDa) 
IS 1110 	 Z28969 	Insertion element Hernandez-Perez et al., 
1994 
IS 1245 	 L33879 	Insertion element. Guerrero etal., 1995 
Specific for M. avium. 
Similar to 1S1081 (M. 
bovis) 























Table 1.2 (continued) 
Gene 	Protein Accession Comments/Function 	Reference 
Size 	number 
(kDa) 
26 Induces a DHT response Rouse et al., 1991 
in sensitised guinea pig; 
20 X76906 Bacterioferritin Inglis et al., 1994 
19 L12235 Function unknown Booth etal., 1993 
18 L12236 Function unknown Booth et al., 1993 
M59264 16S rRNA gene Rogall et a!, 1990a 
X74494 23S rRNA gene van der Giessen et al., 
1994 
L04543 Specific for MAC Thierry et al., 1993a&b 
serovars 2,3,7,12 to 20, 
23, 25 
L4542 Specific for MAC Thierry et al., 1993a&b 






Genes and proteins of M.a. paratuberculocis. 




1S900 43 X16293 Insertion element specific Green et al., 1989 
for Tizard et al., 1992 
M.a. paratubercu!osis. 
1S900 X69575 Putative transposase. Murray et al., 1992 
(ORF2) 
htrA 34 Z23092 Senne protease (subject Cameron et al., 1994 
of this project) 
dnaf Stress protein Takewaki et al., 1994 
F57 clone X70277 Function unknown. Poupart et al., 1993 
Sequence specific for 
Ma. paratuberculosis 
70 X59437 HSP70 family Stevenson et al., 1991 
60 X74518 HSP65 family Colston etal., 1994 
34 X68102 C-terminus specific for Gilot etal., 1993 
M.a. paraluberculosis 
31 A44892 Antigen A Sugden etal., 1991 
20 A44893 Antigen D; Brooks et al., 1991 
bacterioferritin 
X52934 16S rRNA gene Bottger, 1990 
unpublished 
X74495 23S rRNA gene van der Giessen et al., 
1994 
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1.4 Johne's Disease. 
1.4.1 Aetiological Agent. 
Johne's disease (paratuberculosis) is a chronic granulomatous enteritis of ruminants 
caused by infection of the intestinal mucosa and associated lymphoid tissue with M.a. 
paratuberculosis. The disease can affect all ruminants, however it is best known in 
cattle (Chiodini et al., 1984a), sheep and goats (Carrigan & Seaman, 1990; Collins et 
al., 1984), and both farmed and wild deer (Gilmour & Nyange, 1989). The disease 
was first observed in the early 19th century when it was noted that cattle dying from 
this form of enteritis had an unusual thickening and corrugation of the gut mucosa. 
Towards the end of the century, Johne & Frothingham (1895) demonstrated the 
presence of large numbers of acid-fast bacteria in sections of the diseased intestines 
which were indistinguishable from the tubercle bacillus. These authors therefore 
assumed that the disease was an atypical form of tuberculosis. In 1906, Bang re-
examined the disease, established that it was not true tuberculosis, and re-named it 
pseudo-tuberculous enteritis, or Johne's disease. Attempts to culture the acid-fast 
bacillus on all known culture media had been unsuccessful (Johne & Frothingham, 
1895), and was thought to be due to the absence from these media of some 
component essential for growth of this specific acid-fast bacillus. However, the 
organism was successfully cultured in 1912, when grown on a culture medium 
containing ground, heat killed M. tuberculosis (Twort &. Ingram, 1912). After 4 
weeks aerobic incubation, growth was visible to the naked eye, and reached a 
maximum after 8 weeks. Oral inoculation of calves with these cultured organisms led 
to the formation of enteric lesions identical to those found in Johne's disease, and this 
fulfilment of Koch's postulates confirmed the identification and culture of the correct 
organism, which was named M. enteritidis chronicae pseudotuberculosae bovis johne 
(now known as M.a. paratuberculosis) The dead bacilli in the new culture medium 
provided a source of mycobactin, a cell associated iron binding compound produced 
by most mycobacteria when grown in iron limiting conditions, which is now known to 
be essential for the in vitro growth of M.a. paratuberculosis. Early mycobactins used 
in culture media were mycobactin T from M. tuberculosis (Snow, 1965) and 
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mycobactin P from M. phlei (Snow, 1964). The recently discovered mycobactin J 
(Merkal & McCullough, 1982) from M. avium (formerly M.a. paratuberculosis strain 
18) is now commonly used for media preparation in diagnostic laboratories 
1.4.2 Disease and Transmission. 
Although Johne's disease has been well documented for over 100 years, it is still a 
major problem world-wide. The estimates of disease prevalence vary in different 
areas of the world, but in the USA has been reported to be between 7% (Cocito et al., 
1994) and 18% (Chiodini et al., 1984a), and annual losses were estimated to exceed 
$1.5 billion (Cocito et al., 1994). Infected animals have reduced milk output, fail to 
gain weight, and as the disease proceeds become emaciated, suffer from chronic 
diarrhoea, and die from wasting (Chiodini et al., 1984a; Cocito et al., 1994). 
Animals are thought to become infected early in life, possibly during the first 6 months 
after birth (Chiodini et al., 1984a; Cocito et al., 1994), and the disease appears to be 
spread to the immunologically immature calves by both vertical and horizontal 
transmission. M.a. paratuberculosis has been detected in semen samples from 
infected bulls (Larsen & Kopecky, 1970); however this does not appear to contribute 
to vertical transmission, as the organism is rapidly cleared from the uterus of the dam 
after implantation (Merkal et al., 1982; Chiodini et al., 1984a). Intrauterine infection 
of the foetus occurs only in cows classed as heavy faecal shedders of M.a. 
paratuberculosis, and the infection is therefore thought to spread across the placenta 
from the infected dam (Seitz et al., 1989; Sweeney et al., 1992b). The final outcome 
of infection in culture positive foetuses could not be predicted. Bacteria were 
recovered from the visceral organs, but no lesions were detected in the intestines 
(Chiodini et al., 1984; Seitz et al., 1989; Sweeney et al., 1992b), suggesting that this 
type of transmission may not result in the development of clinical paratuberculosis but 
instead produce a disseminated or persistent infection in the animal. 
The most common route of infection is thought to be via ingesting bacterially laden 
faeces either directly from the pasture, or from feeding on faecally contaminated teats 
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(Chiodini et al., 1984a; Cocito et al., 1994). M.a. paratuberculosis has been cultured 
also from the supramammary lymph nodes of infected cows, and from their milk, and 
it is possible that this may provide yet another challenge to the new-born calf 
(Sweeney et al., 1992a; Cocito et al., 1994). After ingestion, the organism appears to 
cross the intestinal mucosa, presumably by penetrating the M cells on ileal Peyers 
patches (Momotani et al., 1988). The mycobacteria then become phagocytosed by 
macrophages, where they multiply and induce the formation of granulomatous lesions 
in the intestines. 
Although infection with M.a. paratuberculosis is thought to occur during the first 6 
months of life, clinical Johne's disease is most commonly observed in animals of 
approximately 3-5 years of age, and the animals are therefore sick and dying during 
what should be their most productive years. Due to the long time course of disease, 
infected animals progress through three clinical stages of paratuberculosis (Table 1.1). 
During stage I, animals appear healthy, are asymptomatic and shed little or no bacteria 
in their faeces. As the disease develops into stage II, the animals remain 
asymptomatic but begin to excrete increasing amounts of acid-fast bacilli in their 
faeces as the bacterial load in the gut continues to rise. Finally in stage III the clinical 
symptoms of Johne's disease become evident, and the animal may excrete up to 10 8 
bacilli per gram of faeces, which can amount to 1012  bacilli excreted per animal per 
day (Chiodini et al., 1984a; Cocito et al., 1994). In a chronically infected herd where 
up to 60% of the animals can be infected (Cocito et al., 1994), the amount of excreted 
bacteria on the pasture represents a major challenge to all susceptible animals within 
an infected herd. 
1.4.3 Immunology of Johne's Disease. 
As with all other mycobacterial infections, the primary immune response in animals 
with Johne's disease is cell mediated. Indeed the immunological profile of Johne's 
disease is similar to that observed in human leprosy, presenting both hyperreactive and 
9.1 
	
Stage 	Mycobacteria 	Immune Response 	Clinical 
Shedding 	Humoral 	Cellular 	Symptoms 
I 	 Low 	Low 	Fligh 	Absent 
II 	Medium 	Medium 	Medium 	Absent 
III 	 High 	High 	Low 	Present 
Table 1.1 	Summary of bacterial shedding and immune status during stages I, II, 
and III of Johne's disease 
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anergic states (Chiodini et al., 1984a; Cocito et al., 1994.). During early stages of 
infection, a strong cell-mediated response is mounted against M.a. paratuberculosis 
(hyperreactive stage), to limit the proliferation of the organism, and the disease 
resembles the tuberculoid form of human leprosy. In many cases this early cell-
mediated immunity clears the infection completely, and Johne's disease does not 
occur. However, in some animals the infection is not cleared by the cell-mediated 
response, and as the disease progresses through an intermediate stage similar to 
borderline leprosy, there is a progressive weakening of the cell-mediated response. 
During early disease little or no antibody to M.a. paratuberculosis is produced, 
however as the cell-mediated response begins to decline, increased levels of 
anti mycobacterial antibodies appear in the circulation (Table 1.1), which corresponds 
to the increasing bacterial load in the intestinal mucosa, and is possibly due to the 
release of bacilli from dying macrophages (Chiodini et al., 1984a). At this stage 
clinical symptoms appear, and the animal becomes anergic, resembling the 
lepromatous phase of leprosy. 
1.4.4 Diagnosis of Johne's Disease. 
The immunological profile of the disease (described in section 1.4.3), combined with 
the long time course of the disease makes diagnosis of asymptomatic Johne's disease 
very difficult. A vast amount of literature has been published on the various methods 
which can be used to diagnose the disease, however most of these methods are still 
ineffective (Hietala, 1992). Serology is the most attractive proposition for diagnosis 
(agar gel immunodiffusion, complement fixation test, and ELISA), as techniques are 
cheap, rapid, and large numbers of animals can be screened at the same time (Chiodini 
et al., 1984a). However, as discussed in section 1.4.3, antibody is not produced early 
in disease and many asymptomatic cases would be missed. At the point where a 
notable antibody response was present, the animals would have entered stage III, and 
could have been diagnosed clinically. Serological techniques are still being 
investigated (for some recent reports see Burnside & Rowley, 1994; Hilbink et al., 
1994; Sweeney et al., 1994), and although these techniques are undoubtedly very 
sensitive, they still appear to lack specificity. Mycobacteria contain many cross- 
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reactive epitopes, and when a crude antigen preparation is used, antibodies may be 
detected which have been raised against an environmental bacterium. Indeed many 
assays (e.g. Johne's absorbed ETA-Commonwealth Serum Laboratories, Parkville, 
Australia, also distributed by IDEXX Laboratories, Westbrook, Maine, USA) are 
based on a partly purified antigen preparation from M.a. paratuberculosis strain 18, 
which is now known to be an 1S901 positive M. avium ;erotype 2. Some ELISA 
assays now routinely pre-absorb serum samples with lysates of M. phlei to remove 
these cross-reacting antibodies, but absorption is rarely 100% efficient, and cross-
reactive antibody against other environmental mycobacteria may still be present. In 
order to produce an ELISA specific for antibody to M.a. paratuberculosis, the 
antigen used in the test would also have to be unique to M.a. paratuberculosis. Until 
recently this has not been possible, as most candidate antigens have been found to 
produce cross-reactions with other mycobacteria, especially M.a. silvaticum and M.a. 
avium. Analysis of the A36 major antigen complex of M.a. paratuberculosis (de 
Kesel et al., 1992) indicated that this protein extract could induce cellular immune 
reactions comparable with Johnin PPD (purified protein derivative; a steam-sterilised 
culture filtrate extract of M.a. paratuberculosis containing a heterogeneous mixture 
of proteins, which induces non-specific inflammatory reactions), and that one 
component of the complex (a 34 kDa protein) appeared to contain epitopes specific 
for M.a. paratuberculosis (Gilot et al., 1992; de Kesel et al., 1992). The gene 
encoding the 34 kDa protein (distinct from the one presented in this thesis) has been 
cloned and sequenced, and appears to encode a cell wall protein (Gilot et al., 1993). 
The entire 34 kDa protein was found to contain cross-reacting epitopes, however a 
clone encoding the C-terminal portion of the protein (clone a362) was obtained which 
contained epitopes specific for M.a. paratuberculosis (de Kesel et al., 1993). 
Recombinant protein expressed from clone a362 has been used successfully in ELISA 
assays (de Kesel et al., 1993; Vannuffel et al., 1994; Cocito et al., 1994) to diagnose 
animals infected with M.a. paratuberculosis. This test therefore appears to be useful 
in detecting infected animals which have seroconverted, however, it will not detect 
subclinically infected animals which have not seroconverted. Complications may also 
occur in animals which are healthy, but have a low level of seroconversion after 
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successfully clearing the organism and becoming immune, as is thought to occur in 
many cases. This type of false positive would be more costly to the fanner, as a 
healthy uninfected animal would be culled on the basis of these results. 
As cell-mediated immunity to M.a. paratuberculosis is the first response mounted by 
an infected animal, detection of a hypersensitivity response has also been investigated 
for diagnosis. However, intradermal inoculation with Johnin PPD is unreliable, as 
animals sensitised by any other Mycobacterium would also react to this protein 
mixture due to extensive cross reactions among members of the genus 
Mycobacterium (Chiodini et al., 1984a). There are also fears that this type of testing 
would interfere in tuberculin testing of cattle for infection with M. bovis. However, 
detection of a positive skin test would not identify diseased animals, as a large 
proportion of animals which had successfully cleared the organism would also react to 
a PPD skin test. This method of testing therefore introduces the same problems as 
serology, where healthy cattle may be unnecessarily culled due to a positive skin test 
result. 
The identification of M.a. paratuberculosis in faecal samples by culture and ZN 
staining is still the most reliable method for identifying infected animals. The presence 
of large numbers of mycobacteria in the faeces implies that the organism is multiplying 
in the intestinal mucosa and being shed in the faeces. The current 'Gold Standard' for 
the diagnosis of infected animals is the culture from faeces of viable organisms which 
are identified as M.a. paratuberculosis, due to their mycobactin dependence, slow 
growth, and possession of the insertion element 1S900. This process is reliable, but 
can take up to 4 months to identify growth of M.a. paratuberculosis, and 
asymptomatic animals which are shedding low levels of the organism may be missed, 
depending on the level of excretion when the sample was taken. Many strains of M.a. 
paratuberculosis excreted by sheep have also proved impossible to culture (Chiodini 
et al., 1984a; Juste et al., 1991). In order to overcome these problems, many 
researchers are now employing PCR analysis of faecal samples and tissue samples 
using primers directed against the specific 1S900 insertion element of M.a. 
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paratuberculosis (Vary et al., 1990; Collins et a/.,1993a&b; Challans et al., 1994). 
One drawback of this method is the occasional presence of inhibitors in faecal samples 
which can prevent amplification by PCR. Each faecal sample must therefore be 
spiked with mycobacteria and processed in order to assess the inhibitory content of 
each specimen. The use of efficient extraction and cell lysis procedures is also 
important in obtaining a high degree of sensitivity by PCR (K. Stevenson, personal 
communication). A commercial test has been produced based on this technique 
(IDEXX Laboratories, Westbrook, Maine, USA), but many researchers have found 
this test to be more expensive and less reliable than 'in-house' PCR tests based on 
1S900 (Whipple et al., 1992; Collins et al., 1993b; K. Stevenson, personal 
communication). 
There is currently no cure for Johne's disease, and herd management appears to be the 
best way of controlling infection. New born calves are raised in areas free from adult 
faecal contamination, and animals identified as faecal shedders are usually culled in an 
attempt to prevent transmission (Gay & Sherman, 1992; Collins, 1994). However 
due to the long incubation period, the majority of a herd can become infected before 
the first clinical cases are evident. Vaccination has been attempted (Cranwell, 1993; 
Kormendy, 1994), but as a heat killed vaccine is used, the level and length of 
protection provided is unknown (Chiodini et al., 1984a). It is feared also that 
widespread vaccination of cattle will interfere with tuberculin testing, and also in other 
tests used to diagnose Johne's disease, as vaccinated animals would react in the same 
way as infected animals (Chiodini et al., 1984a). However, vaccination only protects 
against disease and does not prevent repeated infection with the organism. It is 
possible that the organism would be able to persist in a vaccinated herd, and infect 
susceptible animals before seroconversion from a vaccination. There is still a need for 
new and improved methods of detecting subclinical infections, and for an improved 
understanding of the host's immune response which may aid in the development of 
new effective vaccines. A greater understanding of the organism and its mechanisms 
of pathogenesis is also required in order to develop new methods of control and 
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prevention. 	Each of these developments depend; on further molecular 
characterisation of the causative organism. 
1.5 Crohn's Disease. 
Although M.a. paratuberculosis has been long considered solely an animal pathogen, 
some recent studies have suggested an association with the. human enteritis known as 
Crohn's disease (Thorel, 1989; Thompson, 1994). This disease was first described by 
Dalziel (1913) in a series of patients with chronic intestinal enteritis, which appeared 
to be tuberculous. In his paper he noted the histological similarities with Johne's 
disease; however no acid-fast bacilli could be detected in the diseased human tissue. 
The disease was again described in 1932 as regional ilcitis (Crohn et al., 1932), 
although the authors appeared to be unaware of the work of both Daiziel and Johne & 
Frothingham. This form of enteritis is now well documented and known as Crohn's 
disease (Tanaka & Riddell, 1990), but although the incidence of the disease appears 
to be increasing, the aetiology still remains unknown. 
Several bacteria (Parent & Mitchell, 1978), viruses (Aronson et al., 1976) and more 
recently measles vaccination (Thompson et al., 1995) have been suggested as other 
possible causes of Crohn's disease, but the histological similarities between Johne's 
disease and Crohn's disease have long suggested that M.a. paratuberculosis is in 
some way involved in this human enteritis. However due to the failure to consistently 
culture the organism, or demonstrate acid-fast bacilli in Crohn's tissue, this 
association has been difficult to prove. 
The first indication of the involvement of M.a. paratuberculosis in this human enteric 
disease was the isolation in 1984 of a mycobactin dependent Mycobacterium species 
from two patients with Crohn's disease (Chiodini et al., 1984b&c). This organism 
was shown to most closely resemble M.a. paratuberculosis, and was capable of 
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causing a granulomatous disease of the small intestine when used to inoculate a 7 day 
old goat. Crohn's disease patients were shown also to possess elevated levels of 
antibodies to M.a. paratuberculosis PPD (Thayer et al., 1984), but these serological 
results have been questioned by other groups which failed to show any association 
between Crohn's disease and antibodies to M.a. paratuberculosis (Cho et al., 1986; 
Tanaka et al., 1991; Brunello et al., 1991). Recent work has detected elevated 
antibody titres to defmed mycobacterial antigens (M.a. paratuberculosis 38 kDa 
protein, 24 kDa protein and bacteriofenitin) in sera from Crohn's disease patients 
(Elsaghier et al., 1992) once again suggesting involvement of M.a. paratuberculosis 
in the disease. The detection of antibody to M.a. paratubercu!osis in Crohn's disease 
patients therefore appears to be variable. Serology has previously been shown to be 
unreliable in diagnosing Johne's disease, as only animals in the terminal stages of 
disease have a detectable antibody titre. If Crohn's disease mimics Johne's disease it 
is possible that only a percentage of Crohn's patients will have a detectable antibody 
titre to M.a. paratuberculosis. The serology discussed above may therefore reflect a 
wide range of patients in different stages of Crohn's disease, where only those in the 
late stages of disease are producing detectable levels of antibody. 
Mycobacteria have been isolated from Crohn's disease tissue by several other 
researchers since Chiodini's original observation (McFadden et al., 1987b, 1987c & 
1992; Butcher et al., 1988; Moss et al., 1992b; Wall et al., 1993), and have been 
shown by DNA hybridisation, RFLP and PCR directed at 1S900 to be M.a. 
paratuberculosis. In order to account for the absence of acid-fast bacilli from the 
tissues and the difficulty to culture the organism, it has been suggested that the 
organism is present in the intestinal tissue as a cell-wall deficient form, or 
spheroplastic form (Burnham et al., 1978; Hermon-Taylor et al., 1990; Wall et 
al., 1993; Thompson, 1994). PCR has also been performed directly on tissue 
samples from Crohn's patients (Sanderson et al., 1992; Dell'Isola et al., 1994; Fidler 
et al., 1994; Lisby etal., 1994) to detect M.a. paratuberculosis DNA. This technique 
does not prove viability of the organism, however it is more sensitive than culture and 
may overcome the problems associated with culturing the spheroplastic forms thought 
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to be present in Crohn's tissue. 1S900 was detected in 65% of Crohn's tissues, 4.3% 
of ulcerative colitis tissues and 12.5% of control tissues (Sanderson et al., 1992), and 
sensitivity has recently been increased by using a solid-phase hybridisation capture 
technique before PCR (Millar et al., 1995). PCR also detected 1S901 positive 
organisms in both tissue and cultures from Crohn's disease, suggesting that M.a. 
si!vaticwn (or M. avium RFLP type A/I) could be involved also in Crohn's disease 
(McFadden etal., 1992; Moss et al., 1992b). 
The evidence presented in this section by no means proves that M.a. paratubercu!osis 
is the aetiological agent of Crohn's disease. Nevertheless it is becoming more evident 
that this Mycobacteriuni may be involved in the disease process in some way. 
Crohn's disease is likely to be a multifactorial condition, in which M.a. 
paratubercu!osis may play a particular role in some patient;. An increased knowledge 
of both the disease and the organism is required before any definite association can be 
made between Crohn's disease and M.a. paratubercu!osis. 
1.6 Identification of in vivo Expressed Genes and Proteins of 
M.a. paratuberculosis. 
In order to develop new diagnostic techniques, treatment; and vaccines for Johne's 
disease (and possibly Crohn's disease) a detailed understanding of the causative 
organism at the molecular level is required. The identification of an immunogenic 
M.a. paratuberculosis species-specific protein expressed in vivo would provide an 
excellent target for sensitive and specific diagnosis of the condition, and could also be 
important in vaccine development. Molecular techniques were first utilised in the 
mid-1980's in attempts to identify and characterise major protein antigens in 
mycobacteria, mainly M. tuberculosis and M. leprae. The most commonly used 
technique was to construct genomic expression libraries of the Mycobacterium 
species in question and screen using either MAbs (Young et al., 1985; Lu et al., 1987; 
Morris et al., 1990; Rouse et al., 1991) or rabbit hyper-immune serum (Husson & 
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Young, 1987; Morris et al., 1988; Stevenson et al., 1991) for expression of 
recombinant clones which reacted with the antiserum. However, in most cases the 
antigens identified by these methods were shown to be heat-shock proteins (HSPs) or 
stress proteins (Husson & Young, 1987; Lu et al., 1987; Young & Meihert, 1989), 
which are highly conserved in all living organisms. 
The failure to detect any novel mycobacterial antigens by this method was possibly 
due to the MAbs and antisera used to screen the expression libraries. In order to 
produce MAbs (Engers et al., 1985; KoIk et al., 1989; Rouse et al., 1990) and hyper-
immune sera (Husson & Young, 1987; Morris et al.,1988; Stevenson et al., 1991) 
non-host animals were immunised with either killed or iysed bacilli. This method of 
inoculation did not reflect accurately the immune response of the natural host to 
infection, and the procedure appeared to promote the response to the 
immunodominant stress proteins. The resulting MAbs and hyper-immune sera 
produced by these animals reflected this response in their specificities, and resulted in 
the identification of stress proteins from expression libraries. 
The Paratuberculosis project at the Moredun Research Institute (of which this PhD 
project was a part) was initiated in 1989 to study the genes and proteins expressed in 
vivo by M.a. paratuberculosis. The HSP70 of M.a. paratuberculosis was first 
identified by this group (Stevenson ci' al., 1991) by screening a Xgtl1 genomic 
expression library of a deer isolate of M.a. paratuberculosis with rabbit hyper-
immune serum. The identification of a stress protein was due to the problems 
associated with hyper-immune serum (discussed above). In order to circumvent this 
problem and focus on proteins immunogenic in sheep, the ?cgtl 1 genomic expression 
library was re-screened with serum from a sheep with clinical Johne's disease 
(Stevenson ci' al., 1992; Cameron et al., 1994). By utilising the natural immune 
response of the infected host, antigens expressed during growth in vivo could be 
detected which were absent from or poorly expressed in bacteria grown in vitro, 
suggesting a possible role in pathogenesis (Donachie & Gilmour, 1988; Jonson et al., 
1989). This approach resulted in the identification of several new proteins which 
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were not recognised by mouse MAbs to the major stress proteins or the rabbit hyper-
immune serum originally used to screen the library. These clones were therefore 
thought to represent novel mycobacterial antigens, one of which is characterised in 
this PhD project. 
The value of this technique is now well recognised and several groups have 
subsequently screened M. leprae genomic expression libraries with pooled sera from 
leprosy patients (Clark-Curtiss et al., 1990; Sathish et al., 1990; Wieles et al., 1994). 
This approach again resulted in the identification of several clones which were distinct 
from the previously described M. !eprae stress proteins, and possibly represented 
mycobacterial antigens involved in the host's immune response to leprosy. These new 
antigens may therefore be important in developing future treatments for the disease. 
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Chapter 2 
Materials and Methods. 
2.1 Bacterial Strains and Plasmids. 







Genotype 	 Reference 
hsclS gal (?cIts857 indl Sam7 nin5 	Studier & Moffatt 1986 
lacUV5-T7 gene 1) 
thi supE L(lac-proAB) [nuuS::TnlO] Zell & Fritz, 1987 
[F' proAB laqIM15] 






F - recA 1 endA 1 gyrA96 thi- 1 
hsdR17 ( rk mt.) supE44 relAl 
F - 80d/acZAM15 recAl endAl 
gyrA96 rhi-1 hsdRl7 (rk Mk) supE44 
relAl deoR A(1acZYA-argF)U169 




Yanisch-Perron et al. 1985 
NM522 	 supE thi A(lac-proAB) Ehsd5 (rk mk) Gough & Murray 1983 
(Promega) [F' proAB /aciM15] 
TG1 	 supE hsdtt5 thi E(lac-proAB) F' 	Gibson 1984 




M.a. paratuberculosis MRI type strain, JD88/107; Deer isolate; 1S900 +ve 
M.a. silvaticuni MRI type strain, JD88/1 18; Deer isolate; IS901 +ve 
M. aviuni NCTC 8559; 1S901 +ve. 
M intracellulare NCTC 10425 (ATCC 23068) 
M. scrofulaceuni NCTC 10803 (ATCC 19981) 
M. gordonae Clinical Isolate 38320/93, Scottish Mycobacterium 
Reference Laboratory (SMRL), City Hospital, 
Edinburgh. 
M. kansasii Clinical Isolate 34902/93, SMRL, Edinburgh 
M. niarinuni Clinical Isolate 33811/93, SMRL, Edinburgh 
M. na/nioense Clinical Isolate 35056/93, SMRL, Edinburgh 
M. fortuitu.nz  Clinical Isolate 41780/93, SMRL, Edinburgh 
M tuberculosis Clinical Isolate 20963, SMRL, Edinburgh 
M. bovis Clinical Isolate 3433, SMRL, Edinburgh 
M. phlei MRI Ref. M/1025 
M. sniegniatis 	 NCTC 8159 
M. leprae 	 Lysates and DNA supplied by Dr. M.J.Colston, 
MRC National Institute for Medical Research, Mill 
Hill, London. 
2.1.3 Plasmid Vectors. 
pGEX-12J (Pharmacia) 	 Smith & Johnson, 1988 
pUC1 8 (Pharmacia) 
	
Yanisch-PuTon et al., 1985 
pBluescript KS (Stratagene) 
	
Short etal., 1988 
pMS1S (Gift from M. Schreiber & J. Scaife) 
	
Scherfetal., 1990 




2.2 Chemicals and Culture. 
All enzymes were supplied by Boehringer Mannheim, and used with the supplied 
incubation buffers according to the manufacturers specifications, unless stated 
otherwise. 
All chemicals were supplied by Sigma, unless stated otheiivise, and all solvents were 
supplied by BDH. 
All oligonucleotides were synthesised by OSWEL DNA, Southampton. 
Mycobacteria were propagated both on Stuart's medium (Stuart 1965), and in 
Middlebrooks 7H9 medium, supplemented with 2 tg/ml mycobactin J (Allied 
Monitor, UK) for M.a. paratuberculosis and M.a. si/vaticuni.  
E. co/i were grown in Luria-Bertani (L broth) medium (1% bacto-tryptone [Difco], 
0.5% yeast extract [Difco], 170 mM NaCl, pH 7.5), or L broth solidified with 1.4% 
(w/v) bacteriological agar (Difco)(Sambrook et al., 1989). L broth and L agar 
supplemented with 50 jiglml ampicillin (Veterinary Drug Co., Falkirk) were used to 
select E. co/i transformed with expression vectors. When culturing E. co/i BW313, L 
broth was supplemented with 25 .xg/ml uridine. 
2.3 Gel Electrophoresis of Proteins. 
2.3.1 SDS Polyacrylamide Gel Electrophoresis (SDS PAGE). 
Proteins were separated on SDS PAGE gels using the buffering system of Laemmli 
(1970). Briefly, protein samples were denatured by heating to 100 °C for 90 s in an 
equal volume of x2 Laemmli sample buffer (0.5 M Tris/HC1 pH 6.8, 4% SDS, 8% 2-
mercaptoethanol, 20% [w/v] sucrose, 0.002% [w/v] bromophenol blue). The samples 
were then loaded into the wells of an SDS PAGE gel and separated with a 3% 
stacking gel (3% [w/v] acrylamide, 125 mM Tris/HC1, 3.5 mM SDS pH 6.8), and a 10 
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% resolving gel (10 % [w/v] acrylamide, 375 mM TrisfHCI, 5 mM SDS pH 8.8) in 
Laemmli electrode buffer (25 mM Tris, 192 mM glycine, 3.5 mM SDS pH 8.3), at 
200 V for 35 min (Bio-Rad Mini Protean II), or 20 mA for 3 h (Hoeffer SE600). 
Molecular weight markers (BDH Electran, 42-200 kDa, or 12-78 kDa) were run on 
each gel to allow estimation of the molecular weights of specific proteins. 
2.3.2 Native Polyacrylamide Gel Electrophoresis. 
Proteins were separated under non-denaturing conditions on high pH native PAGE 
gels (Hames, 1981). Protein samples were mixed with an equal volume of sample 
buffer (30 mM Tris/HC1 pH 6.8, 10 % [w/v] sucrose, 0.002 % bromophenol blue), 
and loaded into the wells of a native PAGE gel. The samples were separated with a 
3 % stacking gel (3 % [w/v] acrylamide, 140 mM Tris/HCI pH 6.8), and a 10 % 
resolving gel (10 % [w/v] aciylamide, 375 mM Tris/HC1 pH 8.8) in Tris/glycine 
electrode buffer (0.025 M Tris, 0.2 M glycine, pH 8.3). 
2.3.3 Western Blotting and Immunoscreening. 
Proteins were transferred from SDS PAGE gels onto niirocellulose membranes by 
electroblotting in Tris/glycine blot buffer (25 mM Tris, 192 mM glycine, 20 % [v/v] 
methanol, pH 8.3), at 100 V for 1 h (Bio-Rad Mini Protean II). The membrane was 
stained with Ponceau S to confirm transfer, and then washed in PBS-Tween (PBS 
containing 0.5 % Tween 20, 1 mM EDTA, 350 mM NaCl, pH 7.2) for 15 mm. Blots 
were generally immunoscreened by incubating with test serum or monoclonal 
antibody (MAb) at room temperature (RT) for 1 h, washing 3 x 5 min in PBS-Tween, 
and incubating with horse radish peroxidase (HRP) labelled conjugate (Dako) at RT 
for 1 h. After three further 5 min washes in PBS-Tween, bound antibody was 
visualised with a solution of 100 mM Tris/HC1 pH 7.5, 0.15 % (v/v) H202 , 0.2 % 
(w/v) diaminobenzidine (DAB). 
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2.3.4 Coomassie Blue Staining of SDS PAGE Gels. 
Proteins separated on SDS PAGE and Native PAGE gels were visualised by staining 
in a solution of Coomassie brilliant blue (0.25 % [w/v] Coomassie brilliant blue R-
250, 50 % [v/v] methanol, 9.2 % [v/v] acetic acid) for 20 min at RT, and destaining in 
23 % (v/v) ethanol, 7 % (v/v) acetic acid for approximately 30 min until bands were 
clearly visible. Gels were either photographed, or dried onto Whatmann 3 mm filter 
paper at 80°C for 30-45 min on a Hoeffer SE 1160 slab gel drier. 
2.3.5 Silver Staining SDS PAGE Gels. 
Proteins separated by SDS PAGE were also visualised by staining with silver nitrate 
(AgNO3). Gels were fixed for 20 min in 50 % (v/v) methanol, 10 % (v/v) acetic acid, 
followed by 5 % (v/v) methanol, 7 % (v/v) acetic acid, before staining in 0.1 % (w/v) 
AgNO3 for 20 mm. Bands were developed in 2.5 % (w/v) Na 2CO3 , 0.02 % 
formaldehyde until the desired level of staining was obtained. The reaction was 
stopped by adding 0.05 volumes of 2.3 M citric acid. 
2.4 Production of Recombinant Fusion Protein. 
2.4.1 Culture and Induction. 
E. co/i NM522 containing either the pMS1S/S4 or pMS1S/S8 vector, and E. coli 
DH5(x containing the pGEX/S4 vector were grown in L broth as described in section 
2.2. A single colony was used to inoculate 10 ml L broth containing 50 pg/ml 
arnpicilin, and grown overnight at 37 °C with shaking. One ml of this overnight 
culture was used to inoculate 100 ml of prewarmed L broth containing 50 p.g 
ampicillin, and grown at 37 °C with shaking for approximately 2.5 h until the A600 was 
0.5. The culture was then induced with isopropyl thiogalactopyranoside (IPTG) at 
10 mM for pMS1S vectors, or 1 mM for pGEX vectors, and grown for a further 4 h 
before harvesting the cells at 3800 x g for 15 min at 4°C. The pellet was resuspended 
in 10 ml of 2 mM phenyl methyl sulphonyl fluoride (PMSF), and lysed in a French 
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pressure cell at 1500 psi (10.35 MPa). The resulting lysate was clarified at 
100000 x g for 10 min at 4°C, and the recombinant protein was purified by affinity 
chromatography (section 2.4.2, and 2.4.4) 
2.4.2 Purification of 13 Galactosidase Fusion Protein. 
Amino benzyl thiogalactopyranoside (ABTG) agarose (2 nil) was washed three times 
in 50 mM Tris/HCI pH 8.0, 300 mM NaC1 to remove preservatives, and packed into a 
10 x 1 cm Econo column (Bio-Rad). The clarified E. co/i lysate was adjusted to 
50 mM Tris/HC1 pH 8.0, 300 mM NaCl, and passed through the ABTG agarose 
column under gravity. Samples of pre-column lysate and column flowthrough were 
retained for analysis. The column was then washed with 10 ml of 50 mM Tris/HC1 
pH 8.0, 300 mM NaCl, 5 ml of 50 mM Tris/HC1 pH 8.0, 600 mM NaCl, and 10 ml of 
50 mM Tris/HC1 pH 8.0 before eluting the bound fusion protein with 10 ml of 0.1 M 
borate pH 10.0. The eluate was collected on ice into 1 ml of 2 M Tris/HC1 pH 7.0, 
and dialysed against 10 mM TrisIHCl pH 8.0 overnight, before concentrating to 
2-3 ml with PEG 20000. The concentration of purified fusion protein was determined 
using the Pierce BCA Protein Estimation Assay, as recommended by the 
manufacturer. 
2.4.3 Factor Xa Cleavage of 13-Catactosidase Fusion Protein. 
Affinity purified S4/13-Gal fusion protein (approximately 100 jtg) was digested with 
10 tg of bovine Factor Xa in 500 .tl of Factor Xa buffer (100 mM NaCl, 50 mM 
Tris/HC1 pH 8.0, 1 mM CaC12) overnight at 4°C. Sample; (20 j.xl) were analysed by 
SIDS PAGE as described in section 2.3. 
2.4.4 Purification of Glutathione-S-Transferase Fusion Protein. 
Two ml of glutathione Sepharose 4B (Pharmacia) was washed three times in MTPBS 
(150 mM NaCl, 16 mM Na2HPO4, 4 mM NaH2PO4 pH 7.3) to remove preservatives, 
and packed into a 10 x 1 cm Econo column (Bio-Rad). The clarified E. co/i lysate 
was equilibrated with column buffer by the addition of 0.1 volumes of 10 x MTPBS, 
and passed through the glutathione Sepharose column under gravity. Pre-column and 
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column flowthrough samples were retained for analysis. The column was washed 
with 50 ml of MTPBS under gravity, and the fusion protein eluted with 8 ml of 5 mM 
reduced glutathione in 50 mM Tris/HC1 pH 8.0. The eluate was then concentrated to 
2-3 ml with PEG 20000. The concentration of purified fusion protein was determined 
using the Pierce BCA Protein Estimation Assay, as recommended by the 
manufacturer. 
2.4.5 Thrombin Cleavage of Glutathione S Transfera,e Fusion Protein. 
Affinity purified S4/GST fusion protein (approximately 250 j.ig) was digested with 
2.5 j.tg of thrombin in 200 .t1 of thrombin cleavage buffer (50 mM Tris/HCJ, 150 mM 
NaCl, 2.5 mM CaC12 pH 7.5) at RT, and sampled at 30, 60, 90 and 120 mm. The 
samples were immediately boiled in an equal volume of x2 Laemmli sample buffer, 
and analysed by SDS PAGE as described in section 2.3. 
2.5 Production of Recombinant S8 Protein. 
2.5.1 Culture and Induction. 
The first 1.1 kb of the S8 insert was amplified by PCR as described in section 2.12.1, 
and cloned into the Sacl HindIll sites of pUC18, pBluescipt and pT7-5, as described 
in section 2.12. This resulted in the production of plasmids pUCMS/S8, pBSMS/S8, 
and pT7/S8 respectively. A single colony was used to inoculate 10 ml of L broth 
containing 50 p.g/ml ampicillin and grown overnight at 37 °C with shaking. One ml of 
this overnight culture was used to inoculate 100 ml of prewarmed L broth containing 
50 tgJml ampicillin, and the culture was grown for 2-3 h until the A 6w was 0.5. 
Protein expression was then induced with IPTG (1 mM) and the culture was grown 
for a further 3 h before harvesting at 3800 x g for 15 min at 4 °C. 
43 
2.5.2 Osmotic Shock of Escherichia coli. 
E. coli cells expressing the recombinant protein were subjected to osmotic shock as 
described by Hewinson & Russell (1993) to yield cyloplasmic and periplasmic 
extracts. Induced cells, prepared as described in section 2.5.1, were resuspended in 
9 ml of ice cold 10 mM Tris/HC1 pH 7.5 containing 20 % (w/v) sucrose, before 
adding 300 1.11 of 0.5 M EDTA pH 8.0 and incubating on ice for 10 mm. The 
suspension was divided into 6 x 1.5 ml aliquots (the remainder being retained as a 
whole cell control) and the cells pelleted at 10000 x g for 5 min at 4°C. Each pellet 
was resuspended in 1 ml of ice cold distilled water and incubated on ice for 10 mm, 
before being centrifuged again at 10000 x g for 10 min at 4°C. The supernatant was 
retained as the periplasmic fraction, and each pellet was iesuspended in 1 ml of ice 
cold distilled water to yield the cytoplasmic fraction. All fractions and the whole cell 
control were stored at -20 °C before analysis by SDS PAGE and Western blotting as 
described in section 2.3. 
2.5.3 Chromatographic Purification of the S8 Recombinant Protein. 
The periplasmic fractions of E. co/i expressing both pUCMS/S8 and pT7/S8 were 
subjected to anion exchange chromatography in an attempt to purify the recombinant 
protein. A 1 ml Econo Q cartridge (Bio-Rad) was connected to a low pressure 
peristaltic pump and equilibrated in 10 mM Tris/HCI pH 8.0, at a flow rate of 
1 ml/min. The sample was adjusted to column buffer (10 mM Tris/HC1 pH 8.0), and 
passed through the Econo Q cartridge at a flow rate of 0.5 ml/mm, retaining a pre and 
post column sample for subsequent analysis by SDS PAGE (Section 2.3). The column 
was washed with 10 ml of 10 mM Tris/HC1 pH 8.0, and eluted with 0.5 ml fractions 
of 10 mM Tris/HCI pH 8.0 containing increasing concentraions of NaCl, from 
0.05 M to 1 M, at a flow rate of 0.5 ml/min. The void volume of the tubing (1.5 ml) 
was discarded before collecting the eluate in 0.5 ml fractions and storing on ice. 
Fractions were then analysed for the presence of S8 recombinant protein by SDS 
PAGE, Western blotting and silver staining as described in section 2.3. 
The periplasmic fractions were also subjected to anion exchange chromatography as 
described above, using Bis-Tris/HC1 buffer at pH 6.5. 
2.5.4 Isoelectric Focusing. 
The periplasmic fractions from E. coli expressing pUCMS/S8 and pT7/S8 were 
focused across a liquid pH gradient in a MinipHor isoelectric focusing cell 
(Anachem). 
The periplasmic fraction (7 ml) was mixed with 1 % ampholytes (pH 4-5, pH 5-6, 
pH 6-7 [Anachem]), 10 % (w/v) glycerol, and 0.1 % (w/v) CHAPS (3 - [3-
cholamidopropyl)-dimethylammonio]-l-propane-sulphonat(,-) in 25 ml final volume, 
and loaded into the MinipHor focusing cell as described by the manufacturer. The 
apparatus was run with cooling at 1000 V, 40 W, 200 mA until the readings stabilised 
(approximately 35 mm), then for 20 min further, and finally for 10 min at 500 V. 
Twenty fractions of 1 ml were collected, spanning the p11 gradient, and the pH of 
each fraction was measured using a tapered pH electrode. The fractions were then 
analysed by SDS PAGE, Western blotting and silver staining as described in section 
2.3. 
2.6 Antibody Elution. 
Antibody specific for the S4 recombinant was purified from clinical sheep serum using 
an antibody elution technique as described by Beall and Mitchell (1986). 
Approximately 500 p.g of purified pMS1S/54 fusion protein was run on two SDS 
PAGE gels, and Western blotted onto nitrocellulose as described in section 2.3. The 
blots were stained with Ponceau S. and the fusion protein bands excised. The 
nitrocellulose strips were then incubated for 3 h in a 1: 40 dilution of serum JD87/39 
(collected from a sheep with clinical Johne's disease), and washed for 1 h in several 
changes of PBS-Tween (section 2.3.3). After further wa;hing in 0.1 M boric acid, 
0.5 M NaCl pH 8.0 for 30 mm, and MTPBS (Section 2.4.4) for 30 mm, antibody was 
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eluted from the strips in 2 ml of 0.1 M glycine, 0.15 M NaC1 pH 2.6 for 2-3 mm, and 
immediately neutralised with 3 drops of 2 M Tris/HC1 pH 8.0. The nitrocellulose 
strips were then re-washed in PBS-Tween, and the entire process repeated using the 
same dilution of serum. The pooled eluted antibody was then absorbed with a lysate 
of induced E. coli containing the pMS iS vector with no insert (to remove any 
antibodies to 3-galactosidase or E. co/i), and used to probe Western blots of lysates 
of M.a. paratuberculosis and M.a. silvaticum (Section 2.3). 
2.7 Purification of Native Protein. 
2.7.1 Production of Ascitic Fluid. 
Hybridoma cells producing MAb 5.8 were used to produce ascitic fluid in Balb/c 
mice. Hybridoma cells (5x10 6) were resuspended in 0.5 ml of PBS, and injected 
intraperitoneally into each of 4 Balb/c mice which had. been treated eight days 
previously with 0.5 ml of pristane (2,6,10,14-tetramethylpentadecane). The mice 
were examined regularly for signs of swelling, at which point the ascitic fluid was 
removed with a hypodermic needle. After 14 days, the mice were killed and residual 
ascitic fluid was removed. The pooled ascitic fluid was checked for activity against 
pMS1S/S4 fusion protein by Western blotting (Section 2.3). 
2.7.2 Purification of IgGi from Ascitic Fluid. 
IgGi was purified from the ascitic fluid on a column of protein A Sepharose 
(Pharmacia). Ascitic fluid (1 ml) was mixed with 1.5 ml of distilled water, 2.5 ml of 
4 M NaCl, 2 M glycine pH 8.9, and passed through a 0.45 tm filter. The filtrate was 
collected into 5 ml of 4 M NaCl, 2 M glycine pH 8.9, and washed through with 1 ml 
of 3 M NaCl, 1.5 M glycine pH 8.9, yielding an 11 ml sample in 3 M NaCl, 1.5 M 
glycine pH 8.9. This procedure prevented the formation of a precipitate in 3 M NaCl, 
which was difficult to filter prior to chromatography. 
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The sample was applied to a protein A Sepharose column equilibrated in 3 M NaCl, 
1.5 M glycine pH 8.9, at a flow rate of 0.5 mI/mm, and washed through with 15 ml of 
column buffer at 1 ml/min. The column was then washed with 10 ml of PBS at 
1 ml/min to remove excess salts, and the IgGi eluted with 10 ml of 0.1 M citrate pH 6 
at 0.5 ml/min. Absorbance of the eluate was measured at 260 nm in a flow cell, and 
5 ml of eluate spanning the peak was collected and neutralised with 250 p1 2 M 
Tris/HC1 pH 9. Any remaining lgG (IgG2, IgG3 etc.) was eluted from the column 
with 10 ml of 0.1 M citrate pH 3.0 at a flow rate of 1 ml/mm. The column was then 
washed with 5 ml distilled water, and re equilibrated with 3 M NaCl, 1.5 M glycine 
pH 8.9 at a flow rate of 1 ml/mm. The remaining ascitic fluid was processed as 
above, and the eluted IgGi pooled. 
2.7.3 Construction of Monoclonal Affinity Column. 
Purified IgGi was dialysed against PBS for 16 h at 4°C, and concentrated to 5 mg/nil 
(approximately 2 ml volume) in microconcentrators (Millipore, 30 kDa cut-off). 
Cyanogen bromide activated Sepharose (1 g) was re-hydrated in 20 ml of 1 mM HC1, 
and washed for 15 min on a sintered glass filter with 200 ml of 1 mM HC1. This 
yielded a gel volume of approximately 3 ml. The concentrated IgGi (2 ml) was 
adjusted to coupling buffer (0.2 M NaHCO 3 , 0.5 M NaCI, pH 8.9) by the addition of 
0.67 .tl of x4 coupling buffer (0.8 M NaHCO3 , 2 M NaC), pH 8.5), and mixed with 
the activated Sepharose for 4 h at room temperature. The Sepharose was then 
washed on a sintered glass filter with 100 ml of coupling buffer, rinsed with 30 ml of 
0.1 M Tris/HCI pH 8.0, and then blocked by mixing with 6 ml of 0.1 M Tris/HCI pH 
8.0 overnight at 4°C. The Sepharose matrix was then packed into a 10 x 1.5 cm 
Econo column (Bio-Rad), and equilibrated with PBS buffer supplemented with 0.5 M 
NaCl. 
2.7.4 Affinity Purification of Native Protein. 
A ig (wet weight) pellet of M.a. pararuberculosis was resuspended in 5 ml of PBS 
supplemented with 0.5 M NaC1, and lysed in an Eaton Press (Eaton, 1962). The 






(Approximately half scale) 
Figure 2.1 Eaton Press. 
Diagram of the apparatus used to lyse mycobacteria. After chilling the apparatus to 
-70°C, the mycobacterial suspension was loaded into the top chamber. On applying 
pressure in a hydraulic press, the cells were lysed when forced through the small 
aperture in the top chamber, and the lysate was collected in the bottom chamber. 
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-70°C, and the apparatus was returned to -70 °C for 20 miri to ensure the sample was 
completely frozen. After 10 - 15 min at room temperature, the apparatus was placed 
in a hydraulic press, and pressure applied until the lower part of the frozen sample 
liquefied, and was forced through the small aperture into the bottom chamber, where 
it immediately re-froze. Pressure was re-applied until the entire sample had passed 
into the bottom chamber. The lysate was thawed slowly, and DNA sheared by 
sonication (6 x 6 s at maximum power) before clarification at 15000 x g for 10 min at 
4°C. 
The clarified lysate was mixed with the MAb affinity column matrix (section 2.7.3) on 
a rotating wheel, overnight at 4 °C, and then packed into a to x 1.5 cm Econo column 
(Bio-Rad). The flow-through was collected and stored for analysis by SDS PAGE 
and Western blotting as described in section 2.3. The column was then connected to 
a peristaltic pump, washed with 20 ml of PBS supplemented with 0.5 M NaCl at a 
flow rate of 1 mI/mm, and eluted with 10 ml of 0.1 M glycine pH 2.3 at a flow rate of 
0.5 ml/min. The eluate was immediately dialysed against 10 mM Tris/HC1 pH 8.0, 
concentrated to 2-3 ml with PEG 20 000, and stored at -20 °C before analysis by SDS 
PAGE and Western blotting as described in section 2.3. 
2.7.5 Amino Terminal Sequence Analysis. 
Approximately 2 j.ig of purified native protein was run on SDS PAGE and Western 
blotted (as described in section 2.3) onto polyvinylidine difluoride (PVDF) membrane 
using borate blot buffer (50 mM sodium borate pH 8.0, 20 % (v/v) methanol, 0.02 % 
(v/v) mercaptoethanol). The membrane was washed in distilled water and stained 
with a weak Coomassie blue solution containing no acetic acid (0.025 % (w/v) 
Coomassie brilliant blue R250, 40 % (v/v) methanol). After destaining in 50 % (v/v) 
methanol, the blot was allowed to air dry, and the appropriate bands excised. The 
first 20 amino acids were sequenced from this membrane by Edman degradation, at 
the Microchemical Facility, IAPGR, Babraham, Cambridge. 
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2.8 Serine Protease Assays. 
2.8.1 Digestion of a and 0 Casein. 
Digestion of a and 0 casein was performed as described by Lipinska (1990). Briefly, 
10 pg of a and 13 casein in 10 mM Tris/HC1 pH 8.0 were incubated separately with 
200 ng of purified 34 kDa protein at 37 °C for 30 mm. After incubation, the samples 
were analysed by SDS PAGE, and Coomassie stained, in order to detect any digestion 
of either a or 13 casein. 
2.8.2 Casein Gel Assay. 
Digestion of azocasein immobilised in an acrylamide gel was performed using a 
modification of that described by Sarath (1989). Briefly, a 10 % native PAGE gel 
(section 2.3.2) was prepared containing 2 mg/mi azocasein in the resolving gel, and a 
normal stacking gel with a single block well. The enzyme sample was mixed with 
native PAGE sample buffer (section 2.3.2), loaded into the block well, and 
electrophoresed at 200 V for approximately 35 mm. The gel was incubated overnight 
in a buffer of the appropriate pH, then stained in Coomassie blue, and examined for 
zones of clearing, which indicated that digestion of the azoc:asein had occurred. 
2.8.3 Agar Gel Diffusion Assays. 
A series of 1 % agarose plates were prepared containing either 2 mg/mI azocasein, 
1 % skimmed milk, or 10 % horse blood (Difco). Wells were cut into the agar on 
each plate, and loaded with approximately 1 Op.1 of the enzyme sample. The plates 
were then sealed with parafilm, and incubated overnight at 37°C before examining for 
signs of diffusion and digestion of the substrates. 
2.8.4 Digestion of Casein by Recombinant E. coli. 
Digestion of casein by recombinant E. co/i was performed using a modification of the 
technique described by Arkawa & Kiramitsu (1994). L agar plates were prepared 
containing 50 .tg/m1 ampicilhin and 4 % skim milk as the casein source. As the inserts 
used in this experiment did not contain promoters, IPTG (10 mM) was added also to 
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the agar in order to induce expression of the recombinant protein. A single colony of 
E. coil containing the expression vector and insert was streaked onto one plate, and a 
control colony of E. coli containing only the expression vector was streaked onto 
another plate. Both plates were sealed with parafilm to prevent the agar from drying 
Out, and incubated at 37°C for 7 days. After this time, the plates were examined 
regularly for signs of digestion around the colonies 
2.8.5 Sensitivity to Hydrogen Peroxide. 
E. coil containing the expression vectors and inserts of interest were grown overnight 
in 10 ml L broth plus 50 pg/ml ampicillin, and then diluted 1:8 to give an A 6w of 
approximately 0.2. The diluted cultures (100 .i1) were used to seed L agar plates 
containing 50 ig/m1 ampicillin and 10 mM IPTG in order to induce expression of the 
recombinant protein. Discs of Whatmann 3 mm filter paper (5 mm diameter) 
saturated with 10 p1 of 30 % 1-1 202 were placed in the centre of each plate and 
incubated overnight at 37°C. After incubation, the zones of inhibition around each 
disc were measured and compared to determine any difference in sensitivity. 
2.9 Nucleic Acid Preparation and Manipulation. 
2.9.1 Extraction of High Molecular Weight DNA from Mycobacteria. 
Genomic DNA was extracted from all species of mycobacteria using a modification of 
the method described by Whipple et al., (1987). Mycobacterial cells were harvested, 
washed twice in TE buffer (10 mM Tris/HC1, 1 mM EDTA pH 7.5), and resuspended 
in TE buffer at 200 mg/ml wet weight. DNA was prepared from 500 p1 aliquots 
(100 mg cells) by adding 8000 U of lipase and incubating at 37 °C for 2 h. Lysozyme 
was then added to 5 mg/mi and incubated at 37 °C for a further 2 h. Finally, 
proteinase K and SDS were added to a final concentration of 2 mg/mi and 1 % 
respectively, and incubated at 50 °C for 16 h. Proteins were precipitated by the 
addition of 0.4 volumes of ice cold 5 M potassium acetate, and incubation on ice for 
10 mm. After centrifugation at 10000 x g for 10 min at 4°C, the supernatant was 
51 
removed and extracted with an equal volume of phenol, followed by an equal volume 
of chloroform, before precipitating the DNA with 0.1 volumes of 3 M sodium acetate 
pH 5.2 and 2 volumes of ice cold ethanol, at -20 °C for at least 1 h. DNA was pelleted 
by centrifugation at 10000 x g for 10 min at 4°C, washed with 70 % ethanol and air 
dried. The pellets were then resuspended in 50 .tl of TE buffer and stored at 4°C. 
2.9.2 Small Scale Plasmid Preparation from Escherichia coli. 
A single colony of E. co/i containing the plasmid of interest was used to inoculate 
10 ml of L Broth containing 50 jig/ml ampicihin, and grown overnight at 37 °C. Cells 
were pelleted at 3800 x g for 15 min at 4°C, resuspended. in 1 ml of glucose buffer 
(50 mM glucose, 10 mM EDTA, 25 mM Tris/HCI pH 8.0), and pelleted again at 
10000 x g for 10 min at RT. After resuspending in 400 j.fl of glucose buffer, bacteria 
were lysed by the addition of 300 j.tl of 0.2 M NaOH, 1 % (w/v) SDS, mixed gently 
and left on ice for 5 mm. Protein and genomic DNA was precipitated by the addition 
of 300 jil of high salt buffer (3 M potassium acetate, 1.8 M formic acid). Tubes were 
mixed well by inversion and left on ice for 30 mm. The precipitate was removed by 
centrifugation at 10000 x g for 10 min at RT, and DNA was precipitated from 800 jil 
of supernatant by adding 0.6 volumes of isopropanol and incubating on ice for 10 mm. 
Nucleic acids were pelleted at 10000 x g for 10 min at 4°C, washed with 70 % 
ethanol and air dried. The solution was extracted with an equal volume of phenol, 
followed by an equal volume of chloroform, and the DNA precipitated by adding 0.1 
volumes of 3 M sodium acetate pH 5.2, 2 volumes of ice cold ethanol and incubating 
at -20°C for at least 1 h. DNA was either stored as ethanol precipitates, or pelleted at 
10000 x g for 10 min at 4°C, washed with 70 % (v/v) ethanol, air dried, resuspended 
in 50 j.il TE buffer, and stored at 4°C. 
Plasmid DNA was also extracted from E. coli using the QlAprep spin column kit 
(QIAGEN) as recommended by the manufacturer. This method provided RNA free 
DNA suitable for manual sequencing with Sequenase version 2.0 (Amersham). 
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2.9.3 Large Scale Plasmid Preparation From Escherichia coli. 
A single colony of E. coil containing the plasmid of interest was used to inoculate 
100 ml of L broth plus 50 Vg/ml ampicillin, and grown overnight at 37°C with 
shaking. The overnight culture (50 ml) was used to inoculate a 500 ml flask of L 
broth plus 50 tg/ml ampicilhin, which was grown overnight at 37°C with shaking. 
Cells were pelleted at 5000 x g for 20 min at 4 °C, and the pellet was resuspended in 
8 ml of glucose buffer (section 2.9.2). Glucose buffer (2 ml) containing 50 mg of 
lysozyme was then added to the cell suspension (final concentration 5 mg/mI) and 
incubated at RT for 5 mm, after which 20 ml of a freshly prepared solution of 0.2 M 
NaOH, 1 % (w/v) SDS was added, mixed well by inversion, and left on ice for 
10 mm. Proteins were precipitated by the addition of 15 ml of ice cold 5 M potassium 
acetate and incubation on ice for 10 mm. The precipitate was removed by 
centrifugation at 20000 x g for 20 min at 4°C, and the nucleic acids precipitated from 
the supernatant by the addition of 0.6 volumes of isopropanol and incubation at RT 
for 15 mm. The precipitated nucleic acids were pelleted at 12000 x g for 30 min at 
RT, washed with 70 % (v/v) ethanol, and allowed to air dry before being resuspended 
in 2 ml of TE buffer. 
Plasmid DNA was further purified from host bacterial DNA on a caesium chloride 
gradient of density 1.55 g/ml. The DNA solution was mixed with 15 g of caesium 
chloride and 1 ml of ethidium bromide (10 mg/ml stock), and TE buffer was added 
dropwise until the solution weighed exactly 31 g, giving a final volume of 20 ml, with 
a caesium chloride density of 1.55 glml. The caesium chloride was dissolved 
completely, and a fine precipitate which formed was removed by centrifugation at 
3000 x g for 10 min at RT to provide a cleaner gradient. The clarified solution was 
transferred into quickseal ultracentrifuge tubes (Beckman), overlaid with mineral oil, 
and spun at 220000 x g for 16 h at 20°C in a Ti70 fixed angle ultracentrifuge rotor 
(Beckman). Plasmid and genomic DNA bands were visualised with long wave UV on 
a TM 20 (302 nm) UV tran sill uminator (GRI), and the lower plasmid band removed 
by tube puncture with a needle and syringe. Ethidium bromide was removed from the 
sample by extracting 4-6 times with an equal volume of water-saturated butan- 1 -ol. 
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aesium chloride was removed by dialysing 3 times against 1 litre of TE buffer over 
24 h. Plasmid DNA was then precipitated by the addition of 0.1 volumes of 3 M 
sodium acetate pH 5.2, 2 volumes of ethanol, and incubating at -20°C for at least 1 h. 
DNA was then pelleted at 10000 x g for 10 min at 4°C, washed with 70 % (v/v) 
ethanol, air dried, and resuspended in 100 p1 of TE buffer. The DNA concentration 
of each sample was measured at A 280 in a spectrophotometer, where 1 Absorbance 
unit is equal to 50 ig/m1 ds DNA. 
2.9.4 Preparation of Single Stranded DNA from Eschuichia coli. 
Single stranded DNA was prepared from the phagemid vector pBluescript II KS - 
using the helper phage M13K07 (Bio-Rad). A single colony of E. coli was used to 
inoculate 10 ml of L broth plus 50 pgJml ampicillin, and grown overnight with 
shaking at 37°C. The overnight culture (10 p1) was used to inoculate 10 ml of fresh L 
broth plus 50 j.tg/ml ampidihin and grown at 37 °C until A600 was 0.4 - 0.6. At this 
point, 2 ml of the culture was infected with 1 p1 (7.5 x 10 7 pfu) of helper phage 
M13K07 and grown at 37°C for 1 h. This culture (400 tl) was then used to inoculate 
10 ml of fresh L broth containing 50 .tg/m1 ampidilhin and 70 xg/ml kanan -iycin, and 
grown overnight at 37°C. 
Cells were pelleted from 1.5 ml of the overnight culture, and the supernatant mixed 
thoroughly with 0.3 ml of 2.5 M NaCl, 20 % (w/v) PEG 6000. After 15 min at RT, 
the tube was spun at 10000 x g for 5 min at RI, and the supernatant removed, leaving 
a small pellet of phage heads. The pellet was resuspended in 100 41 of TE buffer, 
extracted with 50 p1 of phenol, followed by 500 p1 of chloroform, and the DNA 
precipitated with 0.1 volumes of 3 M sodium acetate p1-I 5.2, and 2 volumes of 
ethanol at -20°C for at least 1 h. The precipitate was pelleted at 10000 x g for 10 mm 
at 4°C, washed with 70 % (v/v) ethanol, air dried, and resuspended in 50 tl of TE 
buffer. 
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2.9.5 Agarose Gel Electrophoresis. 
DNA digests were mixed with 0.5 volumes of Ficoll based loading dye (15 % [w/v] 
Ficoll 400 [Pharmacia], 0.1 % [w/v] bromophenol blue, 0.1 % [w/v} xylene cyanol if) 
and the fragments were separated on 0.6 % (w/v) agarose gels containing 0.5 jig/ml 
ethidium bromide, at 40 - 100V in lx TBE (89 mM Tris, 89 mM boric acid, 2.5 mM 
EDTA pH 8.3). DNA fragments were then visualised with long wave UV on a TM 
20 (302 nm) transilluminator (GRI), and their size estimated from a 1 kb ladder 
(Gibco BRL) which was run on every gel as a marker. 
2.9.6 Purification of DNA Fragments From Agarose. 
DNA fragments were run on agarose gels (as described in section 2.9.5) containing 
inserts of low melting point (LMP) agarose. Once the fragment in question had 
entered the LMP insert, it was excised under UV light, and transferred to a tared 
1.5 ml microcentrifuge tube. The agarose was mixed with 0.04 volumes of x25 
Agarase buffer (Boehringer), and incubated at 65°C for 15 mm. After cooling to 
45°C, 1 U of Agarase was added per 100 mg of agarose. and the mix incubated at 
45°C for 1 h. After extraction with an equal volume of phenol, followed by an equal 
volume of chloroform, the DNA fragments were precipitated with 0.1 volumes of 3 M 
sodium acetate pH 5.2, and 2 volumes of ethanol at -20°C for at least 1 h. The 
fragments were pelleted at 10000 x g for 10 min at 4 °C. washed with 70 % (vlv) 
ethanol, air dried, and resuspended in a small volume of distilled water (10 - 50 jil). 
2.10 DNA Sequencing. 
DNA was prepared by both QlAprep spin columns (section 2.9.2), and large scale 
alkaline lysis (section 2.9.3) for use in sequencing reactions. Approximately 2 jig of 
double stranded DNA was denatured in 0.4 M NaOH at 37 °C for 30 mm, then 
precipitated with 0.1 volumes of 3 M sodium acetate pH 4.:5 and 2 volumes of ethanol 
at -70°C for 1 h. The DNA was pelleted at 10000 x g for 10 n-dn at 4°C, washed with 
70 % (v/v) ethanol and air dried. The pellet was resuspended in 4 p.1 of distilled 
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water, and mixed with 2 tl of x5 Sequenase reaction buffer and 4 p.1 of a 0.8 p.M 
dilution of sequencing primer. Primers were annealed at 65°C for 20 mm, cooled 
slowly to RT over approximately 1 h, and placed on ice. The S8 gene was sequenced 
using the M13 Universal Primer (Pharmacia), a pMS1S specific primer 
(ACGTACGGTACCAAGCT), and a series of internal 17-mer oligonucleotides 
(Appendix I). Annealing mixes were then sequenced with Sequenase version 2.0 
(Amersham) as recommended by the manufacturer. To achieve better incorporation 
of isotope into the G/C rich mycobacterial DNA, the protocol was changed to include 
dCTP labelling mix, 35S dCTPaS, and a 1:4 dilution of the Sequenase enzyme. 
Reactions were originally run on 7M urea, 8 % (v/v) acrylamide gels, but several 
compressions were encountered which did not resolve correctly under these 
conditions. Subsequently, all reactions were run on 40 % (v/v) formamide, 7 M urea, 
8 % (w/v) acrylamide gels, at 40 mA constant current in glycerol tolerant sequencing 
buffer (1.78 M Tris, 0.57 M taurine, 0.01 M EDTA) to eliminate compressions, as 
recommended by USB. Formamide gels were fixed in 20 % (v/v) methanol 5 % (v/v) 
acetic acid for 15 mm, then dried onto Whatmann 3 mm filter paper and exposed to 
Curix RP1 X-ray film (AGFA) overnight at RT. 
2.11 Polymerase Chain Reaction (PCR). 
2.11.1 PCR of S8 DNA Insert. 
Template DNA was prepared by boiling a single colony of E. coil containing the 
pUC18/S8 plasmid in 100 p.1 of distilled water for 5 mm. PCR amplification of the S8 
insert was achieved by addition of 5 p.1 of template DNA to a reaction mix containing 
50 mM KC1, 10 mM Tris/HCI pH 8.8, 1 mM MgCl,-, 200 p.M each dNTP, 200 p.g/m1 
gelatin, 0.25 U Taq polymerase (Boehringer), and 0.2 p.M both forward 
(CTCGAGCTCCCGCGACCAGGAGGGTGA) and reverse (CTCAAGCTTCAGG 
CCGGCGGCCCCTCCG) primer (50 p.1 final reaction volume). The PCR conditions 
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were optimised at 95°C for 1 mm, 55°C for 1 mm, and 7:5°C for 3 mm (25 cycles), 
followed by 1 cycle of primer extension (75°C, 5 mm). 
2.11.2 PCR of 16S Ribosomal RNA Gene. 
The 16S rRNA PCR was designed to specifically amplify the mycobacterial rRNA 
gene, and was used primarily to identify mycobactei -ia in clinical samples (Wilton & 
Cousins, 1992). However, the PCR product could be used also to identify 
mycobacterial DNA by hybridising to dot blots or Southern blots of test DNA 
(section 8.2.2). PCR amplification of the 16S rRNA gene was achieved by the 
addition of 5 tl of M.a. paratuberculosis DNA (supplied by K. Stevenson) to a 
reaction mix containing 67 mM Tris/HC1 pH 8.8, 16.6 mM ammonium sulphate, 
200 j.tM each dNTP, 2 MM  MgC12, 0.25 U Taq polymerase (Boehringer) and 
0.25 j.tM both forward (AGAGflTGATCTGGCTCAG) and reverse 
(TGCACACAGGCCACAAGGGA) primers (25 il final reaction volume). PCR 
conditions were 1 cycle of 94°C for S mm, 62°C for 3 min and 75°C for 3 mm, 
followed by 34 cycles of 94°C for 30 s, 62°C for 3 min and 75°C for 3 mm. 
2.11.3 Detection of PCR Product on Acrylamide Gels. 
PCR reaction (10 .tl) was mixed with 5 jtl of Ficoll based loading buffer (section 2.9) 
and run on 10 % (w/v) actylamide gels in lx TBE (section 2.9.5) at 200 V for 30 mm 
(Bio-Rad Mini Protean II). Gels were then fixed in 10 % (v/v) ethanol, 1 % (v/v) 
acetic acid for 5 mm, stained in 0.2 % (w/v) AgNO 3 for 5 mm, and finally developed 
in 3 % (w/v) NaOH, 0.75 % (w/v) formaldehyde until bands were visible. The 
reaction was stopped by washing in 200 ml of 0.75 % (w/v) Na 2CO3 . 
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2.12 Cloning PCR Products. 
2.12.1 Ligation into Vector DNA. 
DNA was amplified by PCR as described in section 2.11.1, using primers specifically 
designed to encode different restriction enzyme sites at both 5' and 3' ends of the 
PCR product (Appendix I), and allowed directional cloning of the DNA fragment into 
digested vector DNA. Both PCR product and vector were digested with the same 
restriction enzymes (Sad, HindlII), and purified from LMP agarose as described in 
section 2.9.6. Purified insert and vector were mixed at a ratio of 3:1 respectively 
(usually 150 ng: 50 ng) with 1 U of T4 DNA ligase, and incubated at 12°C overnight 
in lx ligase buffer (Boehringer). A ligation control consisting of linearised vector was 
also incubated overnight with 1 U of ligase to ensure the reaction was successful. 
Ligations were then used to transform competent E. coil. 
2.12.2 Preparation of Competent Cells. 
A single colony of E. coil was used to inoculate 10 ml of L broth plus 50 Lg/ml 
ampicillin, and grown overnight at 37°C with shaking. The culture (100 jil) was used 
to inoculate 10 ml of fresh L broth plus 50 .xgJml ampicillin and grown at 37°C for 
approximately 2.5 h, until the A 600 was between 0.5 and 0.8. Cells were pelleted at 
3800 x g for 15 min at 4 °C, and resuspended in 5 ml of ice cold 100 mM CaC1 2. After 
20 min on ice, the cells were re-pelleted at 3 800 x g for 15 min at 4°C, and 
resuspended in 1 ml of ice cold 100 mM CaC1 2. The competent E. coil cells were 
stored on ice for at least 1 h before use. 
2.12.3 Transformation of Competent Cells. 
Competent E. coil (100 j.tl) were mixed with 1 - 10 .i1 (20 - 50 ng) of ligated DNA 
(section 2.12.1), 50 ng of ligation control, or 50 ng of closed circular vector 
(transformation control), and left on ice for 10 - 60 min. Cells were then subjected to 
heat shock at 42°C for 3 min, and mixed with 500 t1 of pre-warmed L broth 
containing 10 mM MgCl,-, at 37°C for 1 h. Transformed E. coil were then selected by 
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plating 200 j.fl aliquots of each transformation reaction onto L agar plates containing 
50 p.g/ml ampidilin, and incubating overnight at 37 °C. Only cells containing ligated 
vector were capable of growth. 
2.13 Nucleic Acid Hybridisation. 
2.13.1 Southern Blotting. 
Approximately 1 j.tg of genomic mycobacterial DNA was digested overnight at 37 °C 
with 40 U of EcoRI, and the fragments separated on a 0.6 % (w/v) agarose gel, as 
described in section 2.9.5. After photographing with a ruler, the kb ladder was 
removed, and the gel was washed first in denaturing solution (0.2 M NaOH, 0.6 M 
NaC1) for 45 mm, rinsed 3x in distilled water, and then washed in neutralising solution 
(1 M Tris/HC1 pH 7.5, 0.6 M NaCI) for 1 h. Nucleic acids were then transferred to a 
sheet of Hybond (Amersham) by capillary action (Southern et al., 1975; Sambrook et 
al., 1989), using 10 x SSC (1.5 M NaCl, 0.15 M Na3 C6H509. 2H20), Whatmann 
3 mm filter paper, and a stack of paper towels as described previously (Sambrook et 
al., 1989 for diagram). After blotting overnight, the Hyboiid was washed in 2 x SSC, 
air dried, and cross-linked on a calibrated TM 20 (302 nm) UV tran sill uminator (GRI) 
for  mm. 
2.13.2 Dot Blotting DNA. 
Approximately 200 ng of mycobacterial DNA was denaturc:d in 0.4 M NaOH, 10 mM 
EDTA at 100°C for 10 mm, and neutralised by adding an equal volume of 2 M 
NH4Ac pH 7.0. A sheet of Hybond (pre-wetted in 10 x SSC) was cut to fit the 
manifold of a Bio-Rad 96 well Dot Blotter, and assembled according to the 
manufacturers instructions. Any blank wells were sealed off with masking tape, and 
the membrane was washed under vacuum with 500 j.tl of distilled water per well. 
Each sample was applied to a separate well, removed gently under vacuum, and 
washed through with 500 jil of 2 x SSC under vacuum. The blot was then removed 
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from the apparatus, washed in 2 x SSC, air dried, and cross linked on a calibrated TM 
20 (302 nm) UV transilluminator (GRI) for 5 mm. 
2.13.3 Labelling DNA Probes by Random Priming. 
DNA inserts and PCR products were purified from agarose as described in section 
2.9.6. DNA was denatured by heating to 100 °C for 3 mm, and immediately 
quenching into an ice bath. Approximately 200 -500 ng of DNA was mixed with 3 j.tl 
of dNTPs (500 jiM each A G T), 2 jil hexanuclecitides (Boehringer), 5 j.tl 
(1.85 MBq/50 ji.Ci) [(X32  P]dCTP, and 1 jil (2 U) Klenow in 20 j.il final volume, and 
allowed to label overnight at RT. Incorporation of label was checked by thin layer 
chromatography (TLC). Labelling mix (1 jil) was applied to a strip of TLC paper 
(Polygram cel 300; Can -dab) 10 mm from the base, and allowed to dry. The strip was 
then placed in 5 mm of 750 mM KH2PO4 pH 3.5, and left for 20 min at RT, until the 
liquid had travelled up approximately 75 % of the strip. The chromatogram was 
exposed to X-Omat S film (Kodak) for 10 mm, after which the autoradiograph was 
developed. Incorporated label remained in the original spot on the chromatogram, 
and unincorporated label was seen to migrate upwards. If sufficient incorporation had 
occurred (approximately 25 %) the probe was used to hybridise to Southern blots and 
dot blots as described in section 2.13.4. 
2.13.4 Hybridisation and Autoradiography. 
Hybond filters were soaked in prehybridisation mix (6 x SSC, 5 x Denharts, 0.5 % 
[w/v] SDS, 100 jig/ml denatured herring sperm DNA), and inserted into a Hybaid 
tube containing 10 ml of prehybridisation mix warmed to 65°C, and prehybridised 
overnight at 65 °C. The 32P labelled probe (section 2.13.3) was denatured at 100 °C for 
3 mm, added to the prehybridisation mix and filter, and left to hybridise overnight at 
65°C. The probe was carefully decanted, and the filter was washed at 65 °C for 2 h in 
60 ml of 0.1 % (w/v) SDS containing decreasing amounts of SSC (3x SSC down to 
0.1x SSC, changing buffer every 30 mm). The filter was then removed from the 
Hybaid tube, sealed in cingfilm and exposed to X-Omat S film (Kodak) at -70°C 
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overnight. If a weak signal was obtained on developing the autoradiograph, the filter 
was re-exposed for 2-7 days. 
2.14 Site Directed Mutagenesis. 
The method of site directed mutagenesis used (F. Manson, ICMB, University of 
Edinburgh, personal communication) was a modification of that described by Kunkel 
(1985) which utilises ssDNA containing uracil (prepared from E. coli BW313, as 
described in section 2.9.4) as a template for extension of a mutagenic oligonucleotide 
by T4 DNA polymerase. After ligation with T4 DNA ligase, the dsDNA is 
transformed into E. coli TG1 to select for mutated sequences. 
A 27-mer oligonucleotide was synthesised (Oswel), containing a 1 bp mismatch 
(CATCGGGCCACCGGCGTCGCCCGGCTT), which would introduce the desired 
mutation into the S8 gene. The oligo (200 pMols) was phosphorylated with 5 U of 
polynucleotide kinase (PNK) in 30 p.1 of lx PNK buffer (Boehringer) at 37°C for 
45 mm, after which the enzyme was deactivated by heating to 68 °C for 10 mm. The 
ssDNA template (200 ng) was mixed with 4 pMols of freshly phosphorylated oligo in 
40 mM Tris/HC1 pH 7.5 (17p.l final volume), and the primer was annealed at 70°C for 
3 mm, 37 °C for 30 mm, and placed on ice until required. 
The 17 p.1 annealing reaction was mixed with 5 91 of 100 MM M902, 19 p.1 of 
nucleotide mix (2 p.1 each dNTP [A,G,C,T] at 0.9 mM, 2 p.1 of 20 mm ATP, 2 p.1 of 
100 mM dithiothreitol, and 7 p.1 of distilled water), 3U T4 DNA polymerase and 3 U 
T4 Ligase, and incubated at 16°C for 40 h. The mixture (10 p.!) was then used to 
transform E. coli TG  and BW313 as described in section 2.12.3. TG1 transformants 
were then checked for possession of the mutation by DNA sequencing as described in 
section 2.10. 
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Site directed mutagenesis was also performed using the Mutagene Mutagenesis 
System (Bio-Rad), as directed by the manufacturer. Single stranded DNA was 
prepared from E. co/i BW313 as described in section 2.9.4, and the mutagenic 
oligonucleotide described above was annealed to the template DNA before extending 
and ligating with 17 DNA polymerase and T4 DNA ligase respectively (see literature 
supplied with kit for details). 
Chapter 3 
Characterisation of Recombinant Clones. 
3.1 Introduction. 
A Xgtl 1 genomic expression library of M. a. paratuberculosis was screened with serum 
from a sheep with clinical paratuberculosis (Johne's disease) in order to identify genes 
and gene products which were expressed in vivo, and involved in the host's immune 
response to infection. Several clones were identified which were shown by Western 
blotting with known MAbs to be distinct from the major M.a. paratuberculosis heat 
shock proteins, HSP 65 (Colston et al., 1994) and HSP 70 (Stevenson et at., 1992), as 
HSP 70 had previously been isolated from expression libraries by screening with hyper-
immune serum. Two clones of interest, designated S4 (1.6 kbp insert) and S8 (3 kbp 
insert), were found to contain cross-reacting epitopes when expressed as lysogens in E. 
coli Y1089. Specific antibody, which had been prepared by eluting from each lysogen 
(section 2.6), reacted with both S4 and S8 lysogens on Western blots, and also reacted 
with a protein of approximately 34 kDa on Western blots of M.a paratuberculosis 
lysates, but not M.a. silvaticuni lysates. These preliminary results suggested the two 
clones contained overlapping fragments of the same gene, which encoded a species-
specific protein of 34 kDa in M.a. para tuberculosis. 
Although the two clones were originally expressed as lysogens, these constructs 
contained no cloning sites, and were integrated into the E. co/i genome, making further 
genetic manipulation of the clones very difficult. In order to overcome these problems, 
the ? DNA inserts were subcloned into the EcoRI sites of pUC18 (Figure 3.1), and the 
pMS iS (Figure 3.2) and pGEX-1T (Figure 3.3) expression vectors, and transformed 
into E. coli JM109 (pUC18) and NM522 (pMS1S and pGEX). These constructs could 
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be easily purified for use in sequencing reactions, or any further genetic manipulation, and 
also could be used to express large amounts of recombinant fusion protein in E. coil. 
Recombinant proteins encoded by specific DNA inserts can be characterised by two 
different methods. The first is to clone the insert into an expression system, which allows 
the production and purification of large (mg) amounts of recombinant protein. The 
advantage of this system is that recombinant proteins can be expressed and purified in a 
relatively short period of time (2-3 days), overcoming the 6-8 week culture period 
required for the production of M.a. paratuberculosis. The second approach is to 
determine the DNA sequence of the insert, and after identifying the correct ORF, and 
deduce an amino acid sequence which should correspond to that of the native protein. 
These sequences can then be screened in database searches to identify any related genes 
or proteins which have already been characterised. 
The S4 and S8 DNA inserts were characterised by both of these approaches. The inserts 
were expressed as recombinant fusion proteins, and used to raise MAbs which verified 
the molecular weight of the native protein in M.a. paratuberculosis. DNA was prepared 
from these clones and used for sequence analysis to produce both DNA and deduced 
amino acid sequences. These sequences were used in database searches in order to 
identify any related proteins, and any possible function of the native protein represented 
by the S4 and S8 inserts. 
Me- 
3.2 Results. 
3.2.1 Expression and Purification of Fusion Proteins. 
The pMS1S Expression Vector 
The S4 and S8 DNA inserts had been previously subcloned into the pMS1S expression 
vector (Figure 3.2), and transformed into competent E. coil NM522. This vector was 
chosen for its ability to produce an intracellular 3 galactosidase fusion protein on 
induction with IPTG, which could be affinity purified on a column of ABTG agarose, and 
easily detected on Western blots by probing with antiserum to 13 galactosidase. Use of 
this vector enabled also the release of the recombinant antigen from its fusion partner on 
incubation with the protease Factor Xa (Figure 3.2). 
Fusion proteins were expressed in E. co/i NM522 from both pMS1S/S4 and pMS1S/S8 
constructs as described in section 2.4. Initially induced cells were lysed by freeze-
thawing to release the intracellular fusion protein, and after clarification at 100000 x g for 
10 n-dn at 4°C both pellet and supernatant were analysed by SDS PAGE and Western 
blotting (section 2.3). The blots revealed that approximately 70 % of the S4 fusion 
protein and 90 % of the S8 fusion protein was present in an insoluble form in the 
100000 x g pellet. It was also noticed that repeated freeze-thawing of the clarified lysate 
containing the S4 fusion protein (during storage at -20°C) caused the appearance of a 
white precipitate. In order to determine the nature of this material, it was pelleted at 
11000 x g for 10 min at RT, and analysed by SDS PAGE and Western blotting (section 
2.3), which revealed the precipitate to Consist of the remaining fusion protein. This 
indicated that freeze-thaw cycles should be avoided during the purification of these 
particular fusion proteins, and an alternative method of lysis used. Sonication also was 
found to be unsuccessful, as after 10 x 6 s bursts at maximun power, no lysis of the E. 
coil was observed when the cells were examined by phase contrast microscopy. Cells 
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Figure 3.1 The pUC18 Expression Vector. 
The general cloning vector pUC18 contains a multiple cloning site within the lacZ gene, 
and on induction of the lacZ promoter in the presence of X-gal allows screening for 
cloned inserts by blue/white colour selection. Inserts can also be expressed as fusion 







Figure 3.2 The pMS1S Expression Vector. 
The pMS1S expression vector is one of a series of three vectors (pMS1S, pMS2S & 
pMS3S) which allow inserts to be cloned and expressed in all three ORFs. A multiple 
cloning site is situated at the 3' end of the lacZ gene, which on induction of the lac 
promoter with IPTG, allows expression of cloned inserts as fusion proteins with the 
entire 116 kDa 3-ga1actosidase protein. A Factor Xa cleavage site is encoded between - 
galactosidase and the multiple cloning site, which allows separation of the recombinant 
protein from -galactosidase on incubation of the fusion protein with the protease Factor 
Xa. The vector carries the selectable marker for ampicillin resistance. 
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subsequently were lysed in a mini French pressure cell, and the lysate immediately 
clarified (section 2.4.1). Both pellet and supernatant were examined by SDS PAGE and 
Western blotting (section 2.3), and approximately 90 % of the S4 fusion protein was 
found to be in a soluble form in the supernatant. The S4 fusion protein was easily 
purified from the clarified supernatant by affinity chromatography on ABTG agarose 
(section 2.4.2). Approximately 3.5 mg of fusion protein was recovered from a 100 ml 
culture of induced E. coli. Once purified, the fusion protein did not precipitate on freeze-
thawing, and was successfully stored in 1 ml aliquots at -20 °C. 
After lysis in a French pressure cell, the S8 fusion protein remained in an insoluble form 
in the 100000 x g pellet. When solublised in SDS and analysed by SDS PAGE, this 
fusion protein was found to be expressed at a low level (approKimately 5 % of the level of 
S4 fusion protein), and presented an immunogenic band of approximately 55 kDa, as well 
as the fusion protein band at >116 kDa. Due to the insolubility, this fusion protein could 
not be purified by affinity chromatography, and therefore was not characterised further at 
this point. 
The pMS1S expression vector encodes a Factor Xa cleavage site, which is situated 
between lacZ and the multiple cloning site (Figure 3.2). Purified S4/f3Gal fusion protein 
(100 .tg) therefore was incubated for 16 h at 4 °C with 10 p.g of bovine Factor Xa 
protease (section 2.4.3) to obtain release of the recombinant protein from its fusion 
partner. The resulting digestion products were separated by SDS PAGE and visualised 
by staining with Coomassie blue. The S4fl3Gal fusion protein was successfully cleaved as 
indicated by the disappearance of the fusion protein band and the appearance of a 
116 kDa band (13  galactosidase). However, no other digestion products were detected by 
either Coomassie staining or Western blotting (results not shown). The recombinant 
portion of the fusion protein was therefore degraded into small peptides by Factor Xa, 
which were not resolved by the SDS PAGE conditions described in section 2.3.1. The 
degradation may have been due to the presence of internal Factor Xa sites (although none 
were detected on sequencing the insert; section 3.2.3), or to non-specific cleavage by 
Factor Xa, as has been reported by some researchers (Colston et al., 1994; K. Stevenson, 
personal communication). 
The pGEX-1A.T Expression Vector. 
The S4 and S8 DNA inserts had been previously subcloned into the pGEX-l?J 
expression vector (Figure 3.3) which was designed to express recombinant proteins as 
fusions with glutathione-S-transferase (GST). Release of the recombinant antigen from 
its fusion partner could be achieved by incubation of the fusion protein with thrombin. 
The inserts therefore were expressed in this system in an attempt to overcome the 
problems of insolubility and non-specific cleavage by Factor Xa which were associated 
with the -galactosidase fusion proteins. 
GST fusion proteins were expressed in E. co/i NM522 from pGEX/S4 and pGEX/S8 as 
described in section 2.4.1. Cells were lysed in a mini-French pressure cell, as described 
previously, and the lysate immediately clarified. Both supernatant and pellet were 
subsequently analysed by SDS PAGE and Western blotting (section 2.3). The S4/GST 
fusion protein was found to be completely soluble, and have a molecular weight of 
approximately 50 kDa, but a number of other bands between 30 and 40 kDa were present 
which also reacted strongly with the antiserum. The S8 DNA insert could not be 
expressed in this system. SDS PAGE analysis of induced lysa.tes of E. co/i NM522 (both 
supernatant and pellet) containing the pGEX/S8 expression vector produced no 
detectable fusion protein by either Western blotting or Cooinassie staining (results not 
shown). 
The S4/GST fusion protein was purified by affinity chromatography under non- 
denaturing conditions on a column of glutathione Sepharo;e, as described in section 
2.4.4. The fusion protein (50 kDa) was purified from the clarified lysate, but five other 
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Figure 3.3 The pGEX-1?.T Expression Vector. 
The pGEX-1A.T expression vector contains a multiple cloning site at the 3' end of the 
gene for glutathione-S-transferase (GST) which allows the cloning and expression of 
DNA inserts as fusion proteins with GST on induction of the tac promoter with IPTG. 
The vector encodes a thrombin cleavage site between the GST gene and the multiple 
cloning site which allows the separation of the recombinant protein from GST on 
incubation of the fusion protein with thrombin. The vector contains the selectable marker 
for ampidillin resistance, and the pBR322 origin of replication. 
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proteins of molecular weight 30 - 40 kDa were also bound by the column (Figure 3.4, 
lane 2). As these proteins were recognised by the antiserum, and were purified on 
glutathione Sepharose, they probably represented breakdown products or partially 
translated proteins which still contained the GST portion, allowing copurification with the 
fusion protein. As the S4/GST fusion protein was sized at approximately 50 kDa and 
GST was known to have a molecular weight of 27 kDa, the molecular weight of the S4 
recombinant was calculated to be 23 kDa. This is significantly less than the molecular 
weight of the native protein (34 kDa) and indicated that the S4 insert represented a 
fragment of the gene encoding the 34 kDa protein. 
The pGEX-1X.T vector encodes a thrombin cleavage site which is situated between GST 
and the MCS. The S4/GST fusion protein (250 jtg) was therefore digested with 2.5 .tg 
of thrombin (as described in section 2.4.5) to allow release of the 23 kDa recombinant 
from GST (27 kDa). Samples of the digestion mixture were removed at 30, 60, 90 and 
120 mm, and analysed by SDS PAGE and Coomassie staining (Figure 3.4). After 30 mm 
digestion the 50 kDa fusion protein band had reduced, and a corresponding increase in 
released 27 kDa GST was observed, indicating cleavage of the fusion protein. The 
predicted 23 kDa recombinant protein was not evident after digestion, although two 
bands of molecular weight <12 kDa were detected by Coornassie staining (Figure 3.4). 
The appearance of these bands corresponded with the disappearance of the 50 kDa fusion 
protein, and they therefore may represent digestion products of the S4 protein, caused by 
the presence of internal thrombin cleavage sites. However, in samples treated with 
thrombin for more than 30 mm, digestion of the 5 lower molecular weight bands (which 
were copurified with the 50 kDa fusion protein on the glutathione Sepharose column) 
became more apparent, and the two bands at <12 kDa may have been the result of 
digestion of these other proteins. Hence the origin of these digestion products could not 
be confidently determined. 
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Figure 3.4 Thrombin digest of GSTIS4 fusion protein. 
S4/GST fusion protein (250 jig) was digested with Thrombin (2.5 .tg) in order to release 
the recombinant S4 protein from its GST fusion partner. Lane 1, molecular weight 
markers; Lane 2, undigested S4/GST fusion protein after purification on glutathione 
sepharose; Lanes 3-6, purified S4/GST fusion protein plus thrombin, sampled at 30 mm. 
60 mm. 90 min and 120 min respectively; Lane 7, thrombin (2 .tg).  Gel stained with 
Coomassie blue. 
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3.2.2 Identification of Native Protein. 
In order to confirm the preliminary antibody elution results (section 3.1) and verify the 
molecular weight of the native protein represented by the S4 and S8 clones, the 
experiment was repeated using specific antibody prepared by eluting clinical serum 
(JD87/39) from purified S4/JGa1 fusion protein (section 2.6). 
Antibody eluted from 500 ig of purified S4/I3Gal  fusion protein was prepared as 
described in section 2.6, and used to probe Western blotted lysates of both M.a. 
paratuberculosis and M.a. silvaticum. This polyclonal antibody, specific for the S4 
recombinant, recognised a band of 34 kDa in both organisms (Figure 3.5), which 
contradicted the original observations that the protein was specific for M.a. 
paratuberculosis (section 3.1). Monoclonal antibodies raised against S4/Gal fusion 
protein (Cameron et al., 1994) recognised also a protein of 34 kDa in Western blotted 
lysates of both M.a. paratuberculosis and M.a. silvaticuni. Hence the 34 kDa protein 
was recognised by both monoclonal and polyclonal antibody specific to the S4 
recombinant. 
The S4 eluted antibody also was found to recognise S8/I3Gai fusion protein by Western 
blotting (results not shown). This result did not prove conclusively the cross-reactivity of 
the S4 and S8 recombinant clones because absorption of serum is rarely 100 % efficient, 
and this reaction could have been due to the presence of a small amount of anti-13 
galactosidase antibodies, which also would have bound to the fusion protein giving a false 
positive result. However, the S8fl3Gal fusion protein was recognised by the MAbs raised 
against S4/I3GaI fusion protein (which also recognised the native 34 kDa protein), 
suggesting that the S4 and S8 DNA inserts did indeed contain fragments of the same 
gene. 
In order to support the immunological data and confirm the relationship of the S4 and S8 
DNA inserts, a DNA hybridisation assay was performed. Both S4 and S8 DNA inserts 
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Figure 3.5 Antibody Elution From S4II3GaI Fusion Protein. 
Clinical sheep antibody was eluted from purified S4/I3Gal  fusion protein and used to 
probe western blotted lysates of M.a. paratuberculosis (Lane 1) and M.a. silvaticum 
(Lane 2) in order to identify the native protein represented by the S4 and S8 clones. 
Proteins were visualised with Dako anti-sheep HRP conjugate diluted 1:1000. 
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(100 pg) were Southern blotted onto Hybond in duplicate as described in section 2.13.1. 
The blots were then hybridised (section 2.13.4) overnight at 65°C with either S4 or S8 
insert (100 ng) which had been labelled with [a 3' -P1 dCTP (section 2.13.3). After 
washing, the blots were examined by autoradiography. Each probe hybridised with both 
S4 and S8 DNA inserts, confirming the presence of the same sequence in each insert 
(results not shown). 
3.2.3 Characterisation of the Gene Contained in the S4 and S8 DNA Inserts. 
Mycobacterial DNA is characteristically GC rich (approximately 65 - 70 %), and 
consequently can be difficult to sequence. Compressions are commonly encountered 
when reading sequences from highly GC rich regions, which may be 95 - 100 % GC over 
a series of 25 bases. The sequencing strategy adopted had been optimised previously to 
produce clear, readable sequences when sequencing with Sequenase version 2.0 (K. 
Stevenson, personal communication; section 2.10). The combination of high enzyme 
concentration and formamide gels resolved most compressions, providing an accurate 
sequence. However, some compressions were only resolved when sequencing the 
reverse strand. 
The S4 DNA insert had been expressed successfully both as soluble 13-galactosidase and 
GST fusion proteins, and shown to encode 23 kDa of the native 34 kDa protein in M.a. 
paratuberculosis. The S4 insert was therefore chosen for sequencing to identify the 
correct reading frame. Plasmid pMS1S/S4 DNA was prepared from E. coli NM522 as 
described in section 2.9.3, and 2 p.g was used in sequencing reactions with Sequenase 
version 2.0 (Section 2.10). The sequence obtained from pMS1S/S4 DNA was of poor 
quality and proved difficult to read. This difficulty was later attributed to the host 
bacterial strain (NM522), which has been reported to produce DNA of poor quality for 
sequencing (Taylor et al., 1993). However, the sequence across the EcoRI site into the 
S4 insert could be determined in this expressing vector to establish the correct orientation 
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of the clone. Subsequent sequence was obtained from pUC18/S4 DNA, purified from E. 
co/i TM 109 which provided a superior quality of sequence on autoradiographs. 
The S4 DNA insert was found to contain a reading frame of 630 bp terminated by a TGA 
stop codon, which encoded a protein of 210 amino acids, and represented the 3' end of 
the gene. As the S4 and S8 inserts had been shown by antibody elution and DNA 
hybridisation to contain fragments of the same gene (section 3.2.2), the S8 DNA insert 
was sequenced to determine the presence of any further upstream sequence in this clone. 
As before, DNA was prepared from pMS1S/S8 and pUC18/S8 (section 2.9.3) and 
sequencing reactions were performed as described previously (section 2.10). The S8 
insert was found to contain the same ORF as found in the S4 insert, plus an additional 
480 bp upstream (Figure 3.6). This insert also contained a possible Shine Dalgamo 
sequence and ATG start codon (Figure 3.6, positions 11 - 17 and 25 - 27), and 
represented the entire ORF of 1083 bp. These sequence data confirmed that the 2 clones 
contained fragments of the same 1083 bp gene, encoding a protein of 361 amino acids, 
with a predicted molecular weight of 35.7 kDa (using GCG programme 
'PEPTIDESORT'). 
Database searches using the complete deduced amino acid sequence were performed on 
the SERC Daresbury SEQNET computing facility. A SWEEP search (Akrigg et al., 
1988) of the OWL protein database (Bleasby & Wooton, 1990) revealed no exact 
matches. This confirmed that the protein was novel, and was different from the M.a. 
paratuberculosis 34 kDa protein previously described by (lilot (1993). However, an 
overall identity of approximately 30 % was detected with the HtrA proteins of E. coli 
(Lipinska etal., 1988), Salmonella lyphimuriutn (Johnson et al., 1991), Bruce/la abortus 
(Roop et al., 1994), Bartonella (Formerly Rochaliniaea) henselae (Anderson et al., 
OWL Accession number L20127), and Campylobacter jejuni (Wren, OWL Accession 
number X82628; Hiratsuka, OWL Accession number U2727 1). 
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Figure 3.6 Nucleic Acid and Protein Sequence Data. 
Nucleic acid sequence and deduced amino acid sequence obtained from dideoxy chain 
termination sequencing of the S4 and S8 DNA inserts, encoding the 34 kDa protein of 
M.a. paratuberculosis. The deduced amino acid sequence is shown in single letter code. 
The putative Shine-Dalgarno (SD) sequence is underlined, and the N-terminus of the 
native protein is marked by 	and underlined. Possible signal cleavage sites after amino 
acids 37 and 39 marked by . The histidine, aspartate and serine residues homologous 
to those in the HtrA proteins are boxed. This sequence has been assigned the EMBL 
accession number Z23092. 
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10 so 	 30 	 50 
CCCCCCACGCACCAGCGTCACCCCATCAGCAAATCCCACCACCACCCCTCGGTCTCGTGC 
M S K S H H H R S V W W 
70 	 90 	 110 
TCATGGTTCGTCGGTGTCCTGACCCTGGTCGGGCTGGGCCTCGGCCTGGGCTCCGCCGTG 
SWLVCVLTVVGLCLCLG S CV 
130 	 150 	 170 
CGGCTCCCGCCGCCGTCCCCCGCACCGTCGCGCCTGCCCCTCCACCGCTTCGCCGATCGC 
CLAPASAAP S G L A L D R F A D R 
190 	+ 	+ 	210 	 230 
CCCCTCCCCCCGATCCACCCCTCCGCCATCGTCGGTCAGGTCGCGCCCCCTGCTCC 
P L A P ID P S A M V C Q V G P Q V V N 
250 	 270 	 290 
ATCCACACCAAGTTCCGCTACAACAACGCCGTGGGCCCCCGTACCCGCATCGTCATCGAC 
I DTKFGYNNAVGAGTCIV ID 
310 	 330 	 350 
CCCAACCCCGTGCTCCTCACCAACAACCACCTCATCTCGCCCCCCACCGATCAGCGCG 
P N C V V L T N NEJV I S C A T E I S A 
370 	 390 	 410 
TTCCACGTCCCCAACCGGCAGACCTACCCCCTCGACCTGGTCGGCTATCACCGCACCCAG 
FDVCNGQTYAVDVVCYDRTQ 
430 	 450 	 470 
GACATCCCCGTCCTGCAGCTGCGCGGCCCGCCCCGCCTCCCCACCCCCACCATCGCCGGC 
IAVLQLRGAACLPTAT ICC 
490 	 510 	 530 
CACCCCACCGTGCCCCAGCCCATCGTCGCGCTTCCCCGTCCCCGCCCACGCCGGCACC 
E A T V G E P IVALGNVGCQGCT 
550 	 570 	 590 
CCCAACGCCCTCCCCCGCAACCTCCTCGCGCTCCCACACCGTCTCGGCCACCGACACC 
P N A V A C K V V A L N Q S V S A T D. T 
610 	 630 	 650 
CTCACCCGCGCGCACCACAACCTCCGCCGCCTGATCCACGCCCACCCGCCCATCCCCG 
LTCAQENLCGLIQADAP I K P 
670 	 690 	 710 
GGCGACTCCCCTCCCCCCATGGTGAACACCGCCGGGCACGTCATCCCCGTCGACACCGCC 
C DC C P M V N S A C Q V I C V D T A 
730 	 750 	 770 
CCCACCCACACCTACAACATCTCCCCCCCCCAGCCCTTCGCCATCCCCATCCCCCCCGCC 
A T D S Y K M S CCQCFAI P1 CRA 
790 	 810 	 830 
ATCCCCCTCCCCAACCACATCCCCTCCCCCCCCCCCTCCCACCCTGCACATCGCGCCC 
MAVANQIRSCACSNTVHICP 
850 	 870 	 890 
ACCCCATTCCTCCGCCTCCCCCTCACCCACCCCGCCGCCCCCCGCCTGCACCCG 
TAFLCLCVTDNNCNCARVQR 
910 	 930 	 950 
CTGCTCAACACCGCCCCGGCCCCGCCCCCCGGCATCCCGCCCGGCCACCTCATCACCCCC 
VVNTCPAAAACIAPCDVI TG 
970 	 990 	 1010 
CTCGACACCCTCCCGATCAACGCCGCCACCTCCATCACCCACCTCCTCCTCCCCCACCAC 
V D T V P I N G A T S M T E V L V P H H 
1030 	 1050 	 1070 
CCCCGTGACACCATCGCCCTGCACTTCCGCTCCCTCGACCCCCCCCACCCCACCCCCC 
PCDT IAVHFRSVDCC E R T A N 




A MOTIFS search of the PROSITE dictionary (Bairoch 1991) detected a motif 
'GDSGG' at amino acid position 213-217, which showed 100 % identity to the residues 
surrounding the active serine in the trypsin family of serine proteases. This motif is highly 
conserved, and its presence in this sequence strongly suggests that the gene encodes a 
serine protease. A second motif was also detected which was similar to that described for 
an ATP binding site (Blight & Holland, 1990; Kamijo et al., 1990; Rosteck et al., 1991), 
suggesting the protease may require energy provided by the hydrolysis of ATP. 
3.3 Discussion. 
Two overlapping clones isolated from a Xgtl 1 genomic expression library of M.a. 
paratuberculosis were shown by antibody elution to encode a native protein of 34 kDa in 
both M.a. paratuberculosis and the closely related M.a. silvaticum. Preliminary results 
had suggested that the 34 kDa protein encoded by these clones was specific for M.a. 
paratuberculosis. This misleading result may have been due to unequal protein loadings 
on the original Western blot, resulting in a more intense band being evident in the M.a. 
paratuberculosis track. In Figure 3.5, the protein loadings were carefully standardised 
from mycobacterial lysates of known concentration, and the presence of the 34 kDa 
protein in both species of mycobacteria was confirmed. 
The 1083 bp gene isolated from M.a. paratuberculosis was not sub-species specific but 
nevertheless encoded a novel mycobacterial protein. The entire ORF was present in the 
S8 clone, as well as a possible Shine Dalgarno sequence. Database searches were 
performed using the deduced amino acid sequence which showed the S8 protein to 
resemble most closely the trypsin family of serine proteases. This class of protease has 
been well characterised in eukaryotes, and X-ray crystallography has revealed the active 
site to be comprised not only of serine, but also of histidine and aspartate, due to the 
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three dimensional structure of the molecule. The classical trypsin active site triad is His 57 
Asp 102  Ser' 95 , and any protein matching this pattern may be regarded as a potential serine 
protease (Neurath, 1989; Dunn, 1989). Although the S8 protein contains a motif that 
completely matches the serine active site in trypsin (amino acid position 215), no 
corresponding histidine and aspartate residues occur at positions 77 and 122. The 
absence of any significant homology with irypsin, excluding the serine active site, 
suggests the S8 protein is not a form of trypsin. However, other serine proteases such as 
subtilisin maintain the His Asp Ser components of the active site, despite differing from 
trypsin in both amino acid composition and tertiary structure (Neurath, 1989). As shown 
below, this may also be true for the S8 protein. 
Further evidence for the S8 protein being a serine protease was provided by homology 
with five putative bacterial serine proteases: the HtrA protein:; of E. coli (Lipinska et al., 
1988), S. typhiniuriuni (Johnson et al., 1991), Br. abortus (Roop et al., 1994), B. 
henselae (Anderson etal., OWL Accession Number L20127), and C.jejuni (Wren, OWL 
Accession number X82628; Hiratsuka, OWL Accession number U2727 1). As these 
proteins have been described only recently, there are as yet no X-ray crystallographic 
data, and their active sites are not well defined. However, an endopeptidase activity of 
the E. coli HtrA has been reported (Lipinska et al., 1990). Although only 30 % identity 
exists between the entire S8 protein and these five bacterial proteases, a higher degree of 
identity (50-80 %) is observed at three sites, containing histidine, aspartate and serine 
respectively (Figure 3.7). The high degree of conservation of amino acids at these three 
sites suggests that they represent the three important active residues which are brought 
together to form the active site of the protease on folding. 
The deduced amino acid sequence of the S8 protein was shown on a Kyte-Doolittle 
hydrophobicity plot to contain a highly hydrophobic sequence of approximately 40 amino 
acids at the N-terminus (Figure 3.8). N-terminal hydrophobicity is characteristic of a 
signal peptide which directs secretion of a protein across ihe cytoplasmic membrane. 
CLUSTAL V multiple sequence alignment 
1 	VVTNNHVVDNASVIKVQLSDGR-KFDAKMVGKDPRSDIALIQIQNPK-NLTAI -MADSDA 
2 VVTNNHVVDNATVIKVQLSDGR-KFDAKVVGKDPRSDIALIQIQNPK-NLTAI - LADSDA 
3 	VVTNNHVVSDCDAYTVVLDDGT - ELDAKLICADPRTDLAVLKINAPKRXFVYS P LATI IR 
4 V-TNNHVISDGTSYAVVLDDCT- ELNAKLICTDPRTDLAVLKVNE-KRXFSYVDFCDDSK 
5 	HVVDNADKIKVNLPGSDIEYKAKLICKVPKTDLAVIKIE-AN-NLSAITFTNSDD 
6 VLTNNHVISGATEISAFDVCNGQTYAVDVVCYDRTQDIAVLQLRCAA- GLPTATICCEAT 
**. 	. . 	. .* 	*.*.... 
1 	LRVGDYTVGIGNPFCLGET- -VTS-IVSALCRSCLNAE-------NYENFIQTDA-INRG 
2 LRVCDYDVAICNPFGLGET- -VTS-IVSALCRSGLNVE-------NYENFIQTDA-INRG 
3 	CDVCDWVVAVGNPFGLGGT- -VTSGIVSARGAD-ICAG-------PYDDFIQIDAAVNKG 
4 LRVCDWVVAICNPFCLGGT- -VTAGIVSARGRD-IGTG-------VYDDFIQIDAAVNRC 
5 	LMEGDVVFALCNPFCVGFS- -VTSGIISALNKDNIGLN-------HNENFIQTDASINPC 
6 - VCEPIVALCNVGGQGGTPNAVACKVVALNQSVSATDTLTCAQENLCCLIQADAPIKPG 
1 	NSGGALVNLNGELIGINTAILAPDGGNIGIGFAIPS 
2 NSCGALVNLNGELIGINTAILAPDGGNIGIGFAIPS 
3 	NSGGPAFDLSGEVIGINTAIFS PSGGTVGIAFAI PS 
4 NSGGPTFDLNGKVVCVNTAIFSPSGCNVGIAFAIPA 
5 	NSGGALVDSRGYLVCINSAIFLVVGGNNGIGFAI PS 
6 DSGGPMVNSAGQVICVDTAATDSYKMSCGQCFAI P1 
Figure 3.7 Alignment of HtrA Proteins. 
Partial identity of the deduced amino acid sequences of the S8 recombinant protein [6] 
(M.a. paratuberculosis 34 kDa protein) and the HtrA proteins of Escherichia coli [1], 
Salmonella typhimuriwn [2], Brucella abortu.s [3],  Bartonella henselae [4] and 
Campylobacterjejuni [5]. Asterisk donates identical amino acids, dot donates conserved 
amino acids. 
81 
Figure 3.8 Hydrophobicity Plot of S8 Recombinant Protein. 
Areas of hydrophobicity in the deduced amino acid sequence of the S8 recombinant 
protein were identified on a Kyte-Doolittle hydrophobicity plot, using the facilities on the 
SERC Seqnet computer, Daresbury. A hydrophobic area was identified at the N-terminus 
of the protein (a). This area is shown in more detail in (b), and suggested the existence of 
a signal peptide. 
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After secretion, the signal is removed by signal peptidases and the protein is able to fold 
correctly. Signal sequences are also found in the other HtrA proteins, and are usually in 
the region of 26 amino acids. In contrast, mycobacterial signal sequences appear to be 
characteristically longer than 26 amino acids, and are more similar to those of Gram 
positive bacteria (Simonen & Palva, 1993). The signal peptides of the a antigens of M. 
avium Ohara et al., 1993), M. bovis (Matsuo et al., 1988), M. intracellulare Kitaura et 
al., 1993), M. kansasii (Matsuo et al., 1990), M. leprae (Yin, 1994) and M. 
scrofulaceuni (Takano et al., 1994) are all 40 amino acids in length, and the MPB70 of 
M. bovis (Radford et al., 1990) has a signal sequence of 30 amino acids. 
Two possible signal cleavage sites of Ala-X-Ala were detected at positions 35-37 and 37-
39 in the deduced amino acid sequence of the S8 clone. The first of these, Ala 35-Pro36- 
Ala37, can be dismissed, as proline is a 'forbidden' residue and cannot be part of a signal 
cleavage site (von Heijne, 1984). Cleavage after Ala 37-Ser 8-Ala39 is more likely, but 
leaves a sequence of 15 amino acids between the cleavage site and the N-terminus of the 
native protein as determined by Edman degradation (section 7.2.1). It is doubtful that the 
entire peptide of 54 amino acids would be cleaved after Arg 52  -Pro53  -Leu54  , as these 
residues would not be recognised by a signal peptidase (von Heijne, 1984). The 15 
amino acid sequence may have been removed by hydrolysis during the purification of the 
native protein (section 7.2.1). It is also possible that the protein contains a pro-peptide of 
15 amino acids which, although shorter, is similar to that observed with the a-lytic 
protease of Lysobacter enzyrno genes (Epstein & Weisink, 1988) and several secretory 
proteins of the Bacillus family (Simonen & Palva, 1993). In this model, both the signal 
peptide of 39 amino acids and the pro-peptide of 15 amino acids would be removed 
during post-translational modification and possible secretion of the protein. 
The S8/Ga1 fusion protein was shown to be completely insoluble (section 3.2.1), which 
implied that the 361 amino acid protein was not the mature, active form of the protein. 
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Analysis of the deduced amino acid sequence of the S8 DNA insert showed that 
translation of the pMS1S/S8 vector resulted in the production of a fusion protein 
consisting of 3-galactosidase and the product of the first 1.1 kb of the S8 insert. The 
signal peptide was therefore situated in the middle of the fusion protein, and was not 
recognised and processed correctly. The presence of this internal hydrophobic sequence 
could have resulted in the insolubility of the fusion protein. 
The aim of expressing the S4 and S8 inserts as fusion proteins was to enable purification 
of large amounts of free recombinant protein for further characterisation, after enzymatic 
cleavage to remove the fusion partner. DNA sequence data confirmed that the S4 insert 
encoded the C-terminal 210 amino acids of the 34 kDa protein, and therefore lacked the 
histidine and aspartate residues suspected to be involved in the active site of this putative 
serine protease (Figure 3.6). Hence, the S4 recombinant protein would not be active if it 
was successfully cleaved and purified from its fusion partner. The S8 insert contained the 
entire 1083 bp ORF, and was therefore capable of encoding the complete active protease. 
However, due to the presence of a signal peptide, the S8 clone could not be expressed as 
a soluble fusion protein, even in solutions of urea and acetonitrile. If expression of this 
clone had been possible, it is unlikely that the intact recombinant protein would have been 
obtained by cleavage with either Factor Xa or thrombin, as the S4 recombinant protein 
was shown to be further degraded by both of these enzymes. 
Hence, the S4 and S8 DNA inserts were shown to contain fragments of the same 1083 bp 
gene, which encoded a 34 kDa protein present in both M.a. paratuberculosis and M.a. 
silvaticuin. Recombinant fusion protein was used to raise MAbs specific for the 34 kDa 
protein, but attempts to cleave the fusion proteins and purify the recombinant antigen 
were unsuccessful. 
In order to recover large amounts of S8 recombinant protein in a free soluble form, the 
S8 DNA insert would have to be expressed in a system which lacked a fusion partner, 
EIM 
without the need for proteolytic cleavage of the recombinant. The loss of a fusion 
partner would not prevent detection of the recombinant, as MAbs raised against S 4/I3Gal 
fusion protein recognised also the S8 recombinant protein, and could therefore be used to 
screen for expression. Expression of the S8 insert in this type of system would also allow 
utilisation of the mycobacterial signal peptide. If the signal sequence was not recognised 
by the E. co/i secretory mechanisms, the recombinant protein would probably be found as 
an insoluble form in the cytoplasm. However, if the signal sequence was processed 
correctly, the S8 recombinant protein should be secreted across the cytoplasmic 
membrane into the periplasm, where the hydrophobic signal sequence would be removed 
by signal peptidases, yielding soluble S8 recombinant protein, in a near native form. 
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Chapter 4. 
Secretion of S8 Recombinant Protein from Escherichia coil. 
4.1 Introduction. 
The presence of a signal peptide at the N-terminus of a bacterial protein directs its 
secretion across the cytoplasmic membrane of the bacterial cell (von Heijne, 1984). Once 
secreted the hydrophobic signal is cleaved by signal peptidases, either in the periplasm of 
Gram negative bacteria (Pugsley, 1993) or the cell membrane/wall of Gram positive 
bacteria (Simonen & Palva, 1993), to yield the mature protein, which is able to fold 
correctly in its new environment after the loss of the hydrophobic leader. Recombinant 
DNA inserts encoding proteins with signal peptides therefore have the potential to be 
expressed as free proteins in E. co/i and secreted into the periplasm, if the signal peptide 
is recognised and processed correctly by the E. co/i secretory mechanisms. 
Although mycobacterial signal sequences are longer in length than those in E. co/i 
(section 3.3), they still maintain the basic structure of one or two positively charged 
residues followed by a hydrophobic core. Mycobacterial proteins containing their own 
signal peptides, such as MPB70 of M bovis (Fifis et al., 1989), therefore have been 
expressed successfully and secreted in E. coli expression systems. MPB70 is a 22 kDa 
secretory protein, which is translated with a 30 amino acid signal peptide (Radford et al., 
1990). When the entire gene was cloned and expressed in pBluescript II KS (Hewinson 
& Russell, 1993), the recombinant was produced as a free protein rather than the 
predicted fusion protein. This was achieved as a result of translational coupling (Schoner 
et al., 1984). The DNA insert containing the MPB70 gene and its Shine Dalgamo 
sequence had been cloned into the EcoRI / BaniHI site of pBluescript II KS, which 
placed the gene 'Out of frame' with respect to the upstream ORF of lacZ. This frameshift 
introduced a TGA stop codon into the ORF of the insert, which terminated IPTG-
induced translation before entering the MPB70 gene. Translation was re-initiated at the 
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Shine Dalgarno sequence and ATG start codon of the MPB70 gene under control of the 
lacZ promoter. When the induced cells were subjected to osmotic shock, the mature 
form of recombinant MPB70 was located in both the periplasm and the culture 
supernatant. This indicated that the mycobacterial signal peptide was recognised and 
processed correctly, resulting in the secretion of recombinant MPB70 across the 
cytoplasmic membrane. 
The S8 DNA insert contained also a potential TGA stop codon at the end of its Shine 
Dalgarno sequence (Figure 4.1) which could be brought into frame by directionally 
cloning the fragment into an expression vector, such as pUC18. Expression involving 
translational coupling therefore could prevent the production of an S8fl3-galactosidase 
fusion protein, which had been shown previously to be completely insoluble, and allow 
the expression of free, soluble S8 recombinant protein. This free protein would contain 
an N-terminal signal peptide which could be recognised by E. coli secretory mechanisms, 
and direct secretion of the S8 recombinant protein across the cytoplasmic membrane into 
the periplasm. Hence the S8 DNA insert was subcloned into the pUC18 expression 
vector in order to express and secrete S8 recombinant protein into the E. coli periplasm. 
4.2 Results. 
4.2.1 PCR of S8 Insert. 
PCR primers were chosen to amplify a 1.1 kb fragment of the 3 kb S8 insert, containing 
the 1083 bp ORF and the putative Shine Dalgarno sequence. The primer pair (Appendix 
I) was designed to produce a fragment with a 5' Sacl restriction site, and a 3' HindIII 
restriction site which would allow directional cloning of the PCR product into a specified 
ORF of pUC18. 
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A. 
S8 PCR Product. 
Sad 	 Hindu! 
11 




M 	 I 	 SD 	Stop 	M 
....ATG AlT ACG AAT TCG AGC T CC CGC GAC GCA GGA GQQ TGA CGG OAT GAG.... 
lac Z - - S8 insert 
Figure 4.1 Cloning S8 Insert for Expression By Translational Coupling. 
The S8 insert was amplified by PCR and cloned into the Sad / Hind-111 site of pUC18 
(A). This strategy placed the insert out of frame with respect to the lacZ gene (B), so 
that translation from lacZ was terminated at the TGA stop codon in the S8 insert. 
Translation then re-initiated at the SD sequence (underlined) and ATG start codon (bold 
italics) in the S8 insert to express free S8 recombinant protein. (M represents the amino 
acid methionine). 
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Several pilot reactions were performed varying both MgCl, arid primer concentrations, to 
optimise the conditions for amplification of the 1.1 kb fragment. A band of the correct 
size was obtained on silver-stained acrylamide gels (section 2.11.4) when reactions 
contained 1 MM M902 and 10 p.M each primer (section 2.11.1). PCR was therefore 
performed as described in section 2.11.1, and the pooled PC  product from nine 50 p.l 
reactions was purified from LMP agarose (section 2.9.6) for use in cloning. 
4.2.2 Cloning S8 PCR Product into pUC18. 
The S8 PCR product was designed to allow directional cloning into pUC18, placing the 
insert 'out of frame' with respect to the upstream lacZ gene. This strategy should 
prevent the translation of an S8/Gal fusion protein, as the insert would not be present in 
the correct frame for translation. At the same time, this frame;hift would bring into frame 
a TGA stop codon at the end of the Shine Dalgarno sequence (Figure 4.1), and allow 
expression of free S8 recombinant protein by translational coupling (section 4.1). 
Purified S8 PCR product (500 ng) and commercially prepared pUC18 (2 p.g) were 
digested with both Sacl and HindIll to produce compatible ends for directional cloning. 
After digestion, the PCR product and linearised plasmid were purified from LMP agarose 
(section 2.9.6) to remove any small digestion products which might have interfered in the 
ligation reaction. Vector and insert were ligated at a ratio of 1:3 (50 ng pUC18:150 ng 
S8) with 1U of T4 DNA ligase for 16 h at 12°C. Competent E. coli NM522 were 
prepared as described in section 2.12.2; 100 p.1 aliquots were iransformed with either 5 p.1 
of the ligation reaction, or 20 ng of control pUC18 (section 2.12.3) and grown overnight 
on L agar containing 50 p.g/ml ampidillin to select successfully transformed cells. Ten 
colonies were selected from these plates and subcultured onto L agar containing 50 p.g/ml 
ampidillin and also grown overnight in 10 ml of L broth plus 50p.gJml ampidillin from 
which plasmid DNA was prepared as described in section 2.9.2. Purified plasmid DNA 
was digested with Sacl and HindIII, and examined on agarosc: gels (section 2.9.5) for the 
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presence of a 1.1 kb insert and lineaiised vector. All ten plasrnid preparations contained 
the insert and were named pUCMS/S8 [1-10]. One clone (pUCMS/S8 [2]) was selected 
for subsequent expression of the recombinant protein, as described in section 4.2.3, and 
will be referred to hereafter as pUCMS/S8. 
4.2.3 Expression of Recombinant Protein from pUCMS/S8. 
The secretion of a recombinant protein into the periplasm cannot be established by simply 
Western blotting whole cell lysates, as this does not differentiate between periplasmic and 
cytoplasmic proteins. In order to determine the final location of these recombinants, the 
cells must be subjected to osmotic shock (section 2.5.2), which causes primary disruption 
of the outer membrane to yield a periplasmic fraction, followed by disruption of the inner 
membrane to produce the cytoplasmic fraction. These fractions can be analysed by SDS 
PAGE and Western blotting (section 2.3) to determine the exact location and molecular 
weight of the recombinant protein. Successful secretion locates the correctly sized 
recombinant in the periplasm. Unsuccessfully secreted proteins remain in the cytoplasm. 
E. coli NM522 containing the pUCMS/S8 plasmid were cultured and induced with IPTG 
as described in section 2.5.1. After 3 h induction, the bacteria were harvested and 
immediately subjected to osmotic shock (section 2.5.2) to yield cytoplasmic and 
periplasmic fractions. A whole cell lysate was produced also as a control. 
Each fraction (15 .tl) was screened for the presence of S8 recombinant protein by SDS 
PAGE and Western blotting (section 2.3). When Western blots were probed with MAb 
5.8 (raised against S4/3Gal fusion protein), the whole cell control was found to contain 
two major immunogenic bands of approximately 42 kDa and 36 kDa, as well as a number 
of minor bands which were probably degradation products. The 42 kDa and 36 kDa 
proteins were detected also in the cytoplasmic fraction, but only the 36 kDa form was 










Figure 4.2 Osmotic Shock of E. coli NM522 Expressing S8 Recombinant Protein. 
Osmotic shock fractions of induced E. coil containing the pUCMS/S8 plasmid were 
Western blotted and probed with MAb 5.8 in order to ideniify the final location of S8 
recombinant protein. Lanes 1-3, 2 h induction; Lanes 4-6, 3 h induction. Lanes 1 & 4, 
whole cell lysate; Lanes 2 & 5, cytoplasmic fraction; Lanes 3 & 6, periplasmic fraction; 
Lane 7, purified S4/Gal fusion protein (positive control). Western blot probed with 
MAb 5.8, and Dako anti-mouse HRP conjugate diluted 1:1000. 
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form of the recombinant in the periplasm indicated successful secretion of the 
recombinant protein across the cytoplasmic membrane, as a result of the E. co/i correctly 
processing the signal peptide encoded by the mycobacterial DNA insert. However, the 
N-terminal amino acid sequence of the 36 kDa recombinant protein would have to be 
determined to confirm the processing and cleavage of the putative signal sequence. 
4.2.4 Purification of Recombinant S8 by Anion Exchange Chromatography. 
In an attempt to purify the S8 recombinant protein by anion exchange chromatography, 
the periplasmic fraction from a 100 ml culture of induced pUCMS/S8 was adjusted to 10 
mM Tris/HC1 pH 8.0, and applied to a Bio-Rad Econo Q cartridge as described in section 
2.5.3. All proteins were found to bind successfully to the column, as the flowthrough 
was shown by SIDS PAGE and Coomassie staining to be completely free of protein. 
After washing (section 2.5.3), proteins were eluted from the column by the sequential 
application of 0.5 ml aliquots of 10 mM Tris/HC1 pH 8.0 containing 0.1 M, 0.2 M, 0.3 
M, and 1 M NaCl respectively. The fractions collected (4 x 0.5 ml) were analysed by 
SIDS PAGE and Western blotting (Figure 4.3). The majority of the S8 recombinant 
protein was detected in the 0.2 M NaCl eluate (Figure 4.3, lane 5), but was shown by 
silver staining to contain also a large number of other proteins (results not shown). 
In order to investigate whether the S8 recombinant protein could be further purified from 
these proteins by changing the elution conditions, the process was repeated (using a fresh 
periplasmic fraction), eluting the column with 1 ml fractions of 10 mM Tris/HC1 pH 8.0 
containing 0.1 M, 0.125 M, 0.15 M, 0.175 M, 0.2 M and 1 M NaCl respectively. The 0.1 
M eluate was collected as a 1 ml fraction, followed by 9 x 0.5 ml fractions spanning the 
0.125 M - 0.2 M eluates (one extra fraction was collected to allow for any discrepancies), 
and finally 1.5 ml was collected as the final 1 M NaCl eluate, which removed all proteins 
from the column. After analysis by SIDS PAGE and Western blotting, the majority of the 
S8 recombinant protein was detected in the 0.125 M NaCl 
93 




Figure 4.3 Anion Exchange Chromatography of S8 Recombinant Protein. 
Western blot of fractions eluted from an Econo Q cartridge after adsorption of the 
periplasmic fraction from induced E. coil containing the pUCMS/S8 plasmid. Lane 1, 
purified S4Ij3Gal fusion protein (positive control); Lane 2, pre-column periplasmic 
fraction; Lane 3, column flowthrough; Lane 4, 0.1 M NaCl eluate; Lane 5, 0.2 M NaCl 
eluate; Lane 6, 0.3 M NaCL eluate: Lane 7, 1 M NaCl eluate. Western blot probed with 
MAb 5.8, and Dako anti-mouse HRP conjugate diluted 1:1000. 
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Figure 4.4 Anion Exchange Chromatography of S8 Recombinant Protein. 
Western blot of fractions eluted from an Econo Q cartridge after adsorption of the 
periplasmic fraction from induced E. coil containing the pUCMS/S8 plasmid. Lane 1, 
pre-column periplasmic fl -action; Lane 2, column flowthrough; Lane 3, void volume of 
column; Lane 4, 0_1 M NaCI eluate: Lanes 5 & 6, 0.125 M NaC1 eluate; Lanes 7 & 8, 
0.15 M NaCl eluate; Lanes 9 & 10, 0.175 M NaCl eluate; Lanes 11 & 12, 0.2 M NaCl 
eluate. Western blot probed with MAb 5.8, and Dako anti-mouse HRP conjugate diluted 
1:1000. 
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eluate (Figure 4.4). Analysis of the fractions by SDS PAGE and silver staining revealed 
that most high molecular weight proteins had been removed, but a large number of lower 
molecular weight proteins (20 - 40 kDa) still remained, and the S8 recombinant could not 
be discriminated from the other proteins on silver-stained or Coomassie- stained gels 
(results not shown). 
In order to further separate these proteins by altering the buffering conditions on the ion 
exchange column, two aliquots of the 0.125 M eluate were dialysed against 10 mM 
Tris/HC1 at pH 7.5 and 10 mlvi Bis-Tris/HC1 at pH 6.5 respectively. Each sample was 
applied separately to the Econo Q cartridge (re-equilibrated in the appropriate pH Tris 
buffer) and processed as before, sequentially eluting with 1 ml of Tris buffer containing 
0.1 M, 0.2 M, 0.3 M and 1 M NaCl respectively. However, when these samples were 
analysed by SDS PAGE and Western blotting no recombinant protein was detected in any 
of the eluted fractions (results not shown). The pre-column samples were shown also by 
Western blotting to contain very little recombinant protein, indicating the protein had 
degraded during dialysis, which is consistent with the possibility, deduced from the 
sequence data, that the recombinant protein is a protease (section 3.3). The degradation 
of the recombinant protein indicated that although one chromatographic step was 
insufficient for purification, the instability of the protein made it impossible to attempt 
further chromatographic purification. The addition of protease inhibitors may have 
prevented this degradation, but this course of action would have resulted in the recovery 
of an inactive protein, preventing further analysis of any functional activity displayed by 
the recombinant (discussed more fully in section 5.2.6 and 5.3. 
4.2.5 Purification of Recombinant S8 by Isoelectric Focusing. 
The MinipHor Isoelectric Focusing Cell aids protein purification by aligning proteins 
across a liquid pH gradient according to their isoelectric point (p1). The process is non- 
denaturing, and allows the separation of complex mixtures of proteins. This process 
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therefore was used in order to purify the S8 recombinant protein from the periplasmic 
fraction of E. co/i NM522. 
The periplasmic fraction from a 100 ml culture of induced E. co/i NM522 containing the 
pUCMS/S8 expression vector (approximately 7 ml) was prepared for focusing as 
described in section 2.5.4, and loaded into the focusing chamber of the apparatus. After 
focusing (section 2.5.4) 20 x 1 ml fractions were collected spanning the pH gradient. The 
pH of each fraction was plotted against fraction number to give a graphical representation 
of the pH gradient (Figure 4.5). The p1 of the S8 recombinant protein was predicted 
from the deduced amino acid sequence (using the Daresbury package ISOELECTRIC) to 
be approximately 4.4, which corresponded to fraction 16 on Figure 4.5. Hence, fractions 
13 - 20 were analysed by SDS PAGE, Western blotting and Coomassie staining to 
determine the exact location of the recombinant (Figure 4.6a). The Coomassie stain 
revealed a doublet band at approximately 36 kDa (marked on Figure 4.6b), one band of 
which was thought to correspond to the recombinant protein. These bands had been also 
marked on the Western blot (Figure 4.6a) after confirming transfer by staining with 
Ponceau S. The blot revealed that the S8 recombinant protein was distributed between 
fractions 13 - 18, but was most abundant in fractions 14, 15 and 16 (pH 4.5 - 5.0), 
agreeing with the predicted p1. However, from the Western blot, the recombinant 
protein was found to be larger than the marked bands, and corresponded to an area on 
the Coomassie stain where there appeared to be no proteins. Fraction 14 (Figure 4.6a&b, 
lane 4) which produced the most intense band on the Western blot, does on close 
examination of the original Coomassie stain, contain a very faint band which may be the 
recombinant protein. This represented a very small amount of recombinant protein, 
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Figure 4.5 pH Gradient Produced in the MinipHor Isoelectric Focusing Cell. 
The pH of each fraction obtained from the isoelectric focusing cell was measured and 
plotted against fraction number to produce a pH gradient. S8 recombinant protein was 
detected mainly in fractions 14, 15 & 16 (pH 4.5-5.0; marked with asterisks) as predicted 
by the theoretical p1. 
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Figure 4.6 Western blot (a) and Coomassie Stain (b) of Fractions Obtained from 
the MinipHor Isoelectric Focusing Cell. 
Fractions 13-20 obtained after isoelectric focusing the periplasmic fraction of induced E. 
coil containing the pUCMS/S8 expression vector were analysed by SDS PAGE and 
Western blotting. Lane 1, periplasmic fraction of induced E. co/i containing the 
pUCMS/S8 expression vector prior to focusing; Lanes 2-9, MinipHor fractions 13-20. 
A doublet band of approximately 34 kDa was marked (arrow) on boih Coomassie stain 
and the Ponceau stain of the Western blot before probing with MAb 5.8, and Dako anti-
mouse HRP conjugate. 
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The ORF contained in the S8 DNA insert was successfully expressed as a free protein by 
translational coupling (Hewinson & Russell, 1993; Schoner et al., 1984) in pUC18. After 
osmotic shock two forms of the recombinant protein (42 kDa and 36 kDa) were detected 
in the cytoplasmic fraction by Western blotting. Only the 36 lcDa protein was detected in 
the periplasmic fraction, and this appeared to be the mature form of the recombinant 
protein which had been successfully secreted across the cytoplasmic membrane. The 
mycobacterial signal sequence was therefore recognised and correctly processed by the E. 
co/i secretory mechanisms. Processing of the putative signal peptide could have been 
confirmed by obtaining the N-terminal amino acid sequence of the 36 kDa protein, 
however, the recombinant protein could not be purified sufficiently to allow this. 
Detection of the mature 36 kDa form of the recombinant in the cytoplasmic fraction 
could have been due either to cytoplasmic proteolysis of the 42 kDa protein, or to 
incomplete osmotic shock resulting in the presence of some periplasmic proteins in the 
cytoplasmic fraction. The 42 kDa form of the recombinant was found only in the 
cytoplasmic fraction, and probably represented recombinant proteins still possessing the 
hydrophobic signal peptide which were not secreted due to saturation of the E. coli 
secretory mechanisms. These therefore aggregated in the cyloplasm, and were probably 
degraded intracellularly, resulting in the large number of degradation products detected in 
the cytoplasm by Western blotting (Figure 4.2). A small amount of degradation was also 
observed in the periplasm, but this was only of the mature 36 kDa form of the 
recombinant protein. 
A band of 42 kDa was not detected in Western blotted lysates of M.a. paratuberculosis 
(Figures 3.5 & 4.7), as constructs still possessing the signal peptide are not usually found 
in native systems. The signal peptide directs secretion, and is immediately cleaved once 
the protein has traversed the cytoplasmic membrane (Pugsley, 1993). This phenomenon 
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of the presence of full length secretory protein is only encountered in an artificial system 
where the protein is being over-expressed (Hewinson & Russell, 1993). The secretory 
mechanisms of the host bacterial strain become completely saturated before all of the 
expressed protein can be exported, and this results in the intracellular accumulation of full 
length proteins. 
The molecular weight of mature S8 recombinant protein was calculated from Western 
blots to be approximately 36 kDa and could be seen to be disiinctly larger than the native 
34 kDa protein in M.a. paratuberculosis (Figure 4.7). The pndicted molecular weight of 
the protein minus its signal peptide was calculated from the deduced amino acid sequence 
using the SEQNET programme PEPTIDESORT to be 31.8 kDa. Without the 15 amino 
acid pro-peptide (discussed in section 3.3), the estimated molecular weight of the protein 
was reduced to 30.2 kDa, indicating that the pro-peptide (1.6 kDa) could well be 
responsible for the observed differences in molecular weight between the S8 recombinant 
protein and the native 34 kDa protein. The predicted molecular weight of the mature 
protein (30.2 kDa) does not reflect that of the native protein as resolved by SDS PAGE 
(34 kDa). However, this phenomenon appears to be common in mycobacterial proteins 
which are rich in the amino acid proline. The 34 kDa protein contains 7% proline, and 
this high proline content has been reported to reduce the mobility of proteins on SDS 
PAGE (Cherayil & Young, 1988; Thole et al., 1990; Gilot et al., 1993) 
Removal of the 15 amino acid pro-peptide from the native protein probably involved a 
specific mycobacterial enzyme, and it is possible that E. co/i was incapable of removing 
the sequence, resulting in the production of a larger recombinant protein than expected. 
The presence of this 15 amino acid sequence on the S8 recombinant protein could have 
been verified by obtaining the N-terminal amino acid sequence of the periplasmic 36 kDa 
recombinant protein. However, this experiment would have required several .tg of 
purified S8 recombinant protein, which could not be obtained by the methods used in this 
chapter. Purification by both anion exchange chromatography and isoelectric focusing 
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Figure 4.7 Comparison of Molecular Weight of Native and Recombinant Protein. 
The molecular weights of the native 34 kDa protein and the S8 recombinant protein were 
analysed by SDS PAGE and Western blotting. Lane 1, purified native 34 kDa protein; 
Lane 2, periplasmic fraction from E. co/i expressing the pUCMS/S8 plasmid (S8 
recombinant protein); Lane 3, M.a. pararuberculosis protein lysate. Western blot 
probed with MAb 5.8, and Dako anti-mouse HRP conjugate diluted 1:1000. 
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were unsuccessful, as the recombinant appeared to be unstable, and totally degraded 
before a second purification step could be attempted. Analysis of the fractions obtained 
from the MinipHor after isoelectric focusing indicated that there was very little 
recombinant protein present in the sample, despite obtaining a strong signal on Western 
blots probed with MAb 5.8 (Figure 4.6a&b). The protein therefore appeared to be highly 
immunogenic, and the presence of small amounts obtained by these procedures was 
sufficient to produce a strong signal on Western blots probed with this MAb. 
The failure to express significant amounts of S8 recombinant protein could have been due 
to one of four possibilities: 
Expression of the insert by translational coupling in pUC18 was inefficient, and 
resulted in the production of very low levels of recombinant protein 
The expressed recombinant protein was toxic to E. co/i and resulted in the death of 
expressing cells after induction 
The recombinant was expressed in large amounts and secreted into the periplasm, 
where it was degraded by host periplasmic enzymes, and 
The recombinant was expressed in large amounts and secreted into the periplasm, 
where it auto degraded, due to its own proteolytic activity. 
In conclusion, the S8 recombinant protein was successfully expressed in E. co/i by 
translational coupling, and secreted via its own signal peptide across the cytoplasmic 
membrane into the E. co/i periplasm. When attempts were made to purify the 
recombinant from the mixture of proteins in the periplasm, the protein was found to be 
present in very small amounts. The possible reasons for this low yield of recombinant 
protein are listed above, and must be investigated in order to achieve an improved yield 




Expression of S8 Recombinant Protein from the T7 Promoter. 
5.1 Introduction. 
The ORF contained in the S8 DNA insert was successfully expressed as a free protein 
by translational coupling in pUC1 8, and secreted via its own signal peptide into the E. 
coil periplasm (section 4.3). However, the yield of recombinant protein present in the 
periplasm was found to be very low, and therefore insufficient to purify for further 
study. The possible reasons for this low level of expression are discussed in section 
4.3, and the following experiments were designed to address these problems. 
Expression of the S8 insert under the control of the T7 promoter was first 
investigated to determine whether the low yields of recombinant protein were due to 
inefficient translational coupling under the control of the lac promoter in pUC18. The 
strong promoter of bacteriophage Ti is not controlled by a repressor system (as with 
the lac promoter), and will only act as a promoter for bacteriophage T7 RNA 
polymerase, which is not normally produced by E. coli. In order to obtain 
transcription from the Ti promoter, a source of Ti RNA polymerase must be 
provided in the bacterial cell. Host bacteria (BI-21 DE3) therefore have been 
produced which are lysogens of bacteriophage XDE3, and contain the gene for T7 
RNA polymerase under the control of the lacUV5 promoter. This allows the specific 
induction of Ti RNA polymerase on addition of IPTG, and subsequently the 
transcription of genes under control of the Ti promoter. This system is highly 
specific and produces little of the background expression observed with pUC18. 
Cloning the S8 insert into a vector containing the Ti promoter may increase 
expression levels, and allow recovery of a larger amount of protein from the 
periplasm. 
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The low yield of recombinant protein also may have been due to toxicity of the S8 
recombinant protein. Accumulation of a toxic protein within the bacterium would 
lead to cell death, and a reduction in the number of bacteria in the culture containing 
recombinant protein. The overall result of this toxicity would be a reduction in the 
amount of recombinant protein recovered from an induced culture. 
Yields of recombinant protein also can be affected by over-expression of P lactamase 
from transformed bacteria. If the selective pressure in the culture (ampidihin) became 
reduced due to the expression of large quantities of 13-lactamase, the culture could 
become over-grown by bacteria which had lost the plasniid. Although a pellet of 
bacteria would have been obtained after induction, few 'would have contained the 
plasmid, resulting in the observed low yield of recombinant protein. 
Hence, induced cultures were checked for cell death by measuring the A 600 during 
incubation, and for loss of the plasmid by performing bacterial Counts on L agar and L 
agar containing 50 tgJml ampicillin at several time points after induction.. 
Finally, the possibility of proteolytic degradation of the recombinant protein was 
addressed. After translation, the recombinant protein was exported into the E. co/i 
peripla.sm (section 4.2.3), which contains several endogenous proteases (Pugsley, 
1993). The accumulation of recombinant protein may have been prevented by the 
action of E. coli periplasmic proteases, resulting in the low yield of recombinant 
protein obtained after osmotic shock. The effect of adding the protease inhibitor 
PMSF to the culture at induction was examined, and the resulting levels of S8 
recombinant protein determined after osmotic shock. 
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5.2 Results. 
5.2.1 Cloning and Expression in pBluescript II KS. 
The pBluescript II KS phagemid vector (Figure 5.1) was chosen to express the S8 
insert from the T7 promoter. The cloning strategy placed the S8 insert in the wrong 
orientation with respect to the lac promoter, and therefore prevented the production 
of a fusion protein (Figure 5.2). However, the insert was present in the correct 
orientation under the control of the T7 promoter, and could potentially be expressed 
in the presence of 17 RNA polymerase. 
The S8 insert was amplified by PCR as described in section 2.11.1, and cloned into 
the Sacl and Hindul sites of pBluescript II KS as described in section 4.2.2. 
Competent E. co/i NM522 (100 j.tl) were transformed with 5 gI of the ligation 
reaction and transformants were selected on L agar containing 50 tg/ml ampicillin. 
Plasrnid DNA was purified from several colonies, and digested with both Sac! and 
Hindill. The resulting digestion products were separated on 0.6 % (w/v) agarose 
gels (section 2.9.5) to confirm the presence of linearised vector and 1.1 kb insert. 
Plasmids containing the insert were named pBSMS/S8. 
Purified pBSMS/S8 DNA (20 ng) was used to transform 100 p.1 of competent E. co/i 
BL21(DE3) (section 2.12.2), which contained a genomic copy of the gene for T7 
RNA polymerase under the control of the lacUVS promoter. Transformed bacteria 
were selected on L agar containing 50 p.gJml ampicihin, and several colonies were 
chosen for expression. Recombinant S8 protein was expressed as described 
previously (section 2.5.1) and induced E. co/i were subjected to osmotic shock 
(section 2.5.2) to produce cytoplasmic and periplasmic fractions. Each fraction (15 
p.1) was analysed by SDS PAGE and Western blotting (section 2.3) to determine the 
location and level of expression of the recombinant protein. The osmotic shock 
fractions from two separate pBS/S8 colonies were Western blotted onto nitrocellulose 
(Figure 5.3) and probed with MAb 5.8 (raised against S4/13-Gal fusion protein). 
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Figure 5.1 The pBluescript H KS Expression Vector. 
The pBluescript II KS vector is a phagemid vector, which contains the fl origin of 
replication from the fl filamentous phage, and allows rescue of antisense ss DNA 
from transformed E. coli on infection with helper phage. The vector contains also the 
lac promoter and part of the lacZ gene to allow expression of cloned inserts as fusion 
proteins with -ga1actosidase. The multiple cloning site is present within the lacZ 
gene and, on induction of the lac promoter in the presence of X-gal, allows screening 
for cloned inserts by blue/white colour selection. The multiple cloning site also is 
flanked by the T7 and T3 promoters, to allow the in vitro transcription of RNA from 
cloned inserts on addition of a source of 77 or T3 RNA polymerase. The vector 
contains the selectable marker for ampicillin resistance. 
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Figure 5.2 Cloning of S8 PCR Product into pBluescripl: II KS. 
Diagrammatic representation of the cloning strategy adopted to express the S8 insert 
under the control of the T7 promoter in pBluescript II KS. 
The insert was directionally cloned into SacI/HindIII digested pBluescript II KS to 
obtain the construct detailed above. The insert was thus present in the wrong 
orientation to be expressed as a 3-ga1actosidase fusion under the control of the lac 
promoter. However, the insert could potentially be expressed under the control of the 
T7 promoter, which is situated at the 3' end of the multiple cloning site in pBluescript 
II KS. 
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Figure 5.3 Osmotic Shock of E. coil Expressing pBS/S8. 
Western blot of osmotic shock fractions obtained from two E. coli clones expressing 
the pBS/S8 plasmid. Lanes 1 & 2, clone i; Lanes 3 & 4, clone ii; Lane 5, periplasmic 
fraction from E. co/i expressing the pUCMS/S8 plasmid (positive control). 
Lanes 1 & 3, periplasmic fractions; Lanes 2 & 4, cytoplasmic fractions. Western blot 
probed with MAb 5.8, and Dako anti-mouse HRP conjugate diluted 1:1000. 
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Each sample produced very weak bands at 36 kDa and 42 kDa with respect to the 
pUCMS/S8 recombinant control. Expression from this construct therefore appeared 
to produce less recombinant protein than expression from the original pUCMS/S8 
construct. 
5.2.2 Cloning and Expression in pT7-5. 
The poor level of expression obtained from pBS/S8 may have been due to the fact 
that the Ti promoter was included in the vector to allow in vitro transcription of 
RNA, and was not intended to be used to drive expression of recombinant proteins 
(see discussion, 5.3). A second T7 expression vector, pT7-5, therefore was used to 
attempt to express the S8 recombinant protein from the Ti promoter. 
The pT7-5 expression vector (Figure 5.4) was designed to specifically express 
recombinant proteins from DNA inserts under the control of the Ti promoter. The 
vector does not contain the lac promoter, and induction of transformed E. co/i 
BL21(DE3) with IPTG is therefore specific for the production of the Ti RNA 
polymerase encoded by the host bacterium, resulting in transcription of inserts under 
control of the Ti promoter. The vector lacks a Shine Dalgarno sequence and ORF 
downstream from the promoter, and therefore cannot encode a fusion protein, or 
express inserts by translational coupling (section 4.3). Hence, cloned DNA inserts 
must contain their own translational signals for the recombinant protein to be 
expressed by the bacterium. 
The S8 DNA insert was amplified by PCR as described in section 2.11.1, and cloned 
into the Sacl and HindIII sites of pT7-5 as described in section 4.2.2. Competent E. 
coil NM522 (100 pJ) were transformed with 5 p1 of the ligation reaction and 
transformants were selected on L agar containing 50 p.gJml ampidilin. Plasmid DNA 
was purified from several colonies, and digested with both Sacl and Hindu!. The 
resulting digestion products were separated on 0.6 % (w/v) agarose gels (section 
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Figure 5.4 The pT7-5 Expression Vector. 
The pT7-5 expression vector was designed to specifically express proteins under the 
control of the 01017 promoter on addition of a source of '17 RNA polymerase. The 
plasmid contains no translation signals, therefore cloned inserts must encode their 
own translatory signals in order to be expressed as recombinant proteins. The 
selectable marker for ampidilhin resistance is included to allow selection of 
transformed E. coli. When propagated in normal E. coli strains (e.g. NM522, 
JM109) no transcription from the p17-5 vector occurs. Expression is usually 
achieved by transforming into E. co/i BL21(DE3), which contains a genomic copy of 
the gene for 17 RNA polymerase under the control of the lacUVS promoter, which is 
induced on the addition of IPTG. 
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2.9.5) to confirm the presence of linearised vector and 1.1 kb insert. Plasmids 
containing the insert were named pT7/S8. 
Purified pT7/S8 (20 ng) was used to transform 100 tl of competent E. co/i 
BL21(DE3) which contain a genomic copy of the gene for T7 RNA polymerase, and 
transformants were selected on L agar containing 50 JIg/nil ampidihin. Recombinant 
protein was expressed as described in section 2.5.1, and induced E. coli were 
subjected to osmotic shock (section 2.5.2) to yield cytoplasmic and periplasmic 
fractions. Each fraction (15j.tl) was analysed by SDS PAGE and Western blotting 
with MAb 5.8 (Figure 5.5). 
The 36 kDa and 42 kDa forms of the recombinant protein were successfully expressed 
from pT7/S8, and shown by Western blotting to be present in both the whole cell 
lysate and the cytoplasmic fraction (Figure 5.5). As was previously observed on 
expression of pUCMS/S8 (section 4.2.3), only the 36 kDa form was present in the 
periplasm, indicating successful secretion of the recombinant via its own signal 
peptide. From the intensities of the bands obtained on Western blots, expression from 
pT7/S8 was far better than that obtained from pBSMS/S8, and comparable to that 
obtained from pUCMS/S8. By Coomassie staining, the protein profile of the E. coli 
BL21(DE3) periplasm appeared to contain fewer proteins than that of E. co/i 
NM522, (Figure 5.6, lanes 1&2). The band corresponding to the 36 kDa recombinant 
protein was not easily distinguished in the periplasmic fraction of induced E. co/i 
BL21(DE3) containing the pT7/S8 plasmid, however when compared to the 
periplasmic fraction of induced BL2 1 (DE3) carrying the empty pT7-5 expression 
vector, the band corresponding to the recombinant appeared to be the lower of a 
doublet as indicated on Figure 5.6. 
5.2.3 Purification of pT7/S8 Recombinant Protein. 
The periplasmic fraction from a 100 ml culture of induced E. co/i BL21(DE3) 
containing the pT7/S8 expression vector was adjusted to 10 mM Bis-Tris/HC1 pH 6.5 









Figure 5.5 Osmotic Shock of E. coli Expressing pUCMS/S8 and pT7/S8. 
Western blot of fractions obtained on osmotic shock of E. .oli expressing the pT7/S8 
plasmid (Lanes 1-3) and pUCMS/S8 plasmid (Lanes 4-6). Lanes I & 4, whole cell 
lysate; Lanes 2 & 5, cytoplasmic fraction; Lanes 3 & 6, periplasmic fraction. 
Western blot probed with Mab 5.8, and Dako anti-mouse HRP conjugate diluted 
1:1000. 
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Figure 5.6 Expression of S8 Recombinant Protein from the pT7/S8 Plasmid. 
Coomassie Stain (a) and Western blot (b) of the periplasmic fractions from two E. 
coil clones (clone i, lanes 3, 4 & 5; clone ii, lanes 6, 7 & 8) induced at varying stages 
of growth to optimise the induction conditions. Lane 1, periplasmic fraction from E. 
coii expressing plasmid pUCMS/S8 (positive control); Lane 2, periplasmic fraction 
from induced E. coil containing the pT7-5 expression vector (negative control); 
Lanes 3 & 6, cells induced at A600 of 0.5: Lanes 4 & 7, cells induccd at A600 of 0.9; 
Lanes 5 & 8, cells induced at A600 of 1.5. A protein thought to represent the S8 
recombinant protein was marked (arrow) on the Coomassie stain and the Ponceau 






















attempt to purify the recombinant protein. Preliminary experiments showed that 
reducing the buffer pH from 8 to 6.5 caused all of the recombinant protein to bind to 
the column, while many of the other periplasmic proteins did not and were detected 
only in the column flowthrough (Figure 5.7a, lane 2). The column was eluted as 
described previously (sections 2.5.3 & 4.2.4) with sequential 0.5 ml aliquots of 10 
mM Bis-Tris/HC1 pH 6.5 containing 0.1 M, 0.125 M, 0.15 M, 0.175 M, 0.2 M, 0.225 
M, 0.25 M, 0.3 M and 1 M NaCl respectively. Each fraction (20 i.)  was analysed by 
SDS PAGE and both Western blotted and Coomassie stained (Figure 5.7a&b). The 
majority of the recombinant protein was shown by Western blotting to be eluted at 
0.1 M and 0.125 M NaCl, and appeared to match a specific band marked on the 
corresponding Coomassie stain (Figure 5.7a&b, solid arrow). Several contaminating 
bands were present in these fractions, hence the 0.1 M, 0.125 M and 0.15 M fractions 
were pooled and dialysed overnight at 4 °C against 10 mM Tris/HC1 pH 8.0. It was 
intended to apply these fractions to the Econo Q cartridge, at pH 8.0 as described in 
section 4.2.4, as the recombinant was known to elute at 0.125 M NaCl at this pH, and 
may therefore have separated from the contaminating proteins in the sample. 
However, as was observed in section 4.2.4, the recombinant protein degraded during 
the overnight dialysis and the sample therefore contained no recombinant protein to 
apply to the column. Hence the recombinant protein expressed from pT7/S8 
appeared to be unstable, and degraded in the same fashion as that expressed from 
pUCMS/S8. 
5.2.4 Toxicity of the S8 Recombinant Protein on Expression in BL21(DE3). 
If expression of the S8 recombinant protein was toxic to E. coli, it is possible that the 
poor yield of recombinant protein was due to the presence after induction of mainly 
dead and dying cells, which were not capable of expressing high levels of recombinant 
protein. It has been reported also that over expression of 13  lactamase can result in the 
degradation of all anipicillin in the culture medium allowing overgrowth of the 
transformed cells by daughter cells containing no plasmid expression vectors 
(Literature supplied with BL2 1 (DE3); Stratagene). After a 3 h induction period in the 
absence of any selective pressure, this would result in the pellet being comprised 
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Figure 5.7 Anion Exchange Chromatography of S8 Recombinant Protein. 
Coomassie stain (a) and Western blot (b) of fractions eluted from an Econo Q 
cartridge after absorbtion of the periplasmic fl -action from induced E. co/i containing 
the pT7/S8 plasmid. Lane 1, pre-column periplasmic fl -action; Lane 2, column 
flowthrough; Lane 3, void volume of column; Lane 4, 0.1 M NaCl eluate; Lane 5, 
0.125 M NaC1 eluate; Lane 6, 0.15 M NaCl eluate; Lane 7, 0.175 M NaC1 eluate; 
Lane 8, 0.2 M NaCl eluate; Lane 9, 0.225 M NaC1 eluate; Lane 10, 0.25 M NaCl 
eluate; Lane 11, 0.3 M NaC1 eluate; Lane 12, 1 M NaC1 eluate. Two different 
protiens thought to possibly represent the S8 recombinant protein were marked (solid 
and clear arrows) on the Coomassie stain and the Ponceau stain of the Western blot 
before probing with MAb 5.8, and Dako anti-mouse HRP conjugate diluted 1:1000. 
The band marked by the solid arrow appears to correspond to the S8 recombinant 
protein. 
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mainly of bacteria which were not ampicilin resistant, as they lacked the expression 
vector, and were not expressing the recombinant protein. 
In order to assess any toxic effects of the expressed S8 recombinant protein, cultures 
of E. coli BL21(DE3) containing the pT7-5 vector and the pT7/S8 vector were 
grown and induced as described in section 2.5.1 to examine the effects of 
accumulation of the S8 recombinant protein on growth of the host bacteria. The A 
of each culture was measured every 20 min from the point of inoculation until 3 h 
after induction (330 mm), and plotted against time to give the corresponding growth 
curve (Figure 5.8). On induction and 40, 80, and 120 min post induction, a 106 
dilution of E. coli containing the pT7/S8 plasmid was made and 200 Al inoculated 
onto both L agar and L agar containing 50 .tgJml anipicillin. After overnight 
incubation at 37°C colony counts were made to estimate the proportion of 
transformed cells present in the culture (Table 5.1). 
Expression of S8 recombinant protein from the Ti promoter did not appear to be 
detrimental to bacterial growth, as E. co/i BL21(DE3) carrying the pT7/S8 vector 
produced a standard growth curve from inoculation through induction (Figure 5.8). 
However, the bacteria carrying only the pT7-5 vector did not grow as well after 
induction with IPTG. Growth was comparable to the pT7/S8 culture before induction 
and for the following 40 mm, but after this point (still in log phase) growth was 
reduced to approximately 20 % of that observed for pT7/S8. The reason for this 
phenomenon is unclear, but may be due to the increased levels of transcription from 
pT7-5 but not translation, due to the absence of any translational signals on the newly 
transcribed RNA from the empty vector. 
Table 5.1 details the bacterial counts obtained from each culture 40, 80 and 120 mm 
after induction. There appears to be no net cell death in the pT7/S8 culture, and no 
loss of ampicillin resistance. Hence the expressed S8 recombinant protein does not 
appear to be toxic to bacteria, and the plasmid is maintained by the bacteria 
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throughout growth and induction. These factors are therelbre not responsible for the 
low yield of recombinant protein obtained from the culture. 
5.2.5 Inhibition of Proteolytic Activity. 
Proteolytic activity in the periplasm may have been responsible for the observed low 
yield of S8 recombinant protein, therefore the addition of protease inhibitors at 
induction was investigated to determine the effect on the accumulation of recombinant 
protein after secretion into the bacterial periplasm. 
Two 100 ml cultures of E. co/i BL21(DE3) containing the pT7/S8 construct were 
inoculated and grown to A600 of 0.5 as described in section 2.5.1. On induction one 
culture received IPTG (1 mlvi), while the other received both IPTG (1 mM) and 
PMSF (2 mM). As the half life of PMSF is approximately 30 min at 37 °C, this culture 
received a second dose of PMSF (2 mM) 1 h later. The growth of this culture was 
monitored by reading the A600 from inoculation through induction to ensure that the 
addition of PMSF at induction did not cause massive cell death in the culture (Figure 
5.8). After 2 h induction the cells were harvested and subjected to osmotic shock, as 
described in section 2.5.2, to produce periplasmic and cytoplasmic fractions. The 
periplasmic fractions (15 p.1) were analysed by SDS PAGE, and both Coomassie 
stained (Figure 5.9) and Western blotted (Result not shown). On the Coomassie 
stained gel, the periplasmic fraction produced in the presence of PMSF contained a far 
more intense band at 36 kDa corresponding to the recombinant protein than that 
present in the normal periplasmic fraction. This was confirmed by the Western blot, 
which also presented a darker band in the presence of PMSF. Hence the yield of 
recombinant protein was increased significantly when the cells were induced in the 
presence of PMSF, indicating that proteolysis is at least partially responsible for the 
low yields of recombinant protein present in the periplasm of induced bacteria. 
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Figure 5.8 Growth of E. coli Expressing the pT7/S8 and pT7-5 Plasmids. 
In order to assess the toxicity of the S8 recombinant protein, the growth of cultures of 
E. coli containing the pT7-5 and pT7/S8 plasmids was monitored by measuring the 
A,wo from inoculation through induction. The A 0 of a culture which received 2mM 
PMSF at induction and 30 min post induction was monitored also to ensure the 
addition of the protease inhibitor was not killing all of the bacteria in the culture. The 
experiment was performed twice to verify the growth curves obtained. 
122 
Time 	Bacterial Count on 	Bacterial Count 	on L Agar 
(post inoculation) 	L Agar. 	Containing 50 j.tg/ml ampidihin 
160 min 	 5 x 107 	 5 x 107 
200 min 	 1 x 108 1 x 108 
240 min 	 5x109 	 5x109 
280 min 	 5.3x109 	 5.3x109 
Table 5.1 	Bacterial counts obtained from an induced culture of BL21(DE3) 
carrying the pT7/S8 plasmid after inoculating L agar and L agar containing 50 .tg/ml 





66- 	 - 
42-..... 	 _ 
- 
30-u. 	 - 
17_  
12  
Figure 5.9 Effect of PMSF on the Expression of S8 Recombinant Protein. 
Investigation of the effect on expression of S8 recombinant protein of adding PMSF 
to the culture medium after induction. Coomassie stain of periplasmic fractions from 
E. co/i expressing the pT7/S8 plasmid in the presence (Lanes 1 & 3) and absence 
(Lanes 2 & 4) of 2 mM PMSF. Samples were removed after 1 h (Lanes I & 2) and 
2 h (Lanes 3 & 4) induction. The increased levels of S8 recombinant protein observed 
in the presence of PMSF marked by the arrow. 
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5.3 Discussion. 
Recombinant proteins have previously been secreted into the periplasm of E. coli via 
signal peptides encoded by the DNA inserts, and successfully purified for further 
study (Studier & Moffat, 1986; Hewinson & Russell, 1993; Gilbert et al., 1994). 
Although the S8 recombinant protein was successfully expressed and secreted, the 
small amount of recombinant protein found in the peripla;m after osmotic shock of 
the E. coli cells could not be successfully purified. The low yield of recombinant 
protein was initially thought to be due to inefficient expression by translational 
coupling in pUC18 (section 4.3), and the S8 PCR product was therefore subcloned 
into pBluescript II KS and pT7-5 to allow expression of the recombinant protein 
under the control of the T7 promoter, in an attempt to increase these levels of 
expression. 
Although several commercially available vectors contain '['7 promoters (pGEM and 
pSP series, Promega; ?. ExCell and pT7T3, Pharmacia; pET series and pBluescript, 
Stratagene), the pBluescript II KS expression vector was first chosen for subcloning 
due to availability. However, when induced E. co/i BL21(DE3) containing 
pBSMS/S8 were subjected to osmotic shock, very little recombinant protein was 
detected in the periplasmic fraction, the actual yield being lower than that obtained by 
translational coupling in pUCMS/S8. Initially, this implied that the 17 system was 
unsuitable for expression of the S8 recombinant protein. On closer examination of the 
literature it was noted that the pBluescript II KS expression vector was not 
manufactured for this specific application, as the 17 promoter is actually included in 
the vector to allow in vitro transcription of RNA (Stratagene). Expression of 
recombinant proteins in pBluescript II KS is intended to be directed from the lac 
promoter on induction with IPTG. Information supplied with the BL21(DE3) host 
(Stratagene) discourages the use of these vectors for expression of recombinant 
proteins via the 17 promoter, as vectors such as pBluescript II KS, which carry the 
lac promoter without an additional source of lac repressor (lac I) will titrate the 
repressor, due to the presence of multiple copies of the operator, and partially induce 
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the gene for T7 RNA polymerase. Basal polymerase activity therefore becomes 
sufficiently high that many target genes cannot be maintained. This would result in 
reduced levels of expression and low yields of recombinant protein. 
In order to overcome the problems associated with the lac promoter, the S8 PCR 
product was subcloned into the pT7-5 expression vector (kindly supplied by D. Boyle, 
ICMB, University of Edinburgh), which was specifically designed to allow the 
expression of recombinant proteins under the control of the T7 promoter. The pT7-5 
vector does not contain the lac promoter, and therefore does not present the problem 
of repressor titration as was encountered with pBluescript II KS. However, on 
induction and osmotic shock of E. co/i BL21(DE3) containing the pT7/S8 vector, the 
level of S8 recombinant protein detected in the periplasmic fraction was found to be 
similar to that obtained on expression of pUCMS/S8. Hence it appeared that 
translational coupling was as efficient as expression from the T7 promoter, and that 
the original expression system was not the reason for the low yield of recombinant 
protein obtained on induction. 
The expressed recombinant protein may have been toxic to E. coli, resulting in the 
death of transformed bacteria after induction, and the recovery of little recombinant 
protein from the culture. However, the A 600 measured from a culture of pT7/S8 
revealed a standard growth curve before and after induction of the culture with IPTG. 
Bacterial counts on L agar with and without ampidihin revealed no net loss of 
anipidillin resistance, indicating stable maintenance of the expression vector. Hence 
the presence and expression of the S8 insert does not appear to be detrimental to the 
host bacteria, and therefore cannot be responsible for the low yield of recombinant 
protein. 
The serine protease inhibitor PMSF was added to a culture of pT7/S8 at induction to 
examine the possibility of proteolysis being responsible for the low yield of 
recombinant protein obtained from the cells on induction with IPTG. The addition of 
PMSF significantly increased the amount of recombinant protein detected in the 
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periplasm, and indicated that proteolysis was at least partly responsible for the 
reduced yield of recombinant protein observed in this system. 
Although the yield of recombinant protein was increased in the presence of PMSF, the 
actual target of the inhibitor could not be determined from this experiment. As the S8 
insert was thought to encode a serine protease (section 3.3) it was possible that the 
protein was auto-degrading on adopting its native conformation in the periplasm. The 
addition of PMSF (a serine protease inhibitor; Dunn, :1989) would prevent this 
degradation, and result in the accumulation of recombinant protein in the periplasm. 
However, it is also possible that the recombinant protein was not auto-degrading, but 
was being broken down by host proteolytic enzymes in the periplasm, which were 
preventing the abnormal accumulation of foreign protein which could be detrimental 
to the growth and survival of the host (Wulfing & Pluckthun, 1994). The addition of 
PMSF to the culture may have also inhibited these enzymes, allowing accumulation of 
the recombinant protein in the periplasm. Hence this result cannot determine which 
mechanism of proteolysis was responsible for the poor yield of recombinant protein 
observed in the periplasm. It must be considered also that if the S8 recombinant 
protein is indeed a serine protease, its production in the presence of PMSF would 
result in the recombinant protein being irreversibly bound to the inhibitor and 
therefore completely inactive. On purification, this putative protease could not be 
used in any assays to confirm proteolytic activity of the molecule, as was originally 
planned. 
In order to determine the exact mechanism of degradation occurring in the periplasm, 
one variable must be removed to allow the other to be studied more closely. The 
specific inactivation of host proteolytic activity would be difficult to achieve, and 
could result also in the impairment of other important characteristics of growth and 
secretion which are essential for production of the recombinant protein. However, it 
is possible to remove the putative proteolytic activity of the recombinant protein by 
changing one or more of the essential components of the active site. Expression of 
such a mutant clone, which should encode an inactive protease, would help in 
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determining which mechanism of proteolysis was responsible for the low yield of S8 
recombinant protein from both pUCMS/S8 and pT7/S8. If yields of the mutated 
recombinant protein were similar to those obtained from expression of both 
pUCMS/S8 and pT7/S8, it would be likely that degradation due to E. coli host 
proteolytic enzymes was occurring. 
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Chapter 6. 
Site Directed Mutagenesis of the S8 Insert. 
6.1 Introduction. 
In order to investigate the effects of any proteolytic activity displayed by the S8 
recombinant protein on the subsequent yield of recombinant protein, this activity 
would have to be specifically inhibited, if auto-degradation of the recombinant had 
been occurring, specific inhibition of activity would result in the detection of elevated 
levels of recombinant protein in the periplasm. However, if expression levels 
subsequently remained unchanged, the degradation of recombinant protein observed 
in Chapter 5, which was inhibited by PMSF, must have been due to host periplasmic 
proteases. 
Specific inhibition of the recombinant protein could not be achieved by the addition of 
protease inhibitors, as this would also result in the inhibition of host enzymes (section 
5.3). However, the putative active site of the S8 recombinant protein could be altered 
by Site Directed Mutagenesis (SDM) to remove one or more of the elements essential 
to convey proteolytic activity to the protein. 
SDM allows the specific alteration of a known DNA sequence, and is most often 
employed to remove or introduce restriction enzyme sites, or alter the active Site of a 
protease. An oligonucleotide containing the mutated sequence is annealed to single 
stranded plasmid DNA (ssDNA), and extended and ligated to yield double stranded 
plasmid DNA (dsDNA). The plasrnid is then transformed into bacteria, which can be 
screened for possession of the mutant sequence. This process produces a mutation 
frequency of approximately 1 % (Sambrook et al., 1989), and it is therefore laborious 
and time consuming to screen for mutants. However, it is possible to select for 
mutated sequences by destroying the original target sequence, increasing the 
frequency of mutation to around 50 - 80 %. 
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The Kunkel method of SDM (Kunkel, 1985) selects for mutated sequences by 
performing the reaction with template DNA prepared from a duf ung - bacterial 
strain, such as E. co/i BW313 (section 2.1). This organism has a deficiency in 
dUTPase resulting in an increase in the intracellular pool of dUTP, some of which 
becomes incorporated into the cellular DNA instead of dTTP. The organism lacks 
also the enzyme uracil-N-glycosylase, which is responsible for removing any dUTP 
that becomes incorporated into the DNA. The result of the duf ung mutation is 
therefore to produce DNA in which a small number of the Ihymine residues have been 
replaced by uracil. When transformed into E. coil containing an active uracil-N-
glycosylase, this DNA is rapidly destroyed. Hence when a mutagenic oligo is 
annealed to template ssDNA containing uracil (ss'U'DNA and extended and ligated 
in the presence of dATP, dCTP, dGTP and dTTP, the new mutated strand of DNA 
contains no uracil. On transformation of E. co/i containing an active uracil-N-
glycosylase, the original template is destroyed, and all transformants should arise from 
the mutated strand of DNA. This step therefore selects for mutated sequences, and 
increases the frequency of mutation from 1 % to approximately 80 %. 
This method of SDM was therefore employed in order to specifically alter the DNA 
sequence of the S8 insert, resulting in the substitution of the amino acid alanine for the 
active serine (amino acid position 215) in the S8 recombinant protein. The active 
serine in this class of protease is responsible for nucleophilic attack on peptide bonds, 
which results in the cleavage of the bond. The closely related amino acid alanine does 
not possess the hydroxyl side chain responsible for the nucleophilic attack (Figure 6.1) 
and therefore cannot participate in the cleavage of peptide bonds. The substitution of 
alanine for the active serine in the S8 recombinant protein (achieved by changing the 
codon TCC to GCC) should therefore yield an inactive protease, and levels of 
expression of the mutated sequence in E. co/i would determine whether the PMSF 
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Figure 6.1 Serine Protease Mechanism. 	 - 
Nucleophilic attack by the hydroxyl group of serine in a serine protease. The 
proton (H) of the hydroxyl group is transferred to the histidine component of the 
active site and an ester is formed between the free oxygen of the serine and the acyl 
portion of the substrate, cleaving the peptide bond. Enzyme catalysed attack by water 
then dissociates the enzyme from the cleaved substrate. 
Alanine, although structurally similar to serine, does not contain the terminal 




6.2.1 Preparation of Template ssDNA. 
The S8 DNA insert had been previously cloned into the pBluescript II KS vector 
(pBS/S8) in order to express recombinant protein from the T7 promoter (section 
5.2.1). The pBluescript II KS vector is a phagernid, containing the fl origin of 
replication from the fl filamentous phage, which allows the rescue of antisense 
ssDNA from transformed E. coil on infection of the culture with helper phage. Hence 
the pBS/S8 construct could be used to produce ssDNA template for SDM. 
The pBS/S8 vector (50 ng) was used to transform 100 .tl of competent E. coli 
BW313 (sections 2.12.2 & 2.12.3), and positive clones were selected by plating 
200 p.1 aliquots onto L agar containing 50 p.g/ml ampidihin and growing overnight at 
37°C. Single stranded plasmid DNA was prepared from E. coil BW3 13 containing 
the pBS/S8 vector using the helper phage M13K07, as described in section 2.9.4. 
The concentration of DNA was estimated at approximately 40 ng/p.l from comparison 
with a known concentration of single stranded M13 DNA on a 0.6 % (w/v) agarose 
gel, and 50 ng was used to verify the uracil incorporation by transforming (section 
2.12.2) into both E. coil BW313 and E. coil TG1. After plating 200 41 aliquots onto 
L agar containing 50 p.glrnl ampidihin and growing at 37 °C overnight, 348 E. coil 
BW313 transformants, and 3 E. coil TG1 transformaiits were produced. This 
indicated that the ss'U'DNA had been degraded in E. co/i TG1, which possessed an 
active uradil-N-glycosylase, and that the ss'U'DNA had a sufficient amount of uracil 
incorporated to allow its use in the SDM reaction. 
6.2.2 Mutagenesis of the S8 Insert. 
The mutagenesis reaction was performed as described in section 2.14 using a 
modification of the method described by Kunkel (1985). A specific oligonucleotide 
was synthesised (Oswel, Southampton) with the desired one base mutation (changing 
the serine codon [TCC] to an alanine codon [GCC]), which would hybridise only in 
the desired area of the gene to prime DNA synthesis. The mutagenesis reaction 
132 
(10 tl) was used to transform 100 p.l of competent E. coil BW313 and TG1 (sections 
2.12.2 & 2.12.3), and 200 p.1 aliquots were plated onto L agar containing 50 p.g/ml 
ampidilhin to select for successfully transformed cells. After incubation overnight at 
37°C, 40 transformants were obtained of E. coil TG 1, and over 200 of E. coii 
BW313. As this method was reported to produce a 70 - 80 % mutation rate, between 
20 - 30 of the TG 1 transformants should contain the mutation. 
The 40 TG1 transformants were subcultured onto L agar containing 50 p.g/ml 
ampidihin, and the first 18 were used to inoculate 10 ml of L broth containing 
50 p.g/ml ampicihin, and grown overnight at 37 °C. Plasmid DNA was prepared from 
these 18 cultures using the QlAprep spin columns (Qiagen) as recommended by the 
manufacturer, and 2 p.g of purified DNA was used in sequencing reactions (section 
2.10) with a 17 mer oligonucleotide (TCAACCAGAGCGTCTCG: Appendix I) which 
annealed at nucleotide position 572-588 to give the correct region of sequence on a 
2.5 - 3 h sequencing gel. However, on analysis of the sequences obtained, all 18 
plasmids were found to contain the original wild type sequence. No mutant clones 
were detected. 
A new batch of ss'U'DNA was prepared as described in section 2.9.4, and the 
mutagenesis reaction was repeated twice as described above. Again, all transformants 
obtained on transforming E. coil TG1 with the mutagene:;is reaction were found to 
contain the wild type sequence. One possible explanation was that the E. coil 
repaired the 1 bp mismatch before the template 'U'DNA strand had been completely 
destroyed. Hence, the mutagenesis reaction was again repeated as described above, 
and the mix (10p.l) used to transform 100 p.1 of competent E. coli BMH71-18 mutS 
(sections 2.12.2 & 2.12.3), a strain incapable of performing mismatch repair. If 
mismatch repair had been responsible for the previous negative results, any positive 
clones obtained from this transformation should have contained the mutation. The 
transformation mix was plated onto L agar containing 50 p.g/ml ampicilhin, and grown 
overnight at 37 °C. Thirty colonies were obtained, subcultured onto L agar containing 
50 p.g/ml ampidilin, and 18 also were grown overnight in 10 ml of L broth containing 
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50 i.gJml ampicilhin. DNA was prepared using QlAprep spin columns (Qiagen) and 
sequenced as described above. Again, all 18 samples were found to contain the wild 
type sequence. 
6.2.3 Mutagenesis Using the Mutagene Mutagenesis Kit. 
As no positive results were obtained using the method described in section 2.14, it 
was decided to try and introduce the mutation into the S8 insert using the Mutagene 
Mutagenesis kit (Bio-Rad). Information supplied with the kit suggested that the 
previous problems may have been due to the template being contaminated with 
genomic DNA, which was mis-priming with the template DNA, drastically lowering 
the mutation frequency. This could be determined by performing the mutagenesis 
reaction in the absence of the mutagenic oligonucleotide. Any clones obtained on 
transforming E. coli would be due to mis-priming. 
Hence, the ss'U'DNA (200 ng) obtained from E. coli BW313 was used in the 
mutagenesis reaction as described by the manufacturer both with and without the 
mutagenic oligonucleotide. After extension with T7 polyrnerase and ligation with T4 
DNA ligase, reaction mixes (10 j.tl) were transformed into competent E. coli BMH71-
18 mutS (100 tl) to ensure no mis-match repair occurred. Cells were plated onto L 
agar containing 50 .tg/ml ampicillin, and grown overnight at 37°C. The 
transformation frequency of the E. coli BMH71-18 mutS was far higher than E. co/i 
TG 1 (approximately 10-100 fold), however, similar numbers of transformants were 
obtained from both reaction mixes. The reaction containing no mutagenic 
oligonucleotide should have produced no transformants as ss'U'DNA is destroyed by 
E. co/i BMH71-18 niutS. The failure to obtain any mutant sequences appeared to be 
due to problems with the template DNA used in the reactions. 
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6.3 Discussion. 
The substitution of the amino acid alanine for serine in the S8 recombinant protein (at 
amino acid position 215) by site directed mutagenesis of the S8 insert should have 
rendered the recombinant protein incapable of cleaving peptide bonds, and prevented 
any possible auto-degradation of the recombinant protein during induction. 
Subsequent expression of this mutated clone in E. coil would have thus determined 
the exact nature of the observed increase in yield of the S8 recombinant protein when 
E. coil expressing the pT7IS8 plasmid were induced in the presence of the protease 
inhibitor PMSF (section 5.2.6). 
Several attempts were made to introduce a specific 1 bp mutation into the S8 insert by 
the Kunkel method of site directed mutagenesis, which viould have resulted in the 
substitution of the amino acid alanine for the active serine in the S8 recombinant 
protein. However, by using both an 'in house' method and a commercial kit (Bio-
Rad), no mutant clones were obtained. This was initially thought to be due to mis-
match repair by the E. co/i, however, the problem was not solved by the use of E. co/i 
BMH7I-18 mutS which is mis-match repair deficient. The failure to obtain mutants 
appeared instead to be due to problems with the template ss'U'DNA, as 
transformants were obtained when this template was subjected to the 
extension/ligation reaction in the absence of the rriutagenic oligonucleotide. 
Literature supplied with the commercial kit (Bio-Rad) indicated that this was often 
due to contamination of the template DNA with genomic DNA and RNA, which 
results in mis-priming and the production of plasmid DNA which does not contain the 
desired mutation. 
Due to the time constraints of this project, it was not possible to continue with this 
piece of work, and obtain the mutated recombinant protein. Had time allowed, 
several steps could have been taken in an attempt to overcome the problems 
associated with the template ss'U'DNA. 
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The mutagenesis reaction could have been performed on pBluescript II KS with 
no insert to assess whether any mis-priming was occuring specifically with this 
plasmid. If this was found to be so, the S8 insert could have been sub-cloned into 
another M13 derived phagemid vector and the mutagenesis reaction repeated using 
this construct. 
Further purification of the ss'U'DNA, for example on a caesium chloride density 
gradient, could have removed any contaminating genomic DNA or RNA which may 
have been responsible for the mis-priming. 
The mutagenesis reaction could have been transformed into a different mis-match 
repair mutant. The use of a different genetic mechanism to inhibit repair may have 
resulted in the production of the desired mutation. 
The use of a second dut ung bacterial strain may have improved the quality of 
ssDNA used as template. This factor has already been shown to be important in the 
preparation of plasmid DNA for sequencing (section 3.2.3) when the poor quality of 
sequence obtained from pMS 1S/S4 and pMS iS/S 8 plasmid DNA was attributed to 
the E. co/i NM522 host bacterium (Taylor et al., 1993). The Bio-Rad Mutagene 
Mutagenesis kit recommends the use of E. coli CJ236 for the production of uracil-
containing DNA, however E. co/i BW313 was used due to availability. It is possible 
that ssDNA prepared from E. co/i CJ236 may have been a more suitable template for 
this experiment. 
A second mutagenic oligonucleotide could have been synthesised to introduce a 
mutation of several bases into the S8 insert, although this would undoubtedly have 
affected the T. and the annealing reaction. Although the oligonucleotide carrying the 
1 bp mutation should have successfully mutated the gene, the introduction of a larger 
mutation may have been more efficient and easier to achieve. 
Site directed mutagenesis can be performed by several other methods, and these could 
be adopted if the solutions above did not produce the desired mutation in the S8 
insert. The method described by Deng & Nickoloff (1992) utilises two mutagenic 
oligonucleotides, and is the basis of the Chameleon Miitagenesis kit supplied by 
Stratagene. The first oligonucleotide introduces the desired mutation, and the second 
contains a mutation which removes a unique restriction endonuclease site. Both 
oligonucleotides are phosphorylated, annealed to denatured double stranded plasmid 
DNA, and extended and ligated as described previously. After transformation and 
growth in E. coil BMH71-18 niutS to prevent mis-match repair, total plasmid DNA is 
purified and digested with the specific restriction endonuclease to linearise plasmids 
containing the wild-type sequence. The digestion mix is then used to transform 
competent E. coli. Any resulting transformants would be derived from circular 
plasmid DNA containing the mutation, as linear DNA does not transform E. coli 
efficiently. 
The phosphorothioate method of oligonucleotide-directed mutagenesis (Sayers et al., 
1992) utilises a-thiotriphosphates (eg. dCTPaS) in the extension/ligation of the 
mutated oligonucleotide which is annealed to template ssDNA. The template strand 
is then nicked with a restriction endonuclease and subjected to limited digestion with 
exonuclease III, which is unable to digest DNA containing thiotriphosphates, to 
produce a gap spanning the site of mutation. The gap is filled with DNA polymerase, 
incorporating the desired mutation, and the resulting dsDNA used to transform E. 
coil. 
Although the results presented in this chapter describe the failure to obtain a specific 
mutation in the S8 insert, it is possible that by utilising the steps and techniques 
discussed above that the desired mutation could be successfully introduced into the S8 




Characterisation of the Native 34 kI)a Protein. 
7.1 Introduction. 
The ORF contained in the S4 and S8 DNA inserts was identified from expressing 
clones, contained no stop codons, and maintained an overall 3rd position G/C bias as 
is usually found in mycobacterial genes. Analysis of the sequence with the GCG 
programme 'CODONPREFERENCE' revealed no evidence of frameshift, which 
indicated that the correct ORF had been identified. Hence, the deduced amino acid 
sequence of the S8 insert was thought to exactly match that of the native 34 kDa 
protein. However, in order to confirm the sequence data, the native 34 kDa protein 
had be purified and its N-terminal amino acid sequence determined. If this matched 
the deduced amino acid sequence of the clone, it would confirm the presence of the 
correct ORF, and the identification of the true native protein. 
Sequence data suggested also that the S4 and S8 inserts encoded a secretory serine 
protease (section 3.2.3). A possible signal peptide of 39 amino acids and signal 
peptidase cleavage site (Ala-Ser-Ala) were detected in the deduced amino acid 
sequence of the S8 insert. If the native protein was indeed secretory, this sequence 
would be absent from the mature native protein, and would be evident on comparing 
the N-terminal amino acid sequence of the native protein with the deduced amino acid 
sequence of the clone. 
Although the 34 kDa protein was thought to be a serine protease, this had been 
inferred only from sequence data (section 3.2.3), and the observed instability of the 
recombinant protein during purification protocols (section 4.2.4, 4.2.5 & 5.2.4). No 
definite evidence of functional activity had been obtained. Hence once purified, the 
native 34 kDa protein could be used in a series of protease assays in order to detect 
any activity. The identification of a function and physiological substrate could 
provide some clue as to the true function of the protein in M.a. paratuberculosis. 
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7.2 Results. 
7.2.1 Purification of the Native 34 kDa Protein. 
Due to the observed instability of the S8 recombinant protein during purification 
(section 4.2.4, 4.2.5 & 5.2.4), the native 34 kDa protein was purified from lysates of 
M.a. paratuberculosis on a MAb affinity column. Hybridoma cell line 5.8 (secreting 
MAb 5.8) was used to raise ascitic fluid in four Balb/c mice (section 2.7.1), as ascites 
provided a more concentrated source of MAb than that obtained from tissue culture 
medium. Activity of the ascitic fluid was verified by screening against Western 
blotted pMS 1S/S4 fusion protein, and the MAb isotype was determined as IgGi, 
using the ISO-1 Mouse Monoclonal Isotyping kit (Sigma) as recommended by the 
manufacturer. The IgGi was purified on a column of Protein A Sepharose, as 
described in section 2.7.2, and coupled to cyanogen bromide activated Sepharose 
(section 2.7.3) to produce the MAb affinity column. 
The native 34 kDa protein was purified from Eaton pressed lysates of M.a. 
paratuberculosis as described in section 2.7.4. Eaton pressing (Eaton, 1962) had 
been demonstrated previously to produce the most efficient lysis of large pellets 
(approximately 1 g wet weight) of mycobacteria (K. Stevenson, personal 
communication). The rapid freeze-thaw cycles which occur under high pressure 
caused the lysis of > 99 % of the mycobacteria in the sample (verified by phase 
contrast microscopy), and by performing the protocol with a frozen sample, the 
apparatus did not create any potentially hazardous aerosols, as can be produced by a 
French pressure cell. 
The mycobacterial lysate was processed, mixed with the M'Ab affinity column matrix, 
and eluted as described in section 2.7.4. Samples of pre-column lysate, column 
flowthrough and eluate (15 p.1) were analysed by SDS PAGE and both Western 
blotted and silver stained (section 2.3). The silver stained SDS PAGE gel (Figure 
7.1a) revealed the presence of a band of approximately 34 kDa in both the dilute and 
concentrated eluate, and a smaller contaminating band of approximately 30 kDa. This 
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Figure 7.1 Purification of Native 34 kDa Protein From M.a. paratuberculosis. 
Silver stain (a) and Western blot (b) of samples taken during the purification of the 
native 34 kDa protein on a MAb affinity column, constructed with MAb 5.8. Lane 1, 
S4/Ga1 fusion protein (positive control); Lane 2, pre-colunm lysate of M.a. 
paratuberculosis; Lane 3, column flowthrough; Lane 4, eluate containing the 
purified 34 kDA protein; Lane 5, eluate concentrated approximately 3-fold. Western 
blot probed with MAb 5.8, and Dako anti-mouse HRP conjugate diluted 1:1000. 
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band was shown by Western blotting to react with MAb 5.8 (Figure 7.1b) and clinical 
serum JD87/39 (results not shown), confirming the purification of the correct protein 
from the mycobacterial lysate. However, the yield of recovered protein was low, and 
estimated using the Pierce Micro BCA Protein Estimation Assay at approximately 
40 - 50 p.g of purified 34 kDa protein from a 1 g (wet weight) pellet of M.a. 
paratuberculosis. 
The silver stain (Figure 7.1a) revealed that the preparation of 34 kDa protein was 
sufficiently pure to allow the determination of the N-terminal amino acid sequence for 
comparison with the deduced amino acid sequence of the ORF contained in the S8 
insert. Approximately 2 jig of purified 34 kDa protein was resolved by SDS PAGE 
(section 2.3.1) and Western blotted onto PVDF membrane in borate blot buffer, as 
described in section 2.7.5. The transfer was performed in borate blot buffer to avoid 
the use of glycine (Tris-glycine blot buffer; section 2.3.3), which would interfere with 
the sequence obtained from the 34 kDa protein. After staining with Coomassie blue 
the 34 kDa band was excised from the PVDF membrane, and the first 20 N-terminal 
amino acids were obtained by Edman degradation. 
As shown in Figure 3.6, the N-terminal amino acid sequence of the 34 kDa protein 
matched exactly the deduced amino acid sequence of the ORF contained in the S8 
insert, from amino acid position 55 to 74. This confirmed translation of the correct 
ORF in the DNA insert, and also the identification of the corresponding native 
protein. These sequence data also confirmed the presence of a signal peptide, as the 
mature native protein lacked the predicted 39 amino acid signal sequence encoded by 
the ORF contained in the S8 DNA insert, however the native protein lacked also a 
further 15 amino acids which may have represented some form of pro-peptide also 
removed post translationally (section 3.3). These data therefore strongly suggested 
that the newly synthesised protein was secreted across the mycobacterial cytoplasmic 
membrane into the cell wall, where the signal peptide was removed by a mycobacterial 
signal peptidase. 
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7.2.2 Secretion of Native 34 kDa Protein From M.a. paratuberculosis. 
Sequence data from both the S8 DNA insert and the native 34 kDa protein indicated 
that the 34 kDa protein was secretory, and this may have been responsible for the 
observed low yield of native protein recovered from M.a. paratuberculosis cells. 
However, it had been noted in the literature that the HtrA proteins of E. co/i and S. 
lyphimurium were stress proteins induced by heat shock and oxidative stress 
respectively (Lipinska et al., 1990; Johnson et al., 1991). If the native 34 kDa protein 
also was a stress protein, its expression in M.a. paratuherculosis may have been 
down-regulated during growth in the favourable conditions provided by Stuart's 
medium. Hence, placing the organism under stressful conditions (e.g. starvation) may 
result in an increase in the amount of protein expressed. The following experiment 
therefore was designed to demonstrate secretion of the native 34 kDa protein from 
M.a. pararuberculosis, and to detect any increase in the amount of protein secreted 
when the organism was placed under stress of starvation. 
Ten 750 cm2  tissue culture flasks containing 100 ml of solid Stuart's medium (plus 
2tg/ml mycobactin J) were inoculated with M.a. paratuberculosis and grown for 8 
weeks, until confluent growth was visible on all flasks. The cells were harvested 
separately from each flask and five pellets (each of approximately 400 mg) were 
individually re-suspended in 10 ml of Middlebrooks 7H9 liquid medium containing 2 
.tg/ml mycobactin J. The other five pellets were each resuspended in 10 ml of PBS to 
induce starvation conditions, as it had been shown previously that bacteria are capable 
of surviving for long periods of time in PBS without any added nutrients (Porter et 
al., 1991; Porter & Wardlaw, 1993). The cells were incubated at 37 °C, and one 
culture from each group (7H9 & PBS) was harvested after 24 h, 7 days, 14 days, 21 
days, and 28 days. Each supernatant was passed through a 0.45 gm filter to ensure 
the removal of all M.a. paratuberculosis cells and pellets and supernatants were 
stored at -20°C until completion of the experiment. 
Each pellet of M.a. paratubercu!osis was resuspended at 200 mg/ml in PBS 
containing 2 mM PMSF, and 1 ml aliquots were mixed with 0.5 ml of 0.1 mm 
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zirconium/silica beads and lysed by beating for 3 x 30 s in a mini beadbeater (ESPE 
Capmix). The lysates (10 i.l) were then analysed by SDS PAGE and Western blotting 
(section 2.3) which revealed that the level of cell-associated 34 kDa protein appeared 
to have decreased during incubation in both 7H9 medium and PBS. These results are 
not shown, as the intensities of the bands obtained on Western blotting were very 
weak, and did not reproduce on photographing. 
The 0.45 J.tm filtered supernatant from each sample (35 .tl) was also analysed by SDS 
PAGE and Western blotting to detect any 34 kDa protein which had been secreted 
into the culture medium during incubation. Despite the original hypothesis that 
starvation would induce expression of the 34 kDa protein, no reaction was detected in 
the PBS supernatants by Western blotting (results not shown). However, the 34 kDa 
protein was detected in the 7H9 supernatants from days 7, 14, 21 and 28 (Figure 7.2). 
In order to confirm that the presence of the 34 kDa protein in the 7H9 supernatants 
was due to secretion and not cell lysis, the Western blots were repeated and probed 
with a MAb specific for the mycobacterial HSP 65. This protein is not secretory, and 
its presence in the supernatant would indicate that a large amount of bacterial lysis 
had occurred during the incubation period. However, no reaction was obtained with 
either PBS or 7H9 supernatants (results not shown), which indicated that the 34 kDa 
protein was being actively secreted from the M.a. paratuberculosis cells, and was not 
being released due to cell lysis. 
A preliminary experiment had been performed with pellets of M.a. silvaricum, and had 
produced similar results, detecting secretion only into the 7H9 medium, suggesting 
that conditions favouring metabolism were required for the secretion to occur. A 
more notable decrease in the amount of cell associated 34 kDa protein was observed 
with M.a. silvaticum (Figure 7.3), however, these cells appeared to contain more of 
the 34 kDa protein than the M.a. paratuberculosis cells. The reasons for this are 
unclear, as original antibody elution results detected an equal amount of the protein in 
both species of mycobacteria. However, it is possible that the M.a. paratuberculosis 
cells used in this experiment have been over-passaged, and due to this sustained in 
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Figure 7.2 Secretion of the 34 kDa Protein from M.a. paratuberculosis. 
Western blot of supernatants obtained after incubation of M.a. paratuberculosis 
pellets (approx. 1 g wet weight) in 7H9 medium for 24 h - 4 weeks. Lane 1, 
periplasmic fraction from E. co/i expressing the pT7/S8 pla.smid (positive control); 
Lanes 2-6, 7H9 supernatants from cultures incubated for 24 h, 7 days, 14 days. 21 
days and 28 days respectively; Lane 7, sterile 7H9 supernatant (negative control). 
Western blot probed with MAb 5.8, and Dako anti-mouse HRP conjugate diluted 
1:1000. 
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Figure 7.3 M.a. silvaticum Cell Associated 34 kDa protein. 
Levels of 34 kDa protein obtained from lysed pellets of M.a. silvaticum after 
incubation for 24 h, 7 days, 14 days, 21 days and 28 days in 71-19 medium (Lanes 1, 3, 
5, 7 & 9) and PBS (Lanes 2, 4, 6, 8 & 10) respectively. Approximately 1 mg total 
protein loaded from each lysate. Western blot probed with MAb 5.8, and Dako anti-
mouse HRP conjugate diluted 1:1000. 
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vitro growth were not expressing the same level of the 34 kDa protein as was 
observed previously. 
7.2.3 Protease Assays Using Native and Recombinant Protein. 
The HtrA family of proteins are thought to be proteases due to the presence of the 
GDSGG motif which corresponds to the residues surrounding the active serine in 
trypsin. Unfortunately, the functional activity of most of the HtrA proteins has not 
been investigated, and only the HtrA protein of E. coli has been reported to possess 
proteolytic activity, when its ability to degrade casein (especially 0 casein) was 
described (Lipinska et al., 1990). Casein is regularly used as a substrate for proteases 
with unknown specificities, as unlike a synthetic substrate, it contains a large number 
of susceptible bonds available for cleavage (Sarath et al., 1989) and this increases the 
likelihood of a suitable cleavage site being present. As casein is known to be digested 
by trypsin and chymotrypsin, it would appear also to be the obvious choice of 
substrate for an unknown serine protease. If the 34 kDa protein is an homologous 
protease, it should display some of the activity against casein shown by the E. co/i 
HtrA. The following protease assays (described in more detail in section 2.8) 
therefore were performed using both purified 34 kDa protein and S8 recombinant 
protein (periplasmic fraction) in an attempt to detect any functional activity. 
Digestion of a and 13 Casein. 
The purified 34 kDa protein was used in the assay system described by Lipinska 
(1990) in an attempt to show proteolytic activity against casein (section 2.8.1). The 
34 kDa protein (200 ng) was incubated with 10 .tg  of both a and 13 casein, and 
digestion products were separated by SDS PAGE and stained with Coomassie blue. 
No digestion of either a or 13 casein was detected in this assay (results not shown). 
Lipinska (1990) described also an assay which examined the protease activity of the 
HtrA protein as a function of pH. In this experiment 13 casein (0.4 mg/ml) was 
incubated with purified E. coli HtrA protein (20 tg/ml) for 30 min in the presence of 
50 mM buffer of various pHs ranging from 4.8 to 11. However, the details of this 
147 
experiment were not reported precisely, and it could not be repeated. As casein will 
not dissove in solutions below pH 6.0 (Sarath et al., 1989), a precipitate was obtained 
when using buffers of low pH, and it is therefore not clear exactly how the original 
experiment was performed. 
Casein Gel Assay. 
The purified 34 kDa protein and the S8 recombinant protein were both tested for 
proteolytic activity against azocasein immobilised in a native PAGE gel as described 
in section 2.8.2. As the recombinant protein could not be easily purified, the 
periplasmic fraction from induced E. co/i BL21(DE3) containing the pT7/S8 and pT7-
5 expression vectors were run on the gel for comparison. As a positive control, 200 
ng of chymotrypsin was loaded onto a fourth casein gel, and all four were run as 
described in section 2.3.2. The gels were cut into strips and incubated overnight at 
RT in the buffers listed in Table 7.1. ATP was included in 6 of these buffers, as a 
motif representing a possible ATP binding site had previously been detected in the 
deduced amino acid sequence of the S8 insert (section 3.23). It was possible that the 
protease required energy (ATP) in order to display functional activity. After 
incubation, each strip was stained with Coomassie blue for 1 h, destained for 30 mm, 
and examined for signs of digestion. If any proteolysis of the azocasein had occurred, 
the area in the gel would not stain with Coomassie and would be visible as a clear 
band. The chymotrypsin positive control contained a clear band, however all 12 strips 
containing purified 34 kDa protein, pT7/S8 periplasm, and pT7-5 periplasm showed 
no evidence of digestion of azocasein in this assay (Table 7.1). 
Agar Gel Diffusion Assays. 
Agarose plates were prepared containing azocasein, skimmed milk, and horse blood 
as described in section 2.8.3 to screen for proteolytic activity by gel diffusion. Wells 
were cut into the agar and loaded with 10 41 of each periplasmic fraction and 0.2 p.g 
of purified 34 kDa protein. Chymotrypsin (0.2 .tg) was applied to one well on each 
plate as a positive control. The plates were sealed with parauilm, and incubated 
Buffer 	 Digestion of Casein by; 
Purified 34 	pT7/S8 	pT7-5 	Chymotrypsin 
kDa 	periplasm 	periplasm 
Distilled H20 	 - 	 - ND 
PBS 	 - 	 - 	 -. 
Bis Tris/HC1 pH 6.5 	- 	 - ND 
Tris/HC1 pH 7.5 	 - 	 - 	 -• ND 
Tns/HCI pH 8.0 	 - 	 - 	 - ND 
NaAc pH 4.5 	 - 	 - 	 -• ND 
Distilled H20 	 - 	 - 	 -• ND 
+20j.tMATP 
PBS 	 - 	 - ND 
+20j.tMATP 
Bis Tris/HC1 pH 6.5 	- 	 - ND 
+20 j.LM ATP 
Tns/HC1 pH 7.5 	 - 	 - 	 -. ND 
+20j.tMATP 
Tris/HC1 pH 8.0 	 - 	 - 	 -. ND 
+20.tMATP 
NaOAc pH 4.5 	 - 	 - 	 -• ND 
+20j.tMATP 
ND - Not Done 
Table 7.1 Digestion of Casein Immobilised in an Acrylamide Gel. 
Polyacrylamide gels (10 %) containing 20 mg/mi azocasein were used to resolve 
purified 34 kDa protein (2 .tg), the periplasmic fraction from E. coli expressing either 
the pT7/S8 plasmid (lOOjfl) or the pT7-5 plasmid (lOOj.tl),  and chymotiypsin (2 }.tg; 
positive control), and were incubated overnight in the buffers listed in the table above. 
Gels were examined for evidence of casein degradation (+) by staining with 
Coomassie blue. 
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overnight at 37°C to allow diffusion and digestion to occur. The plates were then 
examined for zones of clearing, however, with the exception of the chymotrypsin 
positive control, none of the samples had successfully digested any of the test 
substrates. 
Digestion of Casein by Induced BL21(DE3) Containing pT7/S8. 
Previous researchers have successfully isolated DNA inseits expressing proteases by 
screening for the ability of recombinant clones to digest casein (Arakawa & 
Kuramitsu, 1994). This technique could potentially be used to demonstrate a 
proteolytic activity of the S8 recombinant protein on induction in E. co/i. The clones 
identified by Arakawa & Kuramitsu were expressed via their own promoters, 
therefore, when applying this technique to the S8 DNA insert, IPTG was added to the 
L agar to induce the expression of the recombinant protein. 
Skim milk agar plates were prepared as described in section 2.8.4, and E. coil 
BL21(DE3) containing the pT7/S8 and pT7-5 expression vectors were streaked out 
onto separate plates and incubated for 7 days. No positive control was available for 
this experiment. E. coil BL21(DE3) containing the pT7-5 expression vector was used 
as a negative control, with which to compare any activity of the S8 recombinant 
clone. However, after the 7 day incubation period no digestion of the casein (skim 
milk) was detected around the colonies on either plate. 
Sensitivity to Hydrogen Peroxide. 
The HtrA protein of S. typhiniurium is thought to be involved in the intracellular 
survival of the organism, as mutants with insertions in the gene appear to be more 
susceptible to oxidative stress, such as H 202 (section 9; Johnson et al., 1991). As the 
34 kDa protein displayed 30 % homology to this protein, the sensitivity of E. co/i 
expressing S8 recombinant protein to H 202 was investigated. 
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Medium 	 Organism, Vector 	Zone of Inhibition 
(mm) 
L. agar NM522 33 
L. agar BL21(DE3) 36 
L. agar + 50p.g/ml amp. NM522, pUC18 35 
(L. Amp.) 
L. Amp. NM522, pUCMS/S8 33 
L. Amp. BL21(DE3), p17-5 35 
L. Amp. BL21(DE3), pT7/S8 41 
L. Amp. +10 mM IPTG NM522, pUC18 36 
L. Amp. + 10 mM IPTG NM522, pUCMS/S8 32 
L. Amp. + 10 mM IPTG BL21(DE3), pT7-5 36 
L. Amp. + 10 mM IPTG BL21(DE3), p'1'7/S8 37 
Table 7.2 Sensitivity to Hydrogen Peroxide. 
Lawns of bacteria expressing pUC18, pUCMS/S8, pT7/S8 or no plasmid were 
prepared on the appropriate medium as listed above, and their sensitivity to hydrogen 
peroxide measured by placing a disc saturated with 10 .t1 of 37 % hydrogen peroxide 
in the centre of the plate, and grown overnight at 37°C. Zones of inhibition of growth 
were measured. 
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A lawn of E. coli BL21(DE3) containing the pT7/S8 expression vector was prepared 
on both L agar containing 50 tgJm1 ampidilhin and L agar containing 50 j.Lg/ml 
ampidillin and 1 mM IPTG as described in section 2.8.5. Control plates with a lawn 
of BL21(DE3) containing the pT7-5 expression vector (no insert), and BL21(DE3) 
containing no vector (grown on L agar only) were prepared also. Discs of filter paper 
saturated with H 202 were placed in the centre of each plate (section 2.8.5), and 
incubated overnight at 37 °C. All plates showed inhibition of growth around the H 202 
discs (Table 7.2), however, there was no difference between the control NM522 and 
BL2 1 (DE3) zones and any of those produced with or without IPTG. This indicated 
that expression of the S8 recombinant protein had no effect on the sensitivity of E. 
coli BL21(DE3) to H 202 . 
However, it must be remembered that E. co/i also possesses an HtrA protein. 
Although this is thought to be involved only in response to heat shock (Lipinska et 
al., 1988) it may be induced by H 202 , hence, over-expression of the S8 recombinant 
protein may not alter the observed sensitivity pattern of E. co/i to this type of stress. 
7.2.4 Native PAGE of S8 Recombinant Protein and 34 kDa Protein. 
In order to determine whether the native 34 kDa protein was present in M.a. 
paratuberculosis as a monomer or as a multimer consisting of more than one 34 kDa 
subunit, native PAGE was performed as described in section 2.3.2. The estimation of 
molecular weight from native PAGE gels is difficult, due to the nature of the 
conditions; i.e. the proteins are not being separated simply by molecular weight as in 
SDS PAGE. Markers for native PAGE therefore have to resemble the proteins being 
analysed (Hames, 1981), which is impossible in this case as these proteins have not 
been well characterised. The native PAGE gel was run therefore simply to look for 
the presence of multimeric subunits. Samples of M.a. paratuberculosis lysate 
(approximately 4 mg), purified 34 kDa protein (2 j.tg), arid S8 recombinant protein 
(20 p1 of periplasmic fraction) were loaded onto the native PAGE gel in duplicate, 
one sample in native PAGE sample buffer (section 2.3.2) the other boiled for 90 s in 
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Figure 7.4 Native PAGE. 
M.a. paratuberculosis lysate (Lanes 1 & 2), purified 34 kDa protein (Lanes 3 & 4), 
and the penpiasmic fraction from E. coli expressing the pT7/S8 plasmid (Lanes 5 & 
6) were examined by native PAGE to establish the presence or absence of multimeric 
subunits. Lanes 1, 3 & 5 were loaded in native PAGE sample buffer, and Lanes 2, 4 
& 6 were boiled for 90 s in x2 Laemmli sample buffer to denature any subunits before 
loading. Western blot probed with MAb 5.8, and Dako anti-mouse HRP conjugate 
diluted 1:1000. 
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an equal volume of x2 LSB (section 2.3. 1) to denature the sample and dissociate any 
subunits. The samples were then separated as described in section 2.3.2, and Western 
blotted onto nitrocellulose (section 2.3.3). After probing the Western blot with MAb 
5.8 (Figure 7.4), very little difference was observed between the samples. The 34 
kDa band in the denatured M.a. paratuberculosis lysate did appear to be slightly 
smaller than the non denatured band, but this may have been due to other proteins 
present in the lysate. Both denatured and non denatured samples of purified 34 kDa 
protein and S8 recombinant protein displayed the same molecular weight as the non 
denatured M.a. paratuberculosis lysate suggesting the molecule does not exist as a 
multimer. The S8 recombinant protein also appeared as a doublet on the Western 
blot, which may have been due to expression of the recombinant in a non native 
system, and to the observed difference in molecular weight between the native 34 kDa 
protein and the recombinant 36 kDa protein (section 4.2.3, Figure 4.7). However, the 
overall result of this Western blot suggested that the native protein was not present as 
a multimer in M.a. paratuberculosis, and that the lack of correct tertiary structure 
cannot explain the failure to demonstrate any proteolytic activity of the native and 
recombinant proteins. 
7.3 Discussion. 
Although several secretory proteins have been detected in mycobacteria, most have 
been identified by analysing culture supernatants (Andersen et al., 1992; White et al., 
1994), and the actual mechanisms of secretion have not been determined. The S8 
recombinant protein was shown to be secreted via its own signal peptide, across the 
cytoplasmic membrane of E. coli, and was located in the periplasm (section 4.2.3). 
The recombinant protein therefore was not secreted into the E. co/i culture medium, 
although the native 34 kDa protein had been observed in M.a. paratuberculosis 
culture medium (section 7.2.2), indicating a difference in the secretory mechanisms of 
these two organisms. 
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Mycobacteria do not possess a periplasm, and although they do not Gram stain, they 
more closely resemble Gram positive organisms due to the presence of a single 
cytoplasmic membrane and a cell wall (section 1.1.1). Secretion of proteins from 
Gram positive organisms is not well understood (Simonen & Palva, 1993), but 
appears to be directed also by the presence of an N-terminal signal peptide on the 
target protein. After translocation across the cytoplasmic membrane and cleavage of 
the signal peptide, the proteins are either liberated into the culture medium, or become 
trapped in the cell wall (Gould et al., 1975). Hence, proteins secreted from Gram 
positive bacteria (and mycobacteria) have only one lipid membrane to cross, and it is 
not surprising that the S8 recombinant protein localised in the E. coli periplasm. 
Extracellular proteins of Gram negative organisms must contain another signal, which 
is absent from the S8 recombinant protein, to allow secretion from the periplasm 
across the outer membrane into the extracellular environment. 
Despite the similarities between Gram positive and Gram negative secretory systems, 
the signal peptides of Gram positive bacteria are characteristically longer than those of 
other organisms (von Heijne & Abrahamsen, 1989; Simonen & Palva 1993), and are 
of similar length to those encoded for mycobacterial secretory proteins (section 3.3). 
Some Gram positive organisms, such as those from the Bacillus family, also produce 
secretory proteins with short pro-peptides of 10 - 20 amino acids (Takase et al., 
1988; Paddon & Hartley, 1989), for which no clear function has been demonstrated. 
The peptide does not play an active role in secretion (Sasarnoto et al., 1988), but may 
stabilise the exported protein while it adopts its correct tertiary structure in the 
extracellular matrix (Simonen & Palva, 1993). After secretion, the short peptide is 
rapidly removed by extracellular proteases to yield the native protein (l'akase et al., 
1988; Paddon & Hartley, 1989). It has been suggested also that these short pro-
peptides may act as catalysts, promoting the folding of proteins after secretion and 
removal of the signal peptide (Eder & Fersht, 1995). Once the correct tertiary 
structure has been obtained, the peptide is cleaved in an intramolecular (via 
autocatalysis) or intermolecular (via a second protease) reaction. As the S8 
recombinant protein appears to maintain this 15 amino acid pro-peptide, 
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intramolecular cleavage appears to be unlikely, and the peptide must be removed by 
another mycobacterial protease which also is secreted into the extracellular 
environment. Hence, as the S8 ORF possessed similar signal peptides and short pro-
peptides to those detected in Bacillus species, it is possible that the secretory process 
in mycobacteria is similar to that in Bacillus, and that the pro-peptide of the 34 kDa 
protein is produced and processed for the same reasons in M.a. paratuberculosis. 
Secretion of proteins from mycobacteria has been difficult to prove, as little is known 
of secretory proteins and their mechanisms of export. The detection of a protein in a 
mycobacterial culture medium does not prove it has been secreted, as the protein may 
have been released due to lysis of dead bacteria during the fairly long incubation 
periods required to obtain a mycobacterial culture. However, the failure to detect 
HSP 65 in both PBS and 7H9 supernatants in section 7.2.2 suggested that cell lysis 
had not occurred in this experiment, and that the 34 kDa protein present in the 7H9 
supernatant had been actively secreted from the M.a. paratuberculosis cells. 
The best evidence to support secretion of a protein is to establish the presence of a 
coding sequence in the gene for a signal peptide, and its subsequent processing to 
yield the native protein. Sequence data in section 3.2.3 identified a potential signal 
peptide in the S8 ORF from amino acid 1 - 39. The N-tenninal amino acid sequence 
of the native protein (section 7.1) confirmed the processing of this signal peptide, and 
a 15 amino acid pro-peptide, by matching the deduced amino acid sequence of the 
clone from amino acid position 55. This sequence data, combined with the presence 
of the 34 kDa protein in the mycobacterial culture supematant, strongly implies that 
the native 34 kDa protein is secreted from M.a. paratuberculosis. 
Sequence data has suggested also that the 34 kDa protein is a serine protease (section 
3.3), and the noted instability of the recombinant protein during purification agrees 
with this theory (section 4.2.4 & 4.2.5). However, neither purified 34 kDa protein, 
nor S8 recombinant protein were shown to display any proteolytic activity against a 
and P casein, azocasein, horse blood or skim milk (casein). The protein therefore did 
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not mimic the proteolytic activity of the E. coli HtrA (Lipinska et al., 1990). The 
protease may have a very specific substrate, which possibly could be identified by 
screening a large number of synthetic peptides, or a bacteriophage peptide display 
library (Smith et al., 1995), in order to locate the particular peptide which is cleaved. 
However, it should be noted that the E. co/i HtrA showed no activity against 20 such 
synthetic peptides (Lipinska et al., 1990), suggesting that other factors may be 
involved in determining the specificity of this class of protease. 
The absence of any proteolytic activity in assays of the S8 recombinant protein was 
not completely unexpected, as recombinant proteins often do not fold correctly, and 
are inactive (Wulfing & Pluckthun, 1994). The S8 recombinant protein was also 
thought to possess the 15 amino acid pro-peptide which was absent from the native 
protein, due to its increased molecular weight (36 kDa vs 34 kDa). Although the 
function of this pro-peptide may have been to aid correct folding of the protein, the 
failure to remove the 15 amino acids after folding may have further affected the 
tertiary structure, rendering the protein inactive. 
The lack of any detectable proteolytic activity of either purified native protein or 
recombinant protein could have been due also to the struclure of these molecules. It 
has been reported that protease Do of E. coli (homologous to HtrA) is a high 
molecular weight molecule of approximately 550 kDa in the native state, consisting of 
10 - 12 identical subunits of 51 kDa (Swamy et al., 1983; Yoo et al., 1993). If the 
native 34 kDa protein of M.a. paratuberculosis also existed as a high molecular 
weight molecule, the S8 recombinant protein may not have been assembled in the 
correct tertiary structure in the E. coli periplasm to display functional activity. 
Activity of the native 34 kDa protein may have been affected by the purification 
protocol described in section 7.2.1, as in order to dissociate the antibody/antigen 
complex formed on the affinity column, a low pH of 2.3 was used. It is possible that 
this low pH was responsible for hydrolysis of the 34 kDa protein, altering the tertiary 
structure, and rendering the molecule inactive. The molecular weight of the native 
protein had only been determined by resolution on SDS PAGE, which separated 
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subunits due to the denaturing conditions required for the determination of molecular 
weight (Laemm]i 1970). Any alteration in the structure of the purified native protein 
would not have been apparent from SDS PAGE, and could possibly only have been 
detected by a loss of functional activity. As no activity had been previously attributed 
to the 34 kDa protein, the effect of purification on function could not be assessed. It 
was for this reason that expression and purification of the S8 recombinant protein 
under non-denaturing conditions was so vital, as any activity demonstrated by the 
recombinant protein could have demonstrated functional activity of the protease, and 
that the purification protocol was responsible for the observed inactivity of the native 
protein in these assays. However, after analysis of both native and recombinant 
protein by native PAGE (section 7.2.4) no difference in size between native, purified 
native and recombinant proteins was revealed (Figure 7.6), suggesting the 34 kDa 
protein existed as a monomer in the native state. 
To summarise, the N-terminal amino acid sequence of the native 34 kDa protein 
confirmed the identification of a signal peptide from the DNA sequence data, as the 
native protein was found to lack the first 54 amino acids of the deduced amino acid 
sequence of the S8 DNA insert. This suggested that in addition to the 39 amino acid 
signal peptide predicted from sequence data (section 3.3) the clone encoded a 15 
amino acid pro-peptide (section 3.3 & 4.3) which also was removed post 
translationally, possibly after secretion of the protein. Analysis of M.a. 
pararuberculosis 7H9 culture supernatant also suggested secretion of the native 
protein, after the detection of the 34 kDa protein in the supernatant by Western 
blotting (section 7.2.2). However, despite the presence of a serine protease motif in 
the deduced amino acid sequence of the S8 clone (section 3.2.3), no proteolytic 
activity was displayed by either native or recombinant protein against a and 3 casein, 
azocasein, or horse blood. 
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Chapter 8. 
Distribution of the 34 kDa Protein within the Mycobacterial Family. 
8.1 Introduction. 
The native 34 kDa protein, represented by the S4 and S8 clones, was originally 
thought to be specific for M.a. paratuberculosis, as preliminary antibody elution 
results did not detect a protein in the closely related M.a. silvaticum (section 3.1). 
However, when the experiment was repeated as part of this project, antibody eluted 
from the S4/13-Gal  fusion protein (section 3.2.2) detected a 34 kDa protein in both 
M.a. pai-aruberculosis and M.a. silvaticuni. The result was not surprising, as many of 
the mycobacterial proteins so far identified, such as the stress proteins HSP 65 and 
HSP 70, have been shown to be common to all species of mycobacteria and are of 
little use in species identification. Although the 34 kDa protein identified in this 
project was not sub-species specific, its role in taxonomy was evaluated by screening 
other members of the mycobacterial family for possession of the gene and expression 
of the protein. 
8.2 Results. 
8.2.1 Expression of the 34 kDa Protein Within the Mycobacteriaceae. 
Each species of mycobacteria listed in Table 8. 1, excluding M.a. paratuberculosis and 
M.a. silvaticuni, was cultured on solid Stuart's medium (Stuart 1965), and 
resuspended at 200 mg/nil (wet weight) in PBS containing 2 mM PMSF. The cells 
were lysed by bead beating 1 ml (200 mg) aliquots with 0.5 ml of 0.1 mm 
zirconium/silica beads in a mini bead beater (ESPE Capniix) for 3 x 30 s, and the 
lysates were stored in 50 p.1 aliquots at -20°C. Each lysate was examined by SDS 
PAGE and Coomassie staining (section 2.3) to obtain an estimated protein 
concentration, and each lysate was adjusted to approximately the same total protein 
concentrations by eye. Lysates (approximately 2 mg total protein) were then resolved 
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by SDS PAGE, Western blotted onto nitrocellulose, and probed with MAb 5.8 
(section 2.3) to detect expression of the 34 kDa protein in these species of 
mycobacteria. Purified 34 kDa (0.2 p.g) protein and S4/13-Gal fusion protein (0.5 j.tg) 
were run on the gel as positive controls. 
The 34 kDa protein was detected in M. avium (NCTC 8559), and M. intracellulare 
(Figure 8.1, Table 8.1). In addition, proteins of approximately 32 kDa and 36 kDa 
were detected in M. scrofulaceum and M. phlei respectively, however no reaction was 
observed with the nine other species of mycobacteria. In order to examine the 
relationships of these proteins further, in partcular the 32 kDa and 36 kDa proteins in 
M. scrofulaceurn and M. phlei, the DNA of each species of mycobacteria was 
screened for presence of the ORF contained in the S8 inserl. 
8.2.2 Distribution of the S8 Gene Within the Mycobacteriaceae. 
High molecular weight DNA was prepared from each mycobacterial species listed in 
Table 8. 1, as described in section 2.9.1. Each sample (5 j.tl) was analysed on an 
agarose gel to estimate the DNA concentration, and 200 ng was dot blotted onto 
Hybond membrane as described in section 2.13.2. The membrane was placed in a 
Hybaid tube with 10 ml of prehybridisation mix (section 2.13.4), and incubated 
overnight at 65°C while rotating in a Hybaid oven. 
Approximately 200 ng of purified S8 PCR product (section 2.11.1 and 2.9.6) was 
labelled with [(X32  PIdCTP by random priming (section 2.13.3). The probe was 
checked for incorporation of isotope (section 2.13.3), boiled for three minutes to 
denature the DNA, and added to the prehybridisation mix in the Hybaid tube (section 
2.13.4). The probe and membrane were hybridised overnight at 65°C, then washed 
and exposed to X-ray film as described in section 2.13.4. 
The S8 PCR product hybridised with M.a. paratuberculosis and M.a. silvaticum 
DNA, as expected, and also with M. avium (NCTC 8559), M. intracellulare and M. 
scrofulaceum DNA (Figure 8.2a, Table 8. 1), as suggested by the Western blot data 
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Figure 8.1 Detection of Native 34 kDa Protein in a Panel of Mycobacteria. 
A series of mycobacterial lysates (approximately 2 mg total protein) were screened for 
expression of the native 34 kDa protein. (a) Lane 1, M. leprae; Lane 2, M. 
smegmatis; Lane 3, M. phlei; Lane 4, M. fortuituni; Lane 5, M. inalmoense; Lane 
6, M. kansasii; Lane 7, M. marinuni; Lane 8, M. gordonae; Lane 9, purified 34 kDa 
protein (2 [tg); Lane 10, purified S4/Gal fusion protein (1 tg). 
(b) Lane 1, M. tuberculosis; Lane 2, M. bovis; Lane 3, M. scrofulaieum;  Lane 4, M. 
intracellulare; Lane 5, M. avium NCTC 8559; Lane 6, purified 34 kDa protein (2 
tg); Lane 7, S4fl3Gal fusion protein (1 j.tg). Western blot probed with MAb 5.8, and 
Dako anti-mouse HRP diluted 1:1000. 
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M.a. paratuberculosis 34 kDaa ++ 3.5 kb 
M.a. silvaticum 34 kDaa ++ > 10 kb 
M. avium (NCTC 8559) 34 kDa ++++ > 10 kb 
M. intracellulare 34 kDa ++ 2.2 kb 
M. scrofulaceum 32 kDa ++ 
M. gordonae - - - 
M. marinum - - - 
M. kansasii - 1.8 kb 
M. malmoense - +b 2.2 kb 
M.fortuitum - - - 
M. tuberculosis - - - 
M. bovis - - - 
M. leprae - - - 
M. phlei 36 kDa - - 
M. smegmatis 	 - 
a - results obtained from previous Western blots. 
b - very weak reaction on dot blot compared with MAC. 
c - specific band not determined as DNA had degraded. 
Table 8.1. Reaction of each species of mycobacteria with MAb 5.8 on Western blots, 
and 32P labelled S8 PCR product on both dot blots and Southern blots. Results 
compiled from Figures 8.1, 8.2, & 8.3. 
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(section 8.2.1). No hybridisation was observed with M. phlei DNA, however a very 
faint reaction was observed with both M. kansasii and M. inalmoense DNA, although 
no reaction was observed with these two organisms by Western blotting (Figure 8.1). 
In order to ensure these results were truly representative of the distribution of the S8 
gene, the membrane was re-hybridised with a probe containing the 16S ribosomal 
RNA (rRNA) gene which would detect all species of mycobacteria. The S8 probe 
was stripped from the membrane by boiling for 5 min in 0.5 % (w/v) SDS. The blot 
was then exposed to X-ray film for 5 days at -70°C to ensure all probe had been 
removed. The blot was then prehybridised overnight at 65°C as described previously. 
The 16S rRNA gene, common to all mycobacteria, was amplified from M.a. 
paratuberculosis DNA by PCR as described in section 2.11.2. The PCR product 
from nine reactions was purified from LMP agarose (section 2.9.6), and 200 ng of 
purified PCR product was labelled with [a32  PIdCTP by random priming (section 
2.13.3). After checking for incorporation of isotope (section 2.13.3) the probe was 
boiled for 3 min to denature the DNA, and added to the prehybridisation mix in the 
Hybaid tube. The probe and membrane were allowed to h:ybridise  overnight at 65°C, 
then washed and exposed to X-ray film as described in section 2.13.4. 
Each species of Mycobacterium (except M. leprae, M.a. paratuberculosis and M.a. 
silvaticum) was detected successfully by the 16S rRNA probe (Figure 8.2b), 
confirming the presence of equal amounts of each DNA on the blot. Unfortunately, 
there did not appear to be sufficient M. leprae DNA present on the blot. However, in 
a previous experiment M. leprae DNA was shown to be detected by the 16S rRNA 
probe, but not the S8 probe (data not shown). The amounts of M.a. paratuberculosis 
and M.a. silvaticuin DNA on the dot blot also were too low to be detected with the 
single copy 16s rRNA gene, although they were weakly detected with the S8 probe. 
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8.2.3 Southern Blot of EcoRI Digested Mycobacterial DNA. 
DNA which was found to hybridise with the S8 PCR product by dot blotting was 
digested with EcoRI and analysed by Southern blotting in order to identify any 
restriction patterns between these mycobacteria after hybridisation with the S8 insert. 
Approximately 1 tg of DNA from M.a. paratuberculosis, M.a. silvaticum, M. avium 
(NCTC 8559), M. intracellulare, M. scrofulaceum, M. kansasii and M. malmoense 
was digested overnight at 37°C with 40 U of EcoRI, and separated on a 0.6 % (w/v) 
agarose gel. The DNA was transferred from the gel onto Hybond membrane by 
Southern blotting as described in section 2.13.1. The membrane was prehybridised at 
65°C for 6 h (section 2.13.4), then hybridised overnight at 65°C with 200 ng of [a32P] 
labelled S8 PCR product (section 2.13.3, and 8.2.2). The blot was washed and 
exposed to X-ray film overnight, as described in section 2.13.4 (Figure 8.3). A single 
band which hybridised strongly with the probe was identified in M.a. paratuberculosis 
(3.5 kb), M.a. silvaticum (>10 kb), M. avium (NCTC 8559) (>10 kb), and M. 
intracellulare (2.2 kb). A reaction was observed with M. scrofulaceum DNA, 
however this sample appeared to have degraded and produced a smear instead of a 
dominant band. Unfortunately, no other M. scrofulaceuni DNA was available with 
which to repeat the digest. The S8 DNA insert therefore (lid appear to react with all 
members of the MAC of mycobacteria. 
The S8 probe was shown also to hybridise to a single band in EcoRI digested DNA 
from both M. kansasii and M. Pnaln2oense. An overnight exposure (Figure 8.3) 
identified a band of approximately 1.8 kb in M. kansasii, and a very faint band of 2.2 
kb in M. malmoense, which were intensified by exposing the blot for a further 4 days. 
These bands were far fainter than those detected in the MAC and M. scrofulaceum, 
and probably represented the possession of a small region of homology with the S8 
gene. This is consistent with the observation that lysates of M. kansasii and M. 
malmoense lacked the epitope recognised by MAb 5.8 (Figure 8.1). 
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Figure 8.2 Presence of the Gene Encoding the 34 kDa Protein in a Panel of 
Mycobacteria. 
Autoradiographs of (a) a panel of Dot blotted mycobacterial DNA (200 ng each) was 
screened by hybridisation with the S8 PCR product to detect the presence of the gene 
encoding the 34 kDa protein; (b) the panel of mycobacterial DNA screened with the 
16S rRNA PCR product to ensure equal amounts of DNA were present on the dot 
blot. Both probes labelled with [32P] dCTP. 
1, M. gordonae; 2, M. marinum; 3, M. kansasii; 4, M. malmoense: 5, M.fortuitum; 
6, M. smegmatis; 7, M. phlei; 8, M. leprae; 9, M. bovis; 10, M. tuberculosis; 11, 
M. avium NCTC 8559; 12, M. intracellulare; 13, M. scrofulaceum; 14, M.a. 
paratuberculosis; 15, M.a. silvaticurn. 
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Figure 8.3 Southern Blot of Mycobacterial DNA. 
Autoradiograph of EcoRI digested M. avium NCTC 8559 (Lane 1), M. intracellulare 
(Lane 2), M. scrofulaceun? (Lane 3), M. kansasii (Lane 4), M. malmoense (Lane 5), 
M.a. paratubercu!osis (Lane 6) and M.a. silt'aticuni (Lane 7) obtained after probing 
the blot with [ 32P]dCTP labelled S8 PCR product. 
EcoRI digested DNA from the other species of mycobacteria listed in Table 8.1 were 
also analysed by Southern blotting (as described above) in order to complete the 
results. As expected, no reaction was obtained with any of these species when 
hybridised with the [aP32] labelled S8 PCR product (data not shown). 
8.3 Discussion. 
Many immunogenic clones previously isolated from mycobacterial expression libraries 
using MAbs or hyper immune serum raised against a specific Mycobacterium, were 
found to encode heat shock proteins, common to all species of mycobacteria (Lu et 
al., 1987; Morris et al., 1988 & 1990; Stevenson et al., 1991; Rouse et al., 1991). 
As the 34 kDa protein was detected in both M.a. paratuberculosis and the closely 
related M.a. si!vaticuni (section 3.2.2), it was not sub-species specific (as was 
originally suggested), and may have been common to all mycobacteria, possibly 
performing some housekeeping function within the bacterial cell. 
When a panel of mycobacteria were screened for possession of the gene and 
expression of the gene product, the protein was not found to be encoded by all 
mycobacteria, and therefore was not a common antigen. The gene was detected by 
hybridisation in all members of the MAC (M.a. paratubercu!osis, M.a. silvaticum, 
M.a. avium, and M. intracellulare) and also in M. scrofulaceum (Figures 8.2 & 8.3), 
and each of these species also produced a reaction on Western blots probed with 
MAb 5.8 (Figure 8.1). The members of the MAC are known to be closely related 
(section 1.2), and it is not surprising that each member possessed the gene contained 
in the S8 insert and expressed the 34 kDa protein. M. scrofu!aceum has often been 
mistakenly grouped with the MAC on biochemical properties, however it has been 
shown to be a distinct species (section 1.2), easily differentiated from the MAC. The 
detection by MAb 5.8 of a 32 kDa protein in lysates of M. scrofulaceu,n indicated 
also a difference between M. scrofu!aceum and the MAC. 
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M.a. paratuberculosis, M.a. silvaticuni, M.a. avium, and M. intracellulare have 
previously been difficult to distinguish from each other, due to the high level of DNA 
homology observed between the species (Section 1.2.2). Original classifications 
relied on growth characteristics and biochemical testing, however, this was time 
consuming, laborious work, and often still could not differentiate between M.a. 
paratuberculosis and M.a. silvaticuni, which are both mycobactin dependent on 
primary culture (section 1.2.1), or M.a. avium and M. intracellulare, which are 
biochemically identical with the exception of agglutination serotypes (section 1.2.1). 
Recent developments in molecular biology have eased this problem, and the members 
of the MAC can now be differentiated by restriction fragment length polymorphisms 
(RFLP) and pulsed field gel electrophoresis (discussed in section 1.2.2). However, 
from this project, the results displayed in Figure 8.3 clearly show an RFLP between 
M.a. paratuberculosis, M.a. silvaticum/M. avium (NTC 8559) and M. 
intracellulare when mycobacterial DNA was Cut with EcoRI, Southern blotted, and 
probed with the S8 PCR product. This observation confirms the importance of the 
gene contained in the S8 insert, as it allows discrimination between M.a. 
paratuberculosis and M.a. silvaticuni, and also between M. avium and M. 
intracellulare, by a relatively quick and simple procedure. Unfortunately, the S8 
probe could not differentiate between M.a. silvaticum and the M. avium type strain 
(NCTC 8559). Digestion of the DNA with another restriction enzyme could have 
solved this problem by producing a different restriction pattern, however, the M. 
avium type strain (NCTC 8559) was found to be 1S901 positive by PCR (A. Pine, 
MRI, personal communication) and the possession of this insertion element, which is 
found also in M.a. silvaticum., may have had some bearing on the result. Not all 
strains of M. avium contain 1S901, although it is usually present in M. avium serotype 
2 (Ahrens et al., 1995), and the presence of the insertion element may affect the RFLP 
obtained when probing with the S8 PCR product. As only one strain from each 
species was examined in this experiment, a larger number of samples would have to be 
screened to confirm these results, and a wider range of serotypes of M. avium (both 
IS 901 positive and negative) would have to be examined also to detect any variation 
in the RFLP due to the presence of the insertion element IS 901. 
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The relationship of M. kansasii and M. malmoense with the; MAC appears to be poor, 
as M. kansasii demonstrated only 23 % homology to M.a. paratuberculosis at the 
genomic level (Yoshimura & Graham, 1988) and, although no DNA hybridisation 
data was available for M. malmoense, it was placed in a completely different 
mycobacterial cluster from the MAC when fatty acids, secondary alcohols and 
mycolic acids were typed by capillary gas liquid chromatography and thin layer 
chromatography (Luquin et al., 1991). However, a weak reaction was observed with 
both M. kansasii and M. nialmoense DNA on dot blots and Southern blots probed 
with the S8 PCR product, although no reaction was observed when lysates of the 
organisms were screened with MAb 5.8 (Figures 8.1, 8.2 & 8.3). These results 
suggested that M. kansasii and M. malmoense possessed sequences related to the 
MAC gene contained in the S8 insert, and although they may encode proteins similar 
to the 34 kDa protein, they are not recognised by MAb 5.8, indicating a difference in 
at least one major epitope. Areas of similarity within the genes could possibly be 
identified by re-probing the Southern blots with fragments of the S8 insert containing 
sequences conserved between all htrA genes (section 33). Conversely, M. phlei 
expressed a 36 kDa protein which reacted with MAb 5.8 on the Western blot, but no 
hybridisation of the S8 PCR with M. phlei DNA was observed by either dot blotting 
or Southern blotting. The immunological reaction therefore appeared to be due to the 
presence of a cross reactive epitope, rather than a similar gene and protein. 
The 34 kDa protein encoded by the ORF contained in the S8 DNA insert was not 
common to all species of mycobacteria, and from the results obtained in this chapter, 
appeared to be specific to members of the MAC. Differences in RFLP between M.a. 
paratuberculosis, M.a. silvaticum/M. avium (NCTC 8559), and M. intracellulare 
were observed on probing with the S8 insert, however, further isolates of these 
organisms need to be examined to verify these results. Related genes were detected in 
M. scrofulaceuni, M. kansasii and M. malmoense, which suggested the presence of 




Two immunogenic clones containing fragments of the same gene were extracted from 
a A.gtl 1 genomic expression library of M.a. paratuberculosis by screening with serum 
from a clinically infected sheep. Although the clones were initially thought to encode 
a protein specific for M.a. paratuberculosis they were subsequently shown to 
represent a 34 kDa protein present in all members of the Al. aviwn complex (MAC). 
Sequence analysis revealed the presence of a motif (GDSGG) matching the active site 
found in serine proteases, although no functional activity of the protein (either native 
or recombinant) was observed. An overall similarity was also detected with the HtrA 
family of serine proteases, which comprises E. coil, S. typhimuriwn, Br. abortus, B. 
henselae and C. jejuni. The 5' end of the gene contained the coding sequence for a 
possible signal peptide, and expression of this insert without a fusion partner resulted 
in the secretion of the recombinant protein across the cytoplasmic membrane of E. 
coii. 
Serine proteases have not been described previously in any of the Mycobacteriaceae, 
and possible functions of the 34 kDa protein in members of the MAC therefore are 
speculative. However, recent reports have suggested that serine proteases are 
important components of the pathogenic mechanisms of several intracellular micro-
organisms. Plasmodium falciparum is thought to use a serine protease to gain entry 
to red blood cells during the blood-borne stage of malaria (Braun-Bretton & Pereia da 
Silva, 1993). The P. falciparum gp76 (Braun-Bretton et al., 1988) and Plasmodium 
chabaudi gp68 (Braun-Bretton et al., 1992) are serine proteases which appear to 
specifically degrade the erythrocyte band 3 protein, thereby altering the erythrocyte 
cytoskeleton, allowing entry of the parasite. A senne protease has been identified also 
in Treponema denti cola (Arakawa & Kiramitsu, 1994), the cause of human 
periodontal disease, which appears to play a key role in oral treponemal pathogenicity. 
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The HtrA serine proteases of S. typhimurium (Johnson et al., 1991) and Br. abortus 
(Roop et al., 1994), which displayed 30% identity with the 34 kDa protein, also 
appear to be involved in the virulence of these intracellular pathogens. The first HtrA 
protein was identified in E. coli, and was shown to be a heat shock protein (correctly 
known as stress proteins) essential for the survival of the organism at elevated 
temperatures (Lipinska et al., 1988, 1989, 1990). Cellular proteins damaged during 
heat shock build up within the bacterial cell, and the accumulation of these abnormal 
proteins becomes toxic to the bacterium. The HtrA protein therefore was thought to 
be involved in the degradation of these abnormal proteins, allowing survival of the 
bacterium at elevated temperatures. When mutant S. typhimuriwn and Br. abortus 
were created with insertions in the htrA gene the Br. abortus htrA mutant (but not the 
S. typhimurium mutant) was found to be temperature sensitive (Elzer et al., 1994) as 
was observed in E. coli. Both mutants were found to be less virulent for mice 
compared to the parent strains and appeared to be more susceptible in particular to 
oxidative stress (Johnson et al., 1991; Chatfield et al., 1992; Baumler et al., 1994; 
Elzer et al., 1994). Hence, in these intracellular pathogens the HtrA serine protease 
appears to be involved in the degradation of abnormal proteins damaged by oxidative 
stress, caused by H202 and 02. 
Oxidative killing pathways using H202 and 02 are generally thought to be the primary 
mechanism by which host phagocytes kill internalised organisms, although reactive 
nitrogen intermediates are also involved (Nathan & Hibbs, 1991). However the 
bacterial stress response involving the HtrA protein may be an important way of 
allowing an intracellular pathogen to adapt to the harsh environment of the host 
phagosome, and successfully survive to replicate and cause disease. Although HtrA 
proteins appear to be involved in intracellular survival, it is unlikely that they are the 
only mechanism involved in the process. It has been shown that on infection of 
macrophages over 30 proteins are selectively induced in Salmonella (Buchmeier & 
Heffron, 1990) and these may be involved also in intracellular survival. The HtrA 
protein appears to be an important component of the organism's response to oxidative 
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stress that contributes towards the survival of the bacterium in the hostile environment 
of a phagocyte. 
M.a. paratuberculosis and other members of the MAC are intracellular pathogens 
which persist and replicate within macrophages (Bendixen et al., 1981). The exact 
methods used by pathogenic mycobacteria to evade the killing mechanisms of immune 
cells are currently unknown. Possible mechanisms include preferential use of uptake 
pathways that do not stimulate macrophage oxidative burst, prevention of 
phagosome-lysosome fusion, resistance to lysosomal contents, inactivation of 
lysosomal contents, and escape from the phagosome into the cytoplasm. All of these 
methods have at one time been implicated in mycobacterial intracellular survival 
(Armstrong & Hart, 1971; Frehel et al., 1986; McDonough et al., 1993; de 
Chastellier et al., 1993; Britton et al., 1994); however, it is still unclear which of the 
above methods is most important during mycobacterial infections. It has been 
recently shown that M. avium gene expression is altered during growth in human 
macrophages (Plum & Clark-Curtiss, 1994), indicating that an additional repertoire of 
proteins is required for intracellular survival, one of which may be the 34 kDa HtrA 
protein. This altered gene expression suggests some active interaction between the 
bacterium and host, and possibly favours the inhibition of phagolysosome fusion, or 
resistance to lysosomal contents. 
The effects on virulence due to interruption of the htrA gene have been investigated in 
S. typhimurium and Br. abortus (Johnson et al., 1991; Chatfield et al., 1992; Baumler 
et al., 1994; Elzer et al., 1994). The results suggested that the HtrA protein was 
contributing towards the intracellular survival of these bacteria. Although no such 
studies have been performed on B. henselae and C. jejuni, these organisms have been 
shown to be capable of persisting within erythrocytes (Kordick & Breitschwerdt, 
1995) and intestinal epithelial cells (Russell et al., 1993; Russell & Blake, 1994) 
respectively. It is possible that the HtrA protein may be part of a common survival 
mechanism adopted by many intracellular pathogens, including the members of the 
MAC. It was noted in Chapter 8 that a weak reaction was obtained when Southern 
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blotted DNA from M. kansasii and M. malmoense was probed with the S8 PCR 
product, which suggested that a similar gene was present in these two organisms. 
Both M. kansasjj and M. malmoense are classed as PPEM (section 1.1.2) and can 
cause pulmonary disease in humans (Wayne & Kubica, 1986; Wayne & Sramek, 
1992; Hoffner et al., 1991). The presence of a gene similar to htrA suggests that 
these pathogenic mycobacteria may utilise a similar mechanism for intracellular 
survival as that suggested in the MAC of mycobacteria. No reaction was obtained on 
hybridising the S8 insert with Southern blotted DNA from the well known pathogens 
M. tuberculosis, M. bovis and M. leprae. This result was surprising, as if the HtrA 
protein is an important component of the survival mechanisms of other intracellular 
pathogens, it is likely that it will be expressed by all pathogenic mycobacteria. 
However, as M. tuberculosis, M. bovis and M. leprae display a low percentage 
sequence identity with members of the MAC (Hurley et al.. 1988), they could contain 
htrA-like sequences which were sufficiently different from those in MAC 
mycobacteria to prevent hybridisation with the S8 PCR product at high stringency 
(0.1% SSC 0.1% SDS at 65 °C). If the experiment had been repeated at a lower 
stringency, or using a probe designed to recognise the conserved areas of the gene 
(section 3.3), some hybridisation may have been detected with these other pathogenic 
mycobacteria. 
Virulence Associated with the Mycobacterial HtrA Protein. 
Recent studies of the virulence associated with expression of the HtrA protein in S. 
typhimurium and Br. abortus have been performed by interrupting the gene with 
transposons (Johnson et al., 1991; Chatfield et al., 1992; Baumler et al., 1994), or by 
gene replacement via homologous recombination (Elzer et al., 1994). These mutant 
organisms were then used to infect mice and the virulence of each mutant was noted 
and compared with that of the parent strain. U nfortunately, this approach cannot be 
used to study the importance of the HtrA protein in the MAC at present. The 
genetics of mycobactena are poorly understood, and techniques such as mutagenesis 
and homologous recombination which are routinely performed with bacteria such as 
E. coli and Salmonella have not yet been developed for the MAC. Complementation 
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(Pascopella et al., 1994), and gene replacement via homologous recombination 
(Norman et al., 1995) have recently been achieved in M. bovis BCG, however these 
systems have not yet been applied to the MAC of mycobacteria. 
One possible approach to study the importance of the HtrA protein in the MAC, 
which was not attempted in this project due to time constraints, is expression of the 
34 kDa protein in a non-pathogenic Mycobacterium species such as M. smegmatis, 
which has been shown to lack the gene by Southern blotting (section 8.2.2). A strain 
of M. smegmatis (mc2 155; Snapper et al., 1990) has been produced which maintains 
plasmid DNA more stably than the type strain, and produces an increased efficiency 
from 10 to 104 transformantsfl.tg of plasmid DNA after electroporation. These 
bacteria could be transformed with plasmids containing the M.a. paratuberculosis 
htrA gene and subsequently express the corresponding protein. 
DNA can be introduced into M. smegmatis cells in two forms: (i) as an extra-
chromosomal MycobacteriumlE. coli plasmid shuttle vector, or (ii) as an integrative 
vector (Hatfull, 1993), and both systems will now be discussed. Several different 
mycobacterial shuttle vectors have been described (Husson et al., 1990; Ranes et al., 
1990; Goto et al., 1991; Murray et al., 1992; Houssaini-Iraqui et al., 1992; Das 
Gupta et al., 1993; Timm et al., 1994). Each of these vectors allows initial genetic 
manipulation to be performed in E. coli to produce the desired construct, which is 
subsequently transformed into M. smegmatis by electroporation. These shuttle 
vectors have various origins, however they must contain an E. coli origin of 
replication to allow manipulation in E. coli, and also a mycobactenal origin of 
replication to allow stable maintenance of the plasmid after transformation of M. 
smegmatis (Lazraq et al., 1991; Qin et al., 1994). Foreign genes are usually cloned 
downstream from a mycobacterial promoter (Thomas et al., 1992; Murray et al., 
1992; Das Gupta et al., 1993) to allow efficient expression of the foreign gene by M. 
smegmatis. Finally, these vectors must possess also some selectable marker (usually 
kanamycin resistance) to allow identification of transformants, and to ensure the 
plasmid is maintained by the cells when grown under the selective pressure. The ORF 
contained in the S8 insert could be cloned into one of these shuttle vectors and 
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transformed into M. smegmatis to determine whether the 34 kDa protein was 
expressed by the resulting transformants. M. smegmatis is generally considered to be 
a non-pathogenic environmental Mycobacterium, although some soft tissue infections 
of humans and animals have been reported (Wallace et al., 1988 & 1989), and should 
therefore be incapable of surviving and replicating within macrophages. Hence, the 
effects on M. smegmaris phenotype due to expression of the HtrA protein could be 
investigated by following the fate of transformed M. smegmatis after phagocytosis by 
macrophages. This approach has been successfully used to demonstrate the uptake 
and survival in HeLa cells of E. coli transformed with a specific fragment of DNA 
from M. tuberculosis (Arruda et al., 1993). This DNA fragment appeared to encode 
proteins involved in the virulence associated with M. tuberculosis. However, E. coil 
is a Gram-negative bacterium and therefore structurally different from mycobactena 
(section 1.1). The final cellular location of recombinant mycobacterial proteins, 
especially secretory proteins, in E. coli is therefore unlikely to reflect that in the native 
state, and functional activity of the recombinant may not be evident. Expression of 
these genes in non-pathogenic mycobacteria would increase the likelihood of 
producing a functionally active protein in the correct cellular location. 
However, this approach could present problems if M. smegmatis transformed with a 
shuttle vector containing the htrA gene were used. After phagocytosis the selective 
pressure used in culture (kanamycin) could not be applied as it would not penetrate 
the eukaryotic cell, and it is most likely that the shuttle vector would not be retained 
by the bacterium unless the presence of the htrA gene Was of significant advantage 
after phagocytosis. This in turn may act as a selective pressure, however any 
organisms recovered from macrophages would have to be screened thoroughly for the 
presence of the shuttle vector and htrA gene to confirm this fact. 
A second approach would be to use an integrative vector which could exist as a 
plasmid in E. coil to perform cloning steps, then integrate into the mycobacterial 
chromosome on transformation. This has been achieved by using phasmids consisting 
of mycobacteriophage Li (Snapper et al., 1988), shuttle vectors containing the 
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attachment site and integrase gene from the temperate mycobacteriophage FRAT1 
(Haeseleer et al., 1993), and an integrative vector containing two copies of 1S900 
flanking the sequence of interest (Dellagostin et al., 1993). These vectors integrate 
into the mycobacterial chromosome via either the mycobacteriophage integrase, or the 
M.a. paratuberculosis specific insertion element 1S900 (Green et al., 1989), and 
thereby integrate any foreign gene carried by the vector into the mycobacterial 
chromosome. This method removes the need for a selective pressure to maintain the 
transformed DNA, and successful transformation can be verified by Southern blotting 
of chromosomal DNA. These vectors could be used to investigate the fate of M. 
smegmaris expressing the HtrA protein after phagocytosis by macrophages. 
However, it must be borne in mind that these transformants would be potentially 
hazardous if the HtrA protein did indeed alter the phenotype of the non-pathogenic 
M. smegmatis. Any increase in the pathogenicity of the organism would prove the 
importance of the HtrA protein in virulence, but would also yield a 'new' pathogen 
which would have to be studied and secured in a high containment facility (GMSC 
guidelines, 1992). If the organism was accidentally released into the environment 
there would be little chance of the transformant reverting to its original non-
pathogenic phenotype, as no selective pressure is required to maintain the gene. 
However transformants containing extrachromosomal shuttle vectors must also be 
maintained in a high containment facility, as plasmids may be transferred to other 
bacteria if the organism was accidentally released into the environment. 
Once improved genetic techniques have been applied to the study of MAC 
mycobacteria, it may be possible to disrupt the htrA gene, or replace it by homologous 
recombination in order to determine the effects of the HtrA protein on virulence of 
the members of the MAC. However with the methods currently available, expression 
studies in M. smegrnatis may be the best means by which to study the importance of 
the HtrA protein in MAC mycobacteria. 
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Further Studies Involving the Mycobacterial HtrA. 
The discovery of an HtrA protein in mycobacteria could be important in developing 
new recombinant vaccines based on BCG (badille Calmette-Guerin). The HtrA 
protein is thought to be a stress protein, which is induced in response to oxidative 
stress after internalisation of the organism by macrophages (Johnson et al., 1991). 
The htrA promoter is thought to be activated when the bacteria become intracellular 
(in vivo inducible promoter). Foreign genes under the control of the htrA promoter 
could be controlled and expressed only once the organism had been internalised by 
macrophages. This approach has been used successfully to express -galactosidase 
from the S. typhimuriwn htrA promoter in an attenuated vaccine strain of S. 
typhimurium (Everest et al., 1995). The lacZ gene was cloned into the pTEThtrA-1 
vector containing the htrA promoter (Everest et al., 1995), and introduced by 
electroporation into S. typhimurium BRD915. Expression of -galactosidase was 
found to be increased on internalisation by HEp-2 and Caco-2 cells and in ThP- 1 
macrophages, and also by incubation of the transformed bacteria with 100 p.M 
hydrogen peroxide. Indeed, htrA was the only promoter investigated in this paper 
which demonstrated increased expression in the presence of hydrogen peroxide, 
confirming the theory that the HtrA protein is expressed in response to oxidative 
stress (Johnson et al., 1991). Expression of 13-galactosidase from this vector resulted 
in the plasmid being maintained, despite the lack of selective pressure (ampicillin) 
within eukaryotic cells, indicating that expression from the promoter is optimal in the 
intracellular environment. These transformants could potentially be used as 
multicomponent vaccines, where live attenuated Salmonella capable of expressing 
foreign antigens in vivo are used to produce immunity to a wide range of pathogens. 
Attempts have also been made to use BCG as a multicomponent vaccine, as it is one 
of the most widely used vaccines in the world, is fairly heat stable (for use in 
developing countries) and can be given as a single dose at any age. The incorporation 
of foreign antigens into this vaccine could result in one vaccination producing 
immunity to a wide rage of pathogens as well as tuberculosis. Recombinant BCG 
have been produced where the hsp6O and hsp7O promoters were used in both extra- 
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chromosomal and integrative vectors to express the E. coli lacZ gene (Stover et al., 
1991). Increased expression of 3-ga1actosidase from the integrative vector was 
observed in response to stress with heat, acid, and peroxide, however the effects of 
phagocytosis on the transformed bacteria were not evaluated (Stover et al., 1991). 
HSP60 and HSP70 are undoubtedly stress proteins, and their expression by 
mycobacteria will be up-regulated during the stressful events encountered after 
phagocytosis. However it is possible that expression of foreign genes under the 
control of the htrA promoter could be a more efficient way of expressing foreign 
antigens in vivo in BCG. Although Stover et al. found an increase in 3-galactosidase 
expression on treatment of the transformed BCG with hydrogen peroxide, no increase 
in endogenous HSP60 and HSP70 was observed, suggesting these promoters are not 
optimally induced by peroxide, and therefore may not be efficient in expressing 
foreign genes after phagocytosis by macrophages. Expression of foreign genes via the 
htrA promoter in BCG therefore may result in optimal expression of foreign antigens 
in vivo and result in the production of a more potent and sustained immune response 
to a variety of different pathogens. 
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Oligonucleotides. 	 Function. 
ACGTACGGTACCAAGCT pMS1S sequencing primer. 
ATGGTGAACAGCGCCGG S4-1 forward sequencing primer. 
ATCGCGCCCGGCGACGT S4-2 forward sequencing primer. 
AGCGCACCGCAACATCA S4-3 forward sequencing primer. 
TGTFCGACAGCTTCTCT S4-4 forward sequencing primer. 
ACCGCGATGGTGTCACC S4-5 reverse sequencing primer. 
AGCCCGAGGAATGCGGT S4-6 reverse sequencing primer. 
AGTCGCCCGGC'VFGATC S4-7 reverse sequencing primer. 
TCAACATCGACACCAAG S8 forward sequencing primer. 
CGCAGCTGCAGCACGGC S8 reverse sequencing primer. 
CTCGAGCTCCCGCGACGCAGGAGGGTGA S8 forward PCR primer. 
CTCAAGCYL'CAGGCCGGCGGCCCCTCCG S8 reverse PCR primer. 
CATCGGGCCACCGGCGTCGCCCGGCYI' S8 SDM primer. 
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contained in two overlapping clones, which were shown by antibody elution 
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INTRODUCTION 
Paratuberculosis (syn. Johne's disease) is a chronic 
granulomatous enteritis of ruminants caused by Myco-
bacterium avium subsp. paratubercu/osis and, occasionally, 
by M. avium subsp. si/vaticum (Chiodini et a/., 1984; 
Matthews & McDiarmid, 1979). The outcome of infection 
of the host is variable, ranging from complete recovery in 
the majority, to clinical disease in a small proportion. The 
interaction between host and bacterium is poorly under-
stood due, in part, to inadequate knowledge of the 
properties of these mycobacteria. Consequently, we have 
focussed our interest on M. a. paratuberculosis genes and 
gene products that are involved in the bacterium—host 
interaction, particularly those proteins which are im-
munogenic in the natural ruminant host, and which may 
be involved in pathogenesis. 
Individual proteins have been identified in several myco-
bacteria by producing monoclonal antibodies (mAbs) 
(Engers et al., 1985; Kolk et al., 1989), and using these to 
screen genomic expression libraries (Young et a/., 1985; 
Morris et a/., 1988, 1990; Rouse et al., 1991). However, 
this approach has identified principally heat shock pro-
teins (Husson & Young, 1987; Lu et al., 1987; Young & 
Mehlert, 1989), as the use of mycobacterial lysates in 
immunization procedures does not reflect accurately the 
immune response of the natural host to infection. To 
Abbreviation: mAb, monoclonal antibody. 
The EMBI accession number for the sequence reported in this paper is 
Z23092. 
circumvent this problem, we chose to construct an M. a. 
paratubercu/osis genomic expression library and screen 
with serum from a naturally infected animal. By utilizing 
the natural immune response of the infected host to M. a. 
paratuberculosis we aimed to detect antigens expressed in 
vivo that may be absent from, or very poorly expressed in, 
bacteria grown in vitro, suggesting a possible involvement 
in pathogenesis (Donachie & Gilmour, 1988; Jonson et 
al., 1989). A similar approach in which M. /eprae lambda 
gtl I genomic libraries were screened with pooled sera 
from leprosy patients, resulted in the identification of 
several new proteins which were not detected by mouse 
monoclonal antibodies or rabbit hyper-immune serum 
(Clark-Curtiss et al., 1990; Sathish et al., 1990; \Vieles et 
al., 1994). The present report describes the characteriza-
tion of two overlapping clones isolated from an M. a. 
paratubercu/osis lambda gtl I library, which were found to 
encode a putative serine protease. 
- METHODS 
Bacterial strains, bacteriophages, plasmids and growth 
conditions. Strain JD88/107 of M. a. paratuberculosis, used 
throughout the experiments, was isolated from a commercially 
farmed red deer (Cervus elaphus) and propagated on Stuart's 
medium (Stuart, 1965) supplemented with mycobactin J. 
Escherichia co/i strains NA-1522, JMIOI, Y1088 and Y1089 were 
grown in Luria—Bertani (LB) medium or LB solidified with 
15 % (w/v) agar (Sambrook et al., 1989). Lambda recombinant 
phages were propagated as described by Sambrook et al. (1989). 
Expression plasmid pMSlS (Scherf et a/., 1990) was kindly 
supplied by M. Schreiber and J. Scaife. Plasmids pUC8 and 
0001-8855© 19945GM 	 1977 
R. M.CAMERON and OTHERS 
pUCI8 (Yanisch-Perron etal., 1985) were purchased from Life 
Technologies. 
Library construction and screening. Two hundred milligrams 
(wet wt) of M. a. paratubercu/osis cells were lysed in 4 M 
guanidine isothiocyanate using an Eaton press (Eaton, 1962). 
DNA was purified using standard laboratory procedures 
(Sambrook et al., 1989). The lambda gtll library was con-
structed as described by Young etal. (1985) using EcoRl-cleaved 
lambda gil I DNA and Gigapack II Gold packaging extracts 
from Stratagene. Amplification was performed using E. co/i 
Y1088. 
The library was screened with antiserum from a sheep with 
Johne's disease (JD87/40) using the procedure described by 
Young et a/. (1985) with a few modifications. Nitrocellulose 
filters were incubated with the recombinant phage overnight at 
37 °C and were blocked in 50 mM Tris pH 7, 150 mM NaCl, 
005% (v/v) Tween 20, 50% (v/v) horse serum for 2 h. 
Antibody was absorbed with I ml of a concentrated lysate of 
induced B. co/i Y1090 cells. Bound antibody was detected using 
horseradish peroxidase-conjugated donkey-anti sheep IgG. 
DNA manipulations and sequencing. Recombinant phage 
DNA was prepared from plate lysates and subsequent sub-
cloning into the plasmid vectors pUC8, pUCI8 and pMSIS was 
carried out using standard procedures described by Sambrook et 
al. (1989). Subcloning from lambda gill to pMSIS conserved 
the open reading frame and allowed expression of the recombi-
nant protein. Plasmid DNA was prepared using the alkaline 
lysis procedure and purified by equilibrium centrifugation in 
caesium chloride—ethidium bromide gradients (Sambrook etal., 
1989). Both strands of DNA from the S4 and S8 plasmid clones 
were sequenced by the dideoxy chain termination method 
(Sanger etal., 1977) using Sequenase version 2.0 (United States 
Biochemicals), the M13 universal primer, a pMSIS specific 
primer (ACGTACGGTACCAAGCT), and a series of internal 
17-mer oligonucleotides. The sequencing procedure used was 
that recommended by USB. dCTP labelling mix and [3S] 
dCTPaS were used to achieve better incorporation into the G-C 
rich mycobacterial DNA. The Sequenase enzyme was diluted 
1:4. Reactions were run on 40% (v/v) formamide, 7 M urea, 
8% (w/v) acrylamide gels in 'glycerol-tolerant' sequencing 
buffer (178 M Tris, 057 M taurine, 001 M EDTA) to eliminate 
compressions, as recommended by USB. 
Purification of recombinant fusion protein. A culture of B. co/i 
NM522 containing the pMSIS/S4 or pMSIS/S8 plasmid was 
grown to an 0D 600 of 05, and induced with 10 mM IPTG. 
After a further 4 h growth, cells were pelleted, resuspended in 
10 ml 2 mM PMSF and lysed in a mini French pressure cell at 
1500 p.s.i. (1035 MPa). The lysate was clarified by centri-
fugation at 100000g and adjusted to 300 mM NaCl, 50 mM 
Tris/HCI pH 8. Recombinant fusion protein was purified using 
a 2 ml column of aminobenzyl thiogalactopyranoside (ABTG) 
agarose (Sigma). The column was washed with 10 ml 300 mM 
NaCl, 50 mM Tris/HCI pH 8, 5 ml 600 mM NaCl, 50 mM 
Tris/HCI pH 8 and 10 ml 50 mM Tris/HCI pH 8 and the fusion 
protein eluted with 10 ml 01 M borate pH 10. The eluate was 
collected on ice into I ml of 2 M Tris/HCI pH 7, dialysed 
overnight against 10 mM Tris/HCI pH 8, and concentrated to 
2-3 ml with PEG 20000 (Sigma). Total protein concentration 
was estimated with the Pierce BCA micro protein assay as 
recommended by the manufacturer. 
SDS-PAGE. Protein samples were boiled for 90 s in an equal 
volume of 2 x Laemmli sample buffer [250 mM Tris/HC1 
PH 6-8, 2% (w/v) SDS, 4% (v/v) 2-mercaptoethanol, 20% 
(w/v) sucrose, 0002% (w/v) bromophenol blue] and separated 
on a discontinuous SDS-polyacrylamide gel [3% (w/v) stacking 
gel, 10% resolving gel] using the buffering system of Laemmli 
(1970). Molecular mass standards (BDH Electran; 12-78 kDa 
were run on each gel. 
Western blotting. Proteins were transferred from SDS-poly 
acrylamide gels onto nitrocellulose by electroblotting in Tris 1 
glycine blot buffer [20mM Tris, 153 m glycine, 20% (v/v 
methanol, pH 83] at 100 V for I h. After blotting, thi 
membranes were stained with Ponceau S (Sigma) for 5 mm ix 
confirm transfer, and washed for 30 min in PBS containin 
05% (v/v) Tween 20, 1 mM EDTA, 350 mM NaCl, pH 
(PBS-Tween). Membranes were probed for I h at roorr 
temperature with either clinical sheep serum (absorbed witi 
lysed B. co/i NM522) diluted 1:40 in PBS-Tween, specificall) 
eluted clinical sheep antibodies, or mAb 5.8 (neat tissue cultur 
supernate) raised against S4 fusion protein. Membranes wer 
washed and incubated for I h at room temperature in horse-
radish peroxidase-conjugated swine anti-sheep IgG, or rabbii 
anti-mouse IgG (Dako) diluted 1:2000 in PBS-Tween. Band 
were developed with Oi M Tris/HC1 pH 7•5, 015% (v/v 
H 202 , 02% (w/v) diaminobenzidine. 
Antibody elution studies were performed as described by Beal] 
& Mitchell (1986). 
Monoclonal antibody production. Purified pMSIS/S4 fusion 
protein solubilized in 10 mM Tris/HCI pH 8 was inoculated 
intraperitoneally into 8-10 week old Balb/c mice three times 
over two week intervals. The mice were finally boosted 3,d 
before fusion with the myeloma cell line P3 X63 Ag.8.6.5.3 
using standard procedures (Goding, 1980). 
Hybridoma culture supernates were screened in ELISAs in 
microtitre plates coated with either S4 fusion protein or fi-
galactosidase. Clones reacting with S4 fusion protein but not 
/3-galactosidase were selected. 
Two Balb/c mice were inoculated intraperitoneally with 5 x 10 6 
hybridoma cells, and the resulting ascitic fluid was collected 
after 14 d. IgGI was purified from the ascites on a protein A-
Sepharose column (Pharmacia), and coupled to cyanogen 
bromide-activated Sepharose (Pharmacia) as recommended by 
the manufacturer. The column was then equilibrated in PBS 
supplemented with 05 M NaCl. 
Purification of 34 kDa protein from M. a. paratuberculosis. 
One gram (wet wt) of M. a.paratubercu!osis cells was resuspended 
in 5 ml of PBS supplemented with 05 M NaCl, and lysed in an 
Eaton Press. After sonication to shear DNA, the lysate was 
mixed with the monoclonal affinity column matrix overnight at 
4 °C. The column was then washed with 20 ml PBS supple-
mented with 05 M NaCl and the protein eluted with 10 ml of 
Oi M glycine pH 23. The eluate was then dialysed against 
10 mM Tris pH 8, concentrated to 2-3 ml with PEG 20000 
(Sigma) and further to 500-1000 il with a Millipore Ultrafree 
microconcentrator (10 kDa cutoff). 
N-terminal sequencing. Approximately 2 tg of purified M. a. 
paratubercu/osis 34 kDa protein was run on SDS-PAGE, and 
Western blotted onto PVDF (polyvinylidene difluoride) mem-
brane using borate blot buffer [50 mM sodium borate pH 8, 
20% (v/v) methanol, 002% (v/v) mercaptoethanol]. The blot 
was stained with Coomassie blue, and the bands excised. The 
first 20 amino acids were sequenced from this membrane by 
Edman degradation at the microchemical facility, IAPGR, 
Babraham, Cambridge, UK. 
RESULTS 
Library screening 
The genomic library of M. a. paratubercn!osis (strain 
JD88/107) constructed in bacteriophage lambda gtll was 
shown to contain 8 x 10 individual phage. Subsequent 
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Fig. 1. Western blot demonstrating relationship between 54 
fusion protein and a 34 kDa protein in M. a. paratuberculosis. 
Lane 1, pMS1S/54 fusion protein probed with sheep serum 
JD87/39; lane 2, M. a. para tuberculosis lysate probed with 
JD87/39 antibody eluted from pMS1S/S4 fusion protein; lane 3, 
M. a. paratuberculosis lysate probed with sheep serum JD87/39; 
lane 4, M. a. para tuberculosis lysate probed with mAb 5.8 
raised against pMS1S/54 fusion protein. M, Molecular mass 
mnarkers stained with Ponceau S (Sigma). 
amplification in E. co/i Y1088 yielded a plate stock of 
101 p.f.u. ml. The amplified library contained 65% 
recombinants with an average insert size of 4 kb. Stat-
istical analysis showed this library to be representative of 
the M. a.paratubercu/osis genome (Old & Primrose, 1989). 
Approximately 125000 plaques were screened with anti-
serum JD87/40 obtained from a sheep with naturally 
acquired Johne's disease and eight recombinant clones, 
designated SI to S8, were isolated. The DNA inserts from 
two of these recombinant phage (S4 and S8) were 
subcloned into the plasmid vector pMSI S and the encoded 
antigens expressed in B. co/i as /J-galactosidase fusion 
proteins. 
Due to the random generation of DNA fragments during 
library construction, recombinant clones often contain 
only part of an open reading frame (ORF) and, conse-
quently, express only a part of the bacterial antigen. 
Therefore, the size of the M. a. paratuberculosis protein 
encoded by the clones was determined by an antibody 
elution procedure. Western blots of S4 and S8 fusion 
proteins were incubated with serum from a sheep 
(JD87/39) with clinical paratuberculosis that had been 
shown previously to recognize both clones. Specific 
antibody bound by the fusion proteins was eluted and 
used to probe a Western blot of M. a.paratubercu/osis lysate 
(Fig. 1). Antibodies eluted from both S4 and S8 fusion 
proteins detected a 34 kDa protein in M. a.paratiibercu/osis, 
and also recognized the reciprocal fusion protein after 
absorbing with fl-galactosidase. 
Sequencing of DNA inserts 
DNA sequencing revealed that both the S4 and S8 clones 
contained the same C-terminal portion of a gene encoding 
a predicted protein of 210 amino acids. The S8 clone also 
contained a further 480 bp upstream of this region, and 
was thought to represent the complete gene. This 
contained a possible Shine—Dalgarno sequence (AGGA- 
10 SD 	 30 	 50 
CCCCCCACCCACGA000TCACGGCATCACCAAATCCCACCACCACCCCTCCCTCTCCTGG 
N S K S H H HR S V V V 
70 	 90 	 110 
TCATCGTTGCTCCCTGTCCTCACCCTCGTCGGCCTGGCCCTCC000TCCCCTCCCCCCTG 
SW L 	CV L TV V CL C LC LOS G V 
130 150 	 170 
CCGCTCCCCCCCCCOTCCCCCCCACCCTCGCGCCTCCCGCTGGACCGCTTCCCCCATCCC 
O L A P A 	AAA P S C L A L D R F A D K 
190 	T T 	210 	 230 
C CCC TCC CCCC GATC CACC COT CCGC CATCC TCCCT CAGGTC GCCCCC CAAOTC CT CAAC 
P LA P1 D P S A N V C Q V CF Q V V N 
1 250 	 270 	 290 
ATC CACAC CAACTTC CC C TACAACAACG CCC TCCGCCCCC CTAC CCC CATC CTCATCCAC 
TOT K F C Y N N A V CA CT C I V ID 
310 	 330 	 350 
CC CAAC CCC CTC C TO C TCAC CA.ACAACC ACCT CATCTCCCCCCC CAC CCAAATCAG CCCC 
P N C V V L I N NV I S C A T E I S A 
370 	 390 	 410 
TTCCACCTCCCCAACCCCCACACCTACCCCCTCGACCTCCTCCCCTATGACCCCACCCAG 
F DV ON C Q T Y A V DV V C Y DR. I Q 
430 	 450 	 470 
CACATCOCCCTCCTCCACCTCCCCCCCCCCCCCCCCCTCCCCACCCCCACCATCCOCCCC 
	
AV L 	L RCA AOL PTA TIC C 
490 	 510 	 530 
CACCC CACCCTC CCC CACCC CATC CI CC CCC TTCG CAAC CT CCC CCCC CA000C CC CAC C 
EAT V CE P1 V AL ON V CC Q COT 
550 	 570 	 590 
CCCAACCCCCTOCCCCCCAACCTCCTCCCCCTCAACCACACCCTCTCCCCCACCGACACC 
P N A VA 0KV V AL N Q S V SAT 13 T 
610 	 630 	 650 
C TOAC C CC COCC CAC CACAACCTCCCC CCC CTCATC CACCCC CACCCCC CCATCAAGC CC 
LT GA Q EN L CCLI Q AD A P1K P 
670 	 690 	 710 
CCC CACTC CCGTC C CCC CATGCT CAACAC CCC CCCC CAG CTCATCGCC CTGCACACCC C C 
C DJO G PH V N SAC Q V IC V D TA 
730 	 750 	 770 
OCCACCCACACCTACAACATCTCCCCC000CACCCCTTCGCCATCCCCATCCCCCCCCCC 
AT D S YKH S CC Q CF Al P1 C RA 
790 	 810 	 830 
ATOCC CCTCCC CAAC CACATC CC CTCCCC CC C CCCCTC CAACACCCTC CACATCCCCCCC 
HAVAN Q IRS CAC S N T V H lOP 
850 	 870 	 890 
ACCCCATTCCTCCCGCTGCCCCTGACCGACAACAACCCCAACCCCGCGCCGCTCCACCCC 
TA F LC LC VT D N N C NC AR V Q R 
910 	 930 	 950 
CTCGTCAACACCCGCCCOCCCCCCCCCCCCCCCATCCCGCCCCCCCACCTCATCACCCCC 
V V NT C P A AA A CIA POD VITO 
970 	 990 	 1010 
CTCCACACCCTCCCCATCAACGCCCCCACGTCCATCACCCACCTCCTCCTCCCGCACCAC 
V DIV P1 NGATSHT E 	L 	P H H 
1030 	 1050 	 1070 
CCCCGTCACACCATCCCCCTCCACTTCCCCTCCCTCGACCCCCGCGACCGCACCCCCA.AC 
POD TI A VHF K S V DCC ER TAN 
1090 	 1110 
ATCAC C CTCC CO OAC CCC C CCC CCC C CTCA 
I T L A E G P PA* 
Fig. 2. Nucleotide sequence of the DNA inserts of clones S4 and 
58, encoding the 34 kDa protein of M. a. para tuberculosis. The 
deduced amino acid sequence is shown in single-letter code. 
The putative Shine-Dalgarno sequence (SD) is underlined. The 
N-terminus of the native protein is marked by f and 
underlined. Possible signal cleavage sites after amino acids 37 
and 39 marked by 9 . The histidine, aspartate and serine 
residues homologous to those in the HtrA proteins are boxed. 
This sequence has been assigned the EMBL accession number 
Z23092. 
GGG) and start codon (ATG) preceding a single ORF of 
1083 bp encoding a predicted protein of 361 amino acids 
(Fig. 2). The first 40 amino acids of this sequence were 
highly hydrophobic, suggesting the protein may contain a 
leader or signal sequence which is removed after trans- 
lation. 
Database searches using the complete deduced amino acid 
sequence were run on SEQNET at the SERC Daresbury 
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computing facility. A SWEEP search (Akrigg etal., 1988) 
of the OWL protein database (Bleasby & Wootton, 1990) 
identified four bacterial proteins, the HtrA proteins of B. 
co/i (Lipinska etal., 1988), Salmonella tjphimurium (Johnson 
et al., 1991), Bruce/la abortus (Roop et al., accession no. 
L09274) and Rochalimaea henselae (Anderson et al., ac-
cession no. L20127), which displayed 30% homology to 
the probe sequence. A MOTIFS search using the PRO-
SITE dictionary (Bairoch, 1991) detected a motif 
'GDSGG' at amino acid position 213-21 7, which showed 
100% homology to the residues surrounding the active 
serine in a trypsin-like serine protease. 
Purification of native protein 
The native 34 kDa protein identified by antibody elution 
was purified from lysates of M. a. paratuberculosis on an 
affinity column that was prepared using a monoclonal 
antibody (mAb 5.8) raised against S4 fusion protein. This 
monoclonal antibody also recognized the 34 kDa protein 
on Western blots of M. a. paratuberculosis (Fig. 1). Both 
eluted antibody and mAb 5.8 detected a second band of 
90-100 kfla on Western blots of M. a. paratuberculosis 
lysate (Fig. 1). This 90-100 kDa protein is unlikely to be 
a dimer/trimer, due to the reducing conditions of the gel; 
and other studies (unpublished results) suggest that the 
reaction is due to a cross-reactive epitope. Approximately 
40 jig of pure 34 kDa protein was recovered from I g  (wet 
wt) of Al. a. paratuberculosis. The N-terminal sequence of 
this protein was derived by Edman degradation, and was 
found to be identical to amino acids 55-74 of the S8 
deduced protein sequence (Fig. 2). 
DISCUSSION 
This paper describes the identification and characteriza-
tion of a putative serine protease expressed in vivo by M. a. 
paratuberculosis. The protein was encoded by two over-
lapping clones, which were extracted from a lambda gil I 
genomic expression library of M. a. paratuberculosis by 
screening with serum from a naturally infected sheep. The 
isolated clones therefore were known to encode a 
mycobacterial protein expressed in vivo which was also 
involved in the ovine immune response to infection with 
M. a. paratuberculosis. 
Genes encoding 34 kDa proteins have been described in 
both M. a. paratuberculosis (De Kesel et al., 1993) and M. 
tuberculosis (Barnini et al., EMBL accession no. X69463). 
Comparison of the previously described M. a.paratubercu-
losis 34 kDa protein with S4 and S8 fusion proteins by 
reciprocal reactions with polyclonal antisera and mono-
clonal antibodies failed to demonstrate any relationship 
between them (unpublished results). This lack of hom-
ology has been confirmed further by the absence of any 
homology between the recently published genomic se-
quence (Gilot et al., 1993) and that obtained from S8. 
Similarly, no homology was detected between the S8 
clone and the nucleotide sequence of the M. tuberculosis 
34 kDa protein. The gene contained in the S8 clone 
therefore has not been described previously in any of the 
Mjicobacteriaceae. 
The deduced amino acid sequence of the S8 clone contains 
a highly hydrophobic N-terminus. This is characteristic of 
a signal peptide, and two possible signal cleavage sites of 
Ala-X-Ala are situated at positions 35-37 and 37-39 in the 
protein. The first of these, Ala 35-Pro 36-Ala37 , can be 
dismissed, as proline is a 'forbidden' residue and cannot 
be part of a signal cleavage site (von Heijne, 1984). 
Cleavage after Ala 37 -Set 38-A1a39 is more likely, but leaves 
a sequence of 15 amino acids between the cleavage site and 
the N-terminus of the protein as determined by Edman 
degradation. It is doubtful that the entire peptide of 54 
amino acids would be cleaved after Arg 52-Pro53-Leu 54 , as 
these residues will not be recognized by a signal peptidase 
(von Hei)ne, 1984). The 15 amino acid sequence may have 
been removed during purification of the native protein, as 
elution was performed in 01 M glycine pH 23, which 
may have resulted in hydrolysis of the protein before 
dialysis against Tris pH 8. However, it is also possible 
that the protein contains a pro-peptide of 15 amino acids 
which, although shorter, is similar to that observed with 
the alpha-lytic serine protease of Ljisobacter enjimogenes 
(Epstein & Wensink, 1988). Both the signal peptide of 39 
amino acids and the pro-peptide of 15 amino acids would 
then be removed during post-translational modification 
and possible secretion of the protein. 
Database searches have shown the S8 protein to resemble 
most closely a trypsin-like serine protease. This class of 
protease has been well characterized in eukaryotes, and X-
ray crystallography has revealed the active site to be 
comprised not only of serine, but also of histidine and 
aspartate, due to the three dimensional structure of the 
molecule. The classical trypsin active site triad is His 57 
Asp io 2  Ser195 , and any protein matching this pattern 
may be regarded as a potential serine protease (Neurath, 
1989; Dunn, 1989). Although the S8 protein contains a 
motif that completely matches the trypsin serine active 
site (amino acid position 215), no corresponding histidine 
and aspartate residues occur at positions 77 and 122. The 
absence of any significant homology with trypsin, ex-
cluding the serine active site, suggests the S8 protein is 
not a form of trypsin. However, other serine proteases 
such as subtilisin maintain the His-Asp-Ser components 
of the active site, despite differing from trypsin in both 
amino acid composition and tertiary structure (Neurath, 
1989). Thus the active serine in the conserved motif in the 
S8 protein may combine with a histidine and aspartate 
residue elsewhere in the sequence to form the electro-
statically important active site. 
Further evidence for the S8 protein being a serine protease 
was provided by homology with four possible bacterial 
serine proteases: the HtrA proteins of B. co/i (Lipinska et 
al., 1988), S. typhimurium (Johnson etal., 1991), Br. abortus 
(Roop et al., OWL accession no. L09274), and R. hense!ae 
(Anderson et al., OWL accession no. L20127). As these 
proteins have been described only recently, there are as 
yet no X-ray crystallographic data, and their active sites 
are not well defined. However, an endopeptidase activity 
of the B. co/i HtrA has been reported recently (Lipinska et 
al., 1990). Although only 30% homology exists between 
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Fig. 3. Partial homology of the deduced 
amino acid sequences of the 58 protein and 
the HtrA proteins of Escherichia co/i, 
Salmonella typhimurium, Bruce/la abortus 
and Rochalimaea henselae. Black boxing 
indicates complete identity; shaded boxing 
represents conserved amino acids. Active 
histidine, aspartate and serine are marked 
*. 
higher degree of homology (50-80%) is observed at three 
sites,, containing histidine, aspartate and serine respect-
ively (Fig. 3). The high conservation of amino acids at 
these three sites suggests that they probably represent the 
three important active residues which are brought to-
gether to form the active site of the protease. 
The native 34 kDa protein is highly immunogenic in 
infected sheep, goats and deer. Western blots have shown 
the S4 recombinant fusion protein to be recognized 
strongly by serum from 8/14 (57 %) sheep, 2/2 goats, and 
3/3 deer with clinical Johne's disease. The other six sheep 
reacted weakly (unpublished results). Although this 
protein appears to be important in the immune response 
to M. a. paratuberculosis infection, only 40-50 jig is 
recovered from I g of M. a. paratubercu/osis cells grown in 
vitro. The HtrA proteins of B. co/i and S. tjvphirnurium have 
been shown to be stress proteins (Lipinska et al., 1989; 
Johnson et al., 1991), induced by heat shock and oxidative 
stress respectively. In vivo, mycobacteria undoubtedly are 
exposed to several types of stress during intracellular 
growth, and it is possible that, as with other HtrA 
proteins, levels of expression of the 34 kDa protein may 
increase under these conditions. During less stressful 
growth in vitro the protein may be rapidly degraded 
intracellularly, or its expression accordingly down-regu-
lated. This would account for the poor yield observed 
during the purification of the native protein from 
organisms grown in vitro. 
Serine proteases have not been described previously in the 
Mjcobacteriacae, and possible functions of the 34 kDa 
protein are speculative. However, recent reports suggest 
that serine proteases are important components of the 
pathogenic mechanisms of other intracellular micro-
organisms. Plasmodium fa/ceparurn is thought to use a 
serine protease to gain entry into red blood cells during 
the blood-borne stage of malaria (Braun Breton & Pereia 
da Silva, 1993). The P. fa/ciparurn gp76  and Plasmodium 
chabaudi gp68 appear to be serine proteases which specifi-
cally degrade the erythrocyte band 3 protein, thereby 
altering the erythrocyte cytoskeleton, and allowing entry 
of the parasite. 
The HtrA serine protease of S. tjphimuriurn also has been 
linked with virulence of the intracellular pathogen. 
Mutants with the transposon TnphoA inserted in the 
protease gene show a decreased ability to survive oxi-
dative stress, similar to the killing mechanisms employed 
by macrophages (Johnson et al., 1991). This protein 
therefore may be important in allowing the organism to 
survive and replicate in this usually hostile environment. 
M.a. paratubercsi/osis also is an intracellular pathogen, 
which persists and replicates in macrophages, and the 
mechanisms by which it evades killing within these cells 
are currently unknown. If, however, the native 34 kDa 
protein uses the same physiological substrate as the S. 
typhimurium serine protease, the two proteins may perform 
a similar function that contributes to the intracellular 
survival of these pathogens. 
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Summary 
A lambda gtll geno!nic library of a deer isolate of M. paratuberculosis was screened with serum from 
a sheep with Johne 's disease. A number ofclones were identified, two ofwhich were selectedforfurt her 
study after being found to contain overlapping fragments of the same gene. Antibody elusion studies 
showed these clones to correspond to a 34kDa protein in M. paratuberculosis. Both clones have been 
fully sequenced and were found to contain an open reading frame of I 083bp, translating to a protein 
of361 amino acids. The sequence also contained a possible Shine Dalgarno sequence, start codon, and 
appeared to code for a signal peptide of39 amino acids, andapro-peptide of 15 amino acids-4 Ithough 
the amino acid sequence showed no great overall homology to any previously described protein in the 
E'\IBL database, it did contain a motif (GDSGG) corresponding to the active serine residue in a 
chvmotrvpsin-like serine protease, in which His 57 and Ser' 9' are brought together to form the three 
dimensional active site of the protease. A similar organization can be found in the M. paratuberculosis 
34kDa protein ('His' 02 asp' 33 Ser"). These three sites, however, show a greater homology ('over 70%) to 
those detected in the Htr.4 proteins ofEscherichia coil (His" Asp"" Ser"6). Salmonella typhimurium 
(His 132  Asp' 62 Seri"), and Brucella abortusfHis "2 Asp'3' Ser"), than to the sites in chymnotrvpsin. These 
HtrA proteins are thought to be serine proteases, and these three homologous Sites mavfor,n the three 
dimensional active site of the enzyme. The native 344-Da protein has been affinity-purified using 
monoclonal antibodies, and the ,V terminal sequence of the protein matched the deduced amino acid 
sequence of the two genomic. clones. Experi,m:e,its are underway to determine any proteoivtic activity 
of the native protein. 
Introduction 
The mechanisms of pathogenesis in paratuberculosis are poorly understood, due in part to our 
lack of knowledge of the organism, Mycobacterium paratitberculosis, and its interaction with the 
ruminant host. Our study has therefore focused on identifying M paratziberculosis genes and gene 
products which are involved in the bacterium-host interaction, particularly those proteins which are 
immunogenic in the natural ruminant host, and which may be involved in pathogenesis. 
Isolation and Identification of Clones 
A lambda gt 11 genomic expression library ofM. paraluberculosis was screened with serum from 
a sheep with clinical Johne's disease. The clones detected therefore were known to be involved in the 
hosts immune response to infection. Two of the clones designated S4 (1.8kb) and S8 (3kb) were shown 
by Southern blotting and antibody elution (1) to contain overlapping fragments of a gene encoding a 
34kDa protein in M. paratuberculosis. The two DNA inserts were subcloned into the pMS I S vector, 
which allowed expression of the recombinant proteins as fusions with B-galactosidase. After induction 
with isopropyl thiogalactopyranoside (IPTG) for 4h, E. coli containing the fusion protein were lysed in 
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a French pressure cell, and the resulting lysate clarified at 100 000g. The S8 fusion protein was iflSoIUbt 
and could not be purified further. The S4 fusion protein was purified on a column of aminoben, 
thiogalactopyrano side (ABTG) agarose, and inoculated into Balb/c mice to produce monocl onal  
antibodies (Mabs) that recognized both S4 and S8 fusion proteins, and the 34kDa protein in lysates °fAi 
paraizibercu/osis. 
Purification of Native Protein 
Mab hybridoma cells were used to produce ascitic fluid in 2 Balb/c mice. IgG was purified on a 
column of Protein A sepharose and coupled to activated sepharose to produce a Mab affinity Column for 
the purification of the native protein from M paratuberculosis. Eaton-pressed (2) lysates of M 
paratuberculosis were mixed with the Mab affinity column overnight at 4°C and, after washing, the 34kDa 
protein was eluted with glycine pH 2.3 and dialysed against TrisfHCl pH 8.0. The first 20 NH, terminal 
amino acids of the purified native protein were sequenced from western blots by Edman degradation 
Sequencing and Sequence Analysis 
Both strands of DNA from the S4 and S8 clones were sequenced by the Sanger dideoxy chain 
termination method (3). dCTP labeling mix and 35 S dCTP-cc-S were used to achieve better incorporation 
into the GC-rich DNA. The sequence enzyme was used at a 1:4 dilution, and reactions were run on 
formamide sequencing gels to reduce compressions in the sequence. 
The S8 clone was found to contain the entire gene of I 083bp (EMBL Accession number Z23092), 
as well as a possible Shine Dalgarno sequence and start codon. The deduced amino acid sequence matched 
exactly the sequence derived from the native protein by Edman degradation. However, this match was 
from amino acid position 55-74, which is not the predicted NH, terminus of the clone. The first 40 amino 
acids of the deduced amino acid sequence are highly hydrophobic and characteristic of a signal peptide. 
There is also a possible signal cleavage site of Ala-X-Ala (4) at position 3 7-39, suggesting this is a secreted 
protein in'which the signal peptide is removed after translation. A sequence of 15 amino acids still remains 
between this cleavage point and the NH  terminus of the native protein. This sequence may be some form 
of pro-peptide which is also removed post-translationally to yield the sequence derived by Edman 
degradation. 
Database searches using the deduced amino acid sequence were run on SEQNET at the SERC 
Daresbury computing facility, and detected 30% homology with 4 bacterial proteins; the HtrA proteins 
of Escherichia co/i (5), Salmonella lyphimurium (6), Bruce/la abortus (7), and Rochaliniaea henselae 
(8) (Figure 1). A motif GDSGG also was kietected which showed 100% homology with the residues 
surrounding the active serine in a trypsin-like serine protease (9). The HtrA proteins all contain this motif, 
and are indeed thought to be serine proteases, although proteolytic activity has been demonstrated only 
by the E. coil HtrA (10). 
Serine Proteases 
The active site of a serine protease requires two other essential constituents to endorse the 
molecule with proteolytic activity. In trypsin, these are His 57 and Asp 102,  which combine with Ser' 95 on 3-
dimensional folding to form the charge relay system required for proteolysis of peptide bonds. As these 
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are essential constituents of 
the molecule, they must be 
conserved, and therefore 
E.CoIi VVTNNHVVONASVIKV-QLSDGR.KFDAJoVCKDpRSDtALIQIQHpKN -LTAIMADSDA should be found in the HtrA 
S.typhimurium VVTNN11VVDNATVIKV-QLSDCRKFDAKVVCKDPRSDIALIQIQNPKNLTAILADsDA proteins if they are to be ac- 
B abortus VVTHNHVVSDGDAYTV-VLDDGTELDAJ(LIGADPRTDLV1J(INAPYJJ(FVYSPTITR 
• hense lae IVTNNHVISDCTSYAV-VDDGTELNAKLIGTDPRTDLAVKVNE KRKFSYVDFCDDSK tive. 	Indeed, 	although the 
n. ptb VLTflWISCATEISAFDVCNCQTYAVDVVCYDRTQDIAVLQLRCGLPTATIGGEAT 
.* * overall homologybetween the 
M. paratuberculosis clone 
E.cOlt LRVCDYTVCIGNPrGLGET --- VTSIVSALGRSCLNAE-------NYEHFIQTDA-INRc and the HtrA proteins is only 
s. typhirnurium LP.VCDYDVAIGNPFGLCET --- VTSIVSALGRSCLNVE-------NYENFIQTDA- xmc 
CDVCDWVVAVCNPFGLCGT 	VTSGIVSARCADICAC 30%, this rises to 50-80% in B.abortuS --- 	 ------- PYDDFIQIDAAVNKC 
a. Ptense lae LR'1CD'VAICNPFGLGGT - - VTAC IVSARCRDIGTG-------VYDDFIQIDAAVNRG three specific areas of the Se- n. ptb -VCEPIVALCNVCGQGGTPHAVACKVVALNQSVSATDTLTGAQENLGGLIQADAPIPC 
quence, containing His, Asp, 




- NSCCALVNLNCELICINTAILAPDCGNICIGFAIPsNWJKNLT- I). Hence, the high conserva- 
B. abortus NSCGPAFDLSGEVIGINTAIFSPSGCTVCIAFAXPSSTAKQVVD tion of amino acids at these a. henselae NSCGPTFDLNCKVVGVNTAiFSPSCC?4VCIAFAIpAJ1TANEVVQ 
M.ptb DSCGPMVNSAGQVIGVDTAAThSYKNSCCQCFAIPICRAMAVA three sites suggests they prob- 
ably represent the three im- 
portant active residues which 
Figure 1. Homology of serine protease between different bacterial proteins, are brought together to form 
the active site of the protease. 
Serine proteases have not been described previously in the mycobacteriacae, and possible 
functions of this 34kDa protein are speculative. However, serine proteases have been shown in other 
intracellular organisms to be involved in pathogenesis. Plasmodiumfalciparum uses a serine protease 
to gain entry into erythrocytes during the blood-borne stage of malaria (11), and the HtrA protein of S. 
lyphimurium (which shares 30% identity with the M. paratuberculosis 34kDa protein) is thought to 
contribute to the intracellular survival of the pathogen, as mutants with insertions in the gene show a 
decreased ability to survive oxidative stress (6). This protein therefore may be important in allowing the 
organism to survive and replicate in the usually hostile environment of a macrophage. 
M. paratubercu/osis also is an intracellular pathogen, which persists and replicates in macroph-
ages, and the mechanisms by which it evades killing within these cells currently are unknown. If, however, 
the native 34kDa protein performs the same function as the S. typhimurium HtrA, it also may be 
contributing to the intracellular survival of the pathogen. 
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